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ABSTRACT
The effect of temperature stress on profiles of LH and FSH from pitui­
tary cells; aldosterone, progesterone, cortisol and corticosterone from 
adrenocortical cells; and estradiol and progesterone from granulosa 
cells were evaluated using bovine anterior pituitary, adrenocortical 
and granulosa cells in primary cultures. Cells were grown to confluen- 
cy in a 37°C humidified incubator containing 95% 02 and 5% C02. Upon 
reaching confluency, half of the wells were assigned to 40°C incubation 
temperature while the other half remained at 37°C. The 37°C tempera­
ture represented control conditions whereas 40°C represented heat 
stress. Various biological .substances, that have been reported to 
alter hormone production, were added primarily to determine interac­
tions with incubation temperature.
The effect of temperature on LH release by unstimulated pituitary 
cells, after 24 hr at the higher incubation temperature, varied from 
one of no effect to lower LH secretion. The 40°C incubation tempera­
ture decreased the LH response to GnRH stimulation. Levels of LH 
stored in the cells were not consistently related to incubation tempe­
ratures. LH concentration in the media was lower for 3-endorphin 
treatment at 40°C than at 37°C. This difference was more evident when 
GNRH and estradiol were added to the media. No FSH was detected in the 
incubation media with the assay available. Thus, it appears that heat 
stress decreases the responsiveness of the gonadotrophs to GnRH 
stimulation.
xvii
The 40°C incubation temperature depressed aldosterone production by 
adrenocortical cells. The effect of temperature on progesterone pro­
duction varied from one of no effect to an increase at the higher in­
cubation temperature. Cortisol profiles were also varied from one of 
no effect to an increase or decrease at the higher incubation tempera­
ture. Temperature had no effect on corticosterone levels.
In the ovarian experiment the profiles of estradiol and progesterone 
varied from no effect of temperature on estradiol and progesterone 
secretion, to an increase in estradiol and progesterone secretion at 
the higher incubation temperature, and to a decreased production of 
estradiol at the 40°C temperature.
xviii
LITERATURE REVIEW
An animal's environment is affected by climatic factors that include 
temperature, humidity and vind. Extremes in climate alter energy 
transfer between the animal and its environment and can deleteriously 
affect reproduction. Environmental alterations that lead to reduced 
reproductive efficiency are proposed to be the result of stress 
(Gwazdauskas 1985). Since the pituitary-adrenal axis responds directly 
to stress, it seems logical to test the effects of heat stress on the 
hormones associated with this system in order to gain a greater insight 
into its adverse effects on reproduction.
PITUITARY GLAND
The hypophysis is composed of an anterior and a posterior lobe, sepa­
rated by a cavity. The pars tuberalis and pars distalis constitute the 
anterior lobe or anterior pituitary. The pars intermedia and the in­
fundibular process constitute the posterior lobe or posterior pituitary 
(Granner 1985).
The release (and in some cases the production) of each of the pituitary 
hormones is under tonic control by at least one hypothalamic hormone. 
The hypothalamic hormones are released from the hypothalamic nerve fi­
ber endings around the capillaries of the hypothalamic-hypophyseal sys­
tem .in the pituitary stalk and reach the anterior lobe through the spe­
1
cial portal system that connects the hypothalamus and the anterior 
lobe. The hypothalamic hormones are released in a pulsatile manner 
(Granner 1985).
THE GONADOTROPINS
Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) are 
glycoprotein hormones composed of two noncovalently coupled a- and 
8-subunits. Two asparagine-linked complex oligosaccharide units are 
attached to the a-subunit and one to the 8-subunit (Catt and Pierce, 
1978). The carbohydrates of the complex oligosaccharide units usually 
include glucosamine, galactosamine, mannose, galactose, fucose, and 
sialic acid. Some sugar terminals exist as sulfated hexosamines 
(Pierce and Parsons, 1981).
Immunohistochemical staining techniques have been used to characterize 
the distribution of the gonadotropes. Evaluation of serial sections 
has demonstrated that the gonadotropes are not evenly distributed. In 
the cow, they predominate in the anteriomedial region and appear to be 
continuous with, and an extension of, the pars distalis (Brown and 
Reeves, 1985). Pituitaries were collected from luteal phase cows at 
slaughter. It was then determined that differences existed among re­
gions of the adenohypophysis with regards to the concentrations of LH, 
FSH, and receptors for GnRH. Receptor and gonadotropin concentrations 
were greatest in the anterior lobe.
Biosynthesis of Gonadotropins
3
The biosynthetic pathway for the gonadotropins is thought to involve 
transcription and translation of separate mRNAs for the a- and 3- 
subunits, a cotranslation core glycosylation in which mannose-rich 
oligosaccharide units are attached to specific asparagine moieties, and 
a posttranslational terminal glycosylation in which some of the mannose 
residues are trimmed, followed by sequential addition of the outer ter­
minal sugars (Chappel et al., 1983; Hussa 1980).
Release of Gonadotropins
The major release of LH and FSH from the gonadotropes occurs at estrus 
(Hansel and Convey, 1983). This release is controlled by the concen­
tration of GnRH. GnRH is primarily controlled by circulating levels of 
gonadal hormones that reach the hypothalamus. GnRH acts directly on 
the anterior pituitary to affect gonadotropin release through a cal- 
cium-phospolipid-dependent mechanism. GnRH also has the ability to 
prime the anterior pituitary gland, thereby increasing the quantity of 
LH and FSH released by a standard dose (Crighton and Foster, 1977). 
The capacity to release LH in response to GnRH is greatest during es­
trus and least during the luteal phase of the estrous cycle (Convey 
1973).
4Follicle-Stimulating Hormone
The target cells for FSH are the follicular cells of the ovary and the 
Sertoli cells of the testis. FSH binds to specific receptors on the 
membranes of its target cells. This results in activation of adenylate 
cyclase and increased cAMP production. In the female, FSH promotes 
follicular growth, prepares the follicle for ovulation-inducing action 
of LH, and enhances the LH-induced release of estrogen (Cheesman 1982).
Levels of FSH vary throughout the cycle. During the immediate post- 
estrous period, when ovarian steroid concentrations in blood are rel­
atively low, FSH increases in the absence of any increase in LH. This 
rise in FSH may be due to removal of the negative feedback effect of 
inhibin when its source is destroyed by ovulation (Hansel and Convey, 
1983).
Luteinizing Hormone
LH is the major luteotropic hormone in the cow. The biological activi­
ty of LH is probably due to the carbohydrate moiety (Sairam and 
Schiller, 1979). The removal of the carbohydrate moiety from the gly­
coproteins has led to a reduction in steroidogenic properties following 
receptor binding (Horell et al., 1971; Nwokoro et al., 1981).
Most evidence suggest that LH exerts its steroidogenic effects on lu­
teal tissues by increasing adenylate cyclase and cAMP (Marsh et al., 
1966; Hansel 1967). LH binds to specific plasma membrane receptors and
stimulates the production of adenylate cyclase and cAMP. Protein ki­
nase activation occurs and phosphorylation of steroidogenic enzymes and 
enhanced protein synthesis follows. A portion of the LH bound to the 
receptor is internalized and degraded. LH receptors are recycled via 
secretory granules and incorporated into the plasma membrane by exo- 
cytosis, thus maintaining the full complement of LH receptors
(Niswender et al.r 1981).
LH is secreted in a pulsatile fashion during the estrous cycle in the 
cow. Frequency and magnitude of LH pulses change with steroid hormone 
secretion, i.e., low frequency, high amplitude when progesterone is 
present and high frequency, low amplitude under estrogen dominance 
(Rahe et al., 1980).
In-Vitro System Utilizing Anterior Pituitary Cells
Much work has been done utilizing pituitary cell cultures to elucidate 
the effects of the ovarian steroids on the secretion of the gonadotro­
pins. Padmanabhan et al., (1978) investigated the effects of estradiol 
on basal and LH-releasing hormone (LHRH)-induced release of LH from 
bovine pituitary cells in culture. LHRH increased LH release relative 
to controls. Acute exposure (2 hr) of the cells to estradiol did not 
affect LH release. However, chronic exposure (26 hr) increased basal 
LH .secretion. Acute, but not chronic, exposure to high levels of 
estradiol inhibited LHRH-induced LH release.
Using an ovine pituitary culture system, Huang and Miller, (1980) also
investigated the effects of estradiol on basal and LHRH-induced se­
cretion of LH and FSH. Estradiol decreased basal F5H secretion but 
increased basal LH secretion. Both LHRH-induced FSH and LH release 
were enhanced by estradiol.
Kamel et al., (1987) showed that LH secretion is pulsatile and that LH 
pulse characteristics are affected by the prevailing steroid environ­
ment in perfused rat anterior pituitary cells. Blank et al., (1986) 
showed the inhibitory effects of the endogenous opioids on LH release 
using cultured rat pituitary cells.
THE PRO-OPIOHELANOCORTIN (POHC) PEPTIDE FAMILY
The POHC family consists of peptides that act as hormones (adrenocorti- 
cotropin hormone (ACTH), lipotropin hormone (LPH) and melanocyte stimu­
lating hormone (MSH) ), and others that serve as neurotransmitters or 
neuromodulators (endorphins). POMC is synthesized as a precursor mo­
lecule consisting of approximately 285 amino acids and is processed 
differently in various regions of the pituitary. Processing of POMC 
gives rise to (1) ACTH, which can give rise to MSH and corticotropin­
like intermediate lobe peptide (CLIP) and (2) fi-LPH which can yield 
y-LPH and p-endorphin (Granner 1985).
About 5% of the cells in the anterior pituitary gland secrete POHC. 
Corticotropin-releasing hormone (CRH) is the major factor controlling 
POHC release from the anterior pituitary. Hinor effects on anterior
lobe POMC (ACTH) secretion include direct stimulation by antidiuretic 
hormone (ADH), (Granner 1985).
Adrenocorticotropic Hormone (ACTH)
ACTH is a single-chain polypeptide consisting of 39 amino acids. It 
regulates the growth and function of the adrenal cortex. The 24 N- 
terminal amino acids are required for full biologic activity and are 
invariant between species.
ACTH increases the synthesis and release of adrenal steroids by en­
hancing the conversion of cholesterol (C27) to pregnenolone ($21)' 
This step involves the cleavage of a 6-carbon side chain and is the 
rate limiting step in steroid biosynthesis. ACTH stimulates the cho­
lesterol side-chain-cleavage reaction within a matter of seconds. 
Pregnenolone is the precursor of all adrenal steroids (Kramer et al., 
1983).
Regulation of ACTH production from POMC precursor protein is through a 
negative feedback loop that involves glucocorticoids and CRH. Exces­
sive levels of ACTH may also inhibit CRH production through a short 
loop. The central nervous system is also primarily involved in the re­
gulation of ACTH production and secretion through a variety of neuro­
transmitters (Granner 1985).
8ADRENAL GLAND
The mammalian adrenal glands consist of 2 glands: the cortex and the
medulla. These have different embryologic origins and produce dif­
ferent kinds of hormones. The cortex has 3 distinct zones. The sub- 
capular area is called the zona glomerulosa and is associated with the 
production of mineralocorticoids. Next is the fasciculata, which, with 
the zona reticularis, produces glucocorticoids and androgens (Granner 
1985).
ADRENAL HORMONES
Some 50 steroids have been isolated and crystallized from adrenal 
tissue. Most of these are intermediates with only a small number being 
secreted in significant amounts. Only a few have significant hormonal 
activity. The adrenal cortex makes 3 general classes of steroid hor­
mones, which are grouped according to their predominant action. The 
glucocorticoids are 21-carbon steroids. Cortisol is the major gluco­
corticoid in cattle, and is made in the zona fasciculata. Mineralocor­
ticoids are also 21-carbon steroids. Aldosterone is the most potent 
hormone in this class and is made exclusively in the zona glomerulosa. 
Sex steroids are also produced by the adrenal gland but are not pro­
duced in significant amounts except in abnormal conditions. There is 
little, if any, storage of steroids within the adrenal cell, since 
these hormones are released into the plasma when they are made (Granner 
1985).
Biosynthesis of Adrenal Hormones
Figure 1: Biosynthetic pathvay of adrenal steroids
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Preformed cholesterol is the primary substrate for steroid biosynthe­
sis. Cholesterol is synthesized to some extent within the endocrine 
glands, but the formation of steroids occurs largely from cholesterol
produced at other sites and taken up by the endocrine glands (Chatter-
ton 1982). Cholesterol is transported in the blood in lipoprotein 
complexes. The uptake of low-density lipoproteins by cells that uti­
lize cholesterol is a regulated process involving specific membrane 
receptors (Chatterton 1982).
The pathway in the adrenal cortex leading from cholesterol to the ad­
renal steroids involves several different forms of cytochrome P-450 
(Fig. 1). Cholesterol in the adrenal is esterified and stored in 
cytoplasmic lipid droplets. Upon stimulation of the adrenal by ACTH, 
an esterase is activated, and the free cholesterol formed is trans­
ported into the mitochondrion where a cytochrome P-450 side-chain
cleavage (P-450 ) converts cholesterol to pregnenolone (Yago et al.,see
1970). Cytochrome P-450 is an integral protein of the inner mito- 
chondrial membrane. Cleavage of the side chain involves sequential 
hydroxylations, first at C22 and then at C2Q, followed by side-chain 
cleavage to give the 21-carbon steroid.
The further metabolism of pregnenolone to progesterone proceeds by 
means of microsomal pyridine nucleotide-dependent oxidation of the 
hydroxyl group at C-3 to a ketone group, giving rise to pregn-5-ene-3, 
20-dione. Isomerization yields the A^-derivative progesterone
(Cheesman 1982). The 17-hydroxypregnenolone which is produced by the 
action of 17 a-hydroxylase enzyme on pregnenolone may be converted to
17-hydroxyprogesterone by the above enzyme system.
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Cortisol synthesis requires 3 hydroxylases that act sequentially on the 
C17’ C21 an(* C11 P°s^t:^ons pregnenolone. The first 2 reactions are
rapid, while hydroxylation is relatively slow. The 17 a-hydroxy­
lase enzyme is found in the smooth endoplasmic reticulum of the adre­
nal cell. It acts upon progesterone, or more commonly, pregnenolone at 
the C17 position. The 17 a-hydroxyprogesterone which is formed is then 
hydroxylated at C2  ^position to form 11-deoxycortisol. The 11-deoxy-
cortisol is then hydroxylated at to form cortisol. If 17-hydroxy- 
pregnenolone is formed, it is converted to 17-hydroxyprogesterone by
the 3|3-hydroxysteroid dehydrogenase-isomerase enzyme system (Fig. 1). 
The secretion of cortisol is dependent on ACTH (Granner 1985).
If the C2  ^position is hydroxylated first, the action of 17 a-hydroxy- 
lase is impeded and the mineralocorticoid pathway is followed. Hydrox­
ylation of progesterone at the Cj^ position produces 11-deoxycorticos­
terone. As a result corticosterone or aldosterone is formed depending 
on the cell type (Granner 1985).
The primary regulators of aldosterone production by the glomerulosa
cells are the renin-angiotensin system and potassium. Renin, which is 
an enzyme produced in the juxta-glomerulosa cells of the renal afferent 
arteriole, acts on angiotensinogen to convert it to angiotensin I. An- 
giotensinogen is an O2~globulin which is made in the liver. Angioten­
sin I is converted to angiotensin II in the lungs It acts on the 18- 
OH-dehydrogenase enzyme thus increasing the conversion of 18-hydroxy-
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corticosterone to aldosterone (Granner 1985).
In-Vitro System Utilizing Bovine Adrenocortical Culture
The initial steroidogenic response of bovine adrenocortical cells in 
monolayer culture to ACTH is characterized by comparable increases in 
the secretion of cortisol and corticosterone as well as increases in 
the production of steroidogenic intermediates such as pregnenolone, 
progesterone, 17 a-hydroxypregnenolone, 17 a-hydroxyprogesterone, 11- 
deoxycortisol and 11-deoxycorticosterone (Kramer et al., 1983).
The mechanism by which ACTH transforms the bovine adrenocortical cell 
from one that produces a mixture of 17 a-hydroxylated steroids to one 
that produces primarily 17 a-hydroxysteroids is unknown. However, the 
increase in the production of 17 a-hydroxysteroids and C^g-steroids 
coupled with the marked suppression of corticosterone and 11-deoxycor­
ticosterone production is suggestive of an effect on 17 a-hydroxylase 
activity (Kramer et al., 1983).
ACTH also acts to increase the total cytochrome P-450 content of bovine 
adrenocortical cells maintained in monolayer culture. In addition, bo­
vine adrenocortical cells respond initially to ACTH by an increase in
the synthesis of cytochrome P-450 (DuBois et al., 1981). Kramer etsee
al.,. (1982) reported an increase in cytochrome P-450^^^ and adrenodoxin 
content of bovine adrenocortical cells in primary culture. These cells 
did not however maintain an elevated rate of cytochrome P-450see
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synthesis even though they were continuously exposed to ACTH (DuBois et 
al., 1981).
In other studies utilizing an in-vitro system, it has been shown that 
ACTH acts to increase the concentration of low-density lipoprotein
(LDL) receptors on the bovine adrenocortical cell surface and conco­
mitantly to increase LDL uptake and degradation (Kovanen et al., 1979; 
Ohashi et al., 1982).
The ability of bovine adrenocortical cells in primary culture to main­
tain elevated glucocorticosteroid output is controversial. Goodyer et 
al., (1976); Horera et al., (1978); and Duperray and Chambaz, (1980) 
all reported decreased output of glucocorticoids, whereas, Hornsby and 
Gill, (1978) found no decrease in glucocorticoid output with time.
Kramer et al., (1983) reported that the initial stimulation of steroi­
dogenesis induced by ACTH is followed by a dose- and time-dependent 
refractoriness in the capacity of the cultured bovine adrenocortical 
cells to produce cortisol.
In adrenal glands of hypophysectomized rats, the concentrations of mi­
tochondrial P-450 and adrenodoxin decreased with a half-life of about 4 
days. Concomitantly, the activities of cholesterol side-chain cleavage 
and of 11-3 hydroxylase decayed with a similar half-life. If ACTH vas 
administered to these animals, these activities and the content of ad­
renal mitochondrial P-450 were gradually restored to control levels 
over a period of days (Purvis et al., 1973). This action of ACTH is
believed to be a chronic effect.
The direct precursor of aldosterone in the biosynthetic pathway is
18-hydroxycorticosterone. Kojima et al., (1982) studied the formation 
of aldosterone from 18-hydroxycorticosterone by bovine adrenocortical 
mitochondria and suggested that cytochrome P-450 is involved in the 
reaction. Cytochrome which is present in adrenocortical mito­
chondria is known to catalyze 11-0 hydroxylations of 11-deoxycortico­
sterone and 18-hydroxylation of corticosterone (Kim et al., 1983; Momoi 
et al., 1983). Wada et al., (1984) using an in-vitro system involving 
purified bovine adrenal cytochrome P-450^^p reported the formation of 
aldosterone from corticosterone or 18-hydroxycorticosterone.
Foster et al., (1981) investigated the role of calcium in the angio­
tensin II- or potassium-mediated increase in aldosterone production in 
isolated glomerulosa cells prepared from bovine adrenal glands. It was 
found that angiotensin II and potassium activated the cells of the glo­
merulosa by increasing the entry of calcium into the cells. Calcium 
served an important messenger function in response of the cell to 
either angiotensin II or potassium.
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OVARY
The ovaries are bifunctional organs that produce estrogens* progestins 
and ova. The most active naturally occurring hormones of these classes 
are 17 0-estradiol and progesterone. The postpubertal ovary is the 
site of a rapid and continuous process of cellular proliferation 
occurring primarily within follicles and involving granulosa cells. 
The factors controlling the proliferation of granulosa cells in the 
early phase of follicle morphogenesis in-vivo are still unknown (Savion 
et al., 1981). The ovulatory follicle has two basic functions: to 
provide the proper environment for the growth and development of the 
oocyte and to coordinate all the events of the follicular phase by 
secreting hormones that affect specific targets, both outside the ovary 
and within the ovary itself (Fortune 1986).
OVARIAN HORMONES
Androstenedione, testosterone and estradiol are the major secretory 
products of bovine follicles and their concentrations in the peripheral 
circulation fluctuate markedly, and often asynchronously (Dobson and 
Dean, 1974; Vise et al., 1982).
Synthesis of ovarian steroids requires the coordinated activities of 
several ovarian cell types and the two gonadotropins. Androgens are 
produced in the theca under the influence of LH and are aromatized to 
estradiol in the granulosa cells of the follicle under the influence of 
FSB (Hansel and Fortune, 1978).
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Biosynthesis of Ovarian Hormone
Figure 2: Biosynthetic Pathway of Ovarian Steroids:
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A major precursor for estradiol-17p is 4-androstene-3f 17-dione which 
is synthesized in the theca interna cells of the ovary (Fig. 2). The 
conversion of pregnenolone to androstenedione has been considered to 
proceed in three steps catalyzed by two enzymes. Pregnenolone is first 
converted to 17-hydroxypregnenolone by the 17 a-hydroxylase enzyme sys­
tem (Fig. 1). The 17-hydroxypregnenolone is subsequently converted to 
dehydroepiandrosterone and then to androstenedione via a 3fJ-dehyrogeh- 
ase isomerase. Androstenedione is then aromatized to estradiol-17p in 
the granulosa cells. Granulosa cells of cows are capable of producing 
estradiol only when provided with an aromatizable substrate or cocul­
tured with thecal cells which are the sites of androgen synthesis in
the follicle (Hansel and Fortune, 1978).
In Vitro System Utilizing Ovarian Cell Culture
Isolated bovine granulosa cells aromatized exogenous androgen to estra­
diol and appeared incapable of de novo synthesis of androgen (Fortune 
1981; Fortune 1986). Preparation of bovine follicular wall containing 
both theca and granulosa cells produced higher levels of androstenedi­
one than did isolated theca interna (Fortune 1981).
For optimal estradiol biosynthesis it is thought that a functional 
interaction between theca interna and granulosa cells is required, with 
the two key variables being the amount of LH-induced androstenedione or 
testosterone synthesized by the theca interna cells and the level of
aromatase activity in granulosa cells (Hillier 1981; McNatty et al.,
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1984). McNatty et al., (1984) reported the presence of high andros­
tenedione and testosterone and low or undetectable levels of estradiol 
in follicular fluid of small healthy bovine follicles. This, coupled 
with low or undetectable aromatase activity in the granulosa cells and 
an LH-responsive theca, provided strong evidence that early developing 
anthral follicles develop an ability to synthesize androgens before 
significant aromatase activity is expressed in the granulosa cells.
Fortune (1986) postulated that granulosa cells might supply theca cells 
with additional progestin precursors and thereby enhance the ability of 
theca cells to synthesize androgens. Increased androgens would then 
increase the production of estradiol by granulosa cells. Using an in- 
vitro system, theca interna cells secreted large quantities of andro­
stenedione. Secretion of androstenedione was increased by LH and not 
by FSH. Progesterone increased androstenedione secretion by the theca 
cells. It was then concluded that bovine theca interna cells use the 
delta pathway to make androstenedione. Pregnenolone made by the gran­
ulosa cell compartment enhanced the production of androstenedione by 
the theca, and testosterone made by the granulosa cells from thecal 
androstenedione increased the capacity of the granulosa cells to make 
estradiol.
Antidiuretic Hormone
Antidiuretic hormone (ADH) is primarily synthesized in the supraoptic 
nucleus and is transported through axons in association with specific
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carrier proteins called neurophysins. The neural pulses that trigger 
ADH release are activated by a number of different stimuli (Granner
1985).
Arginine vasopressin is also synthesized by ovarian tissue. tfathes et 
al., (1983) shoved that the bovine corpus luteum contained picogram 
amounts of vasopressin. An ovarian function for this peptide has not 
yet been proposed. Arginine vasopressin has also been identified in 
the adrenals of both rats and humans (Ang and Jenkins, 1984).
PHYSIOLOGY OF THE ESTROUS CYCLE
Primordial follicles are established in the ovary during embryonic 
development. These follicles enter a pool of growing follicles during 
the lifetime of the female in response to a stimulus which remains 
undefined. Hoor et al., (1978) and Carson et al. (1981) classified 
follicles as estrogen-active and estrogen-inactive based upon histolo­
gical assessment of the granulosa and steroid hormone content of the 
follicular fluid. Luteolysis initiates a series of events that culmi­
nates in a surge release of gonadotropins which results in ovulation.
As was mentioned previously, the release of the gonadotropins is con­
trolled by GnRH. GnRH is released in a pulsatile manner. A close re­
lationship between GnRH pulses and LH pulses has been demonstrated 
(Levine et al., 1982; Clarke and Cummings, 1982). This suggested that 
steroid-induced changes in LH pulse characteristics may be a direct re­
flection of changes in GnRH pulse characteristics.
20
Kamel et al., (1987) investigated the effects of GnRH pulse amplitude 
and frequency on LH secretion by perfused rat anterior pituitary cells. 
Increases in pulse amplitude consistently elevated both mean LH levels 
and the amount of LH released in response to individual GnRH pulses. 
Increases in pulse frequency also increased mean LH levels. However, 
frequencies of 3 or more pulses per hr were associated with a decrease 
in the amount of LH released per pulse.
Nett et al., (1987) quantified the hypothalamic content of GnRH, the 
pituitary content of LH and FSH and the number of hypophyseal receptors 
for GnRH and estradiol at different stages of the estrous cycle in the 
bovine. Emphasis was given to the period around the preovulatory surge 
of LH and to ovulation. Content of receptors for GnRH remained un­
changed during the first 18 days postestrus. This was followed by a 
subsequent decrease from day 19 through day 21. No change in the GnRH 
content of the hypothalamus was observed. LH content of the anterior 
pituitary increased from day 6 thru day 18. On day 19, LH content de­
clined sharply and returned to previous levels on day 20. An increase 
in the number of cytosolic receptors for estradiol was noted on day 18 
of the cycle. It was, therefore, concluded that the preovulatory surge 
of LH in heifers was preceded by an increase in number of receptors for 
estradiol in the pituitary gland. This was followed by a decrease in 
the . number of receptors for GnRH. Pituitary stores of LH decreased 
with GnRH receptor number.
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Ovulatory follicles grow in size and the number of LH receptors in the 
theca and granulosa increase. As a result, these follicles become more 
responsive to LH and acquire an increased ability to secrete estradiol 
(Hansel and Convey, 1983). Estradiol increases in the peripheral blood 
supply during the preovulatory period, reaching a peak at estrus 
(Hansel and Fortune, 1978).
As was mentioned previously, the major release of the gonadotropins oc­
curs at estrus. This surge release of gonadotropins is triggered by a 
positive feedback effect of estradiol from the pre-ovulatory follicle 
(Hansel and Convey, 1983). Rawlings et al., (1984), however, demon­
strated that rising estrogen levels are not required for preovulatory­
like gonadotropin surges in sheep.
Padmanabhan et al., (1978) studied the effect of estradiol-17p in re­
gulation of basal and GnRH stimulated release of LH from bovine anteri­
or pituitary in primary culture. GnRH at various concentrations stimu­
lated LH release. Acute exposure (2 hr) of the cells to estradiol did 
not affect basal LH secretion. In contrast, chronic exposure (26 hr) 
to estradiol increased basal LH levels above the control values. LH 
release increased linearly, with log dose of GnRH, when estradiol was 
added to the media beginning 2 or 26 hr before GnRH. LH content of the 
cells was increased by exposure to estradiol. These results therefore 
indicate that estradiol does affect LH release. Exposure time to 
estradiol seems to be an important factor.
Ramsey et al., (1987) studied the effects of GnRH and estradiol on LH
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biosynthesis and release in cultured rat pituitaries. GnRH stimulated 
LH release. The results suggested that GnRH regulated both LH glycosy- 
lation and LH polypeptide synthesis since GnRH increased uptake of ra­
diolabeled precursors. Furthermore, estradiol lowered the physiologi­
cal concentration of GnRH necessary to stimulate this biosynthetic 
response. Estrogen's enhancement of GnRH-stimulated LH release seemed 
to be due to its action on mechanisms regulating the release of previ­
ously-synthesized stored hormone as well as the release of newly-syn­
thesized LH.
Progesterone levels at this time are low. A progesterone decrease is a 
prerequisite to the estradiol caused gonadotropin surge since estradiol 
does not exert a positive feedback in heifers bearing a corpus luteum 
(Kesner et al., 1981).
Jefcoate et al., (1984) treated ewes with either blank (no steroid) or 
3 different sizes of rubber implants to study the effect of maintain­
ed progesterone levels on preovulatory events. Preovulatory surges of 
LH and FSH occurred in all treatment groups except the group with the 
highest levels of progesterone (1.85 + 0.04 ng/ml).
The mechanism by which estradiol induces the gonadotropin surge is not 
completely understood but Hansel and Convey, (1983) postulated the fol­
lowing mechanisms:
1. .Estradiol increases the capacity of the pituitary gonadotrophs to 
release LH and FSH in response to GnRH.
2. Estradiol increases GnRH self-priming.
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3. Estradiol sets a timed mechanism in the hypothalamus which culmi­
nates in a surge release of GnRH that induces the gonadotropin 
surge.
Kamel et al., (1987) observed the GnRH self-priming effect in perfused 
rat anterior pituitary cells. When cells were stimulated with GnRH the 
increase in responsiveness of the cells persisted for 1-2 hr, after 
which the amount of LH per pulse decreased. This period of self-prim­
ing was also followed by increased desensitization of the cells to 
GnRH. The basal LH concentrations remained elevated during the period 
of desensitization.
Both increased GnRH secretion and increased pituitary responsiveness 
are necessary for the preovulatory LH and FSH surges (Kesner and 
Convey, 1982). The gonadotropin surge is terminated by the gonado­
trophs becoming refractory to GnRH (Kesner and Convey, 1982) and not to 
depletion of gonadotropin content (Convey et al., 1981).
Following the preovulatory gonadotropin surge estradiol concentration 
decreases (Henricks et al., 1972). Estradiol content in the follicular 
fluid and LH-binding to theca and granulosa cells decrease, while 
progesterone content of the follicular fluid increases (Ireland and 
Roche, 1983). During the postovulatory period the releasable pool of 
LH is depleted and LH concentrations remain low even though the princi­
ple . feedback hormones, estradiol and progesterone, are low (Hansel and 
Convey, 1983).
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As mentioned above, the immunological LH profiles have been extensively 
characterized. An awareness has, however, developed that these immuno­
logical LH measurements may not adequately describe the biological ac­
tivity or stimulation of the target tissue. Mathison et al., (1986) 
compared the immunological and biological activities of LH at different 
stages of the bovine estrous cycle by both bioassay and radioimmuno­
assay. The pattern of biological release was qualitatively similar to 
that of immunological release with both concentrations fluctuating in a 
pulsatile manner throughput the cycle. Biological LH values tended to 
be lower. Relative biological activity was greatest during the luteal 
phase of the cycle with a decrease during the follicular phase. Lowest 
biological activity occurred during the LH surge. It was, therefore, 
suggested that both quality and quantity of LH released may be impor­
tant in regulating LH action at the target tissue.
The corpus luteum increases during the postestrus period and reaches 
mature size by day 7 (Donaldson and Hansel, 1965). Progesterone con­
centration increases in the peripheral circulation reaching a peak at 
approximately day 10 of the cycle (Hansel et al., 1973).
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EFFECTS OF CLIMATE ON REPRODUCTIVE HORMONES
Figure 3: Diagram shoving the effects of heat stress on reproductive
hormones
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The diagram overleaf shovs the relationship between the hypothalamus 
and the pituitary-adrenal-ovarian-axis. The effects of heat stress on 
the various hormones are indicated by arrows.
Luteinizing Hormone
Madan and Johnson, (1973) found lower basal and preovulatory surge 
concentrations of LH in cattle housed in controlled hyperthermic en­
vironments. Eighty-seven percent of control heifers exhibited an LH 
surge compared with 37.5% of heat-stressed heifers. Although this was 
an apparent reduction of number of animals with an LH surge, samples 
were collected only twice daily, and the LH peak may have been missed. 
Gwazdauskas et al., (1981); Rosenberg et al., (1982) collected blood at 
more frequent intervals from lactating and nonlacfating cows under con­
trolled and naturally hot environmental conditions. They found no ef­
fect of hyperthermia on preovulatory surges of LH or upon ovulation. 
This suggested that thermal environment may not affect LH.
It has been established that morphine has an inhibitory effect upon 
pituitary secretion of gonadotropins and ovulation in animals. Blank 
et al., (1986) reported that morphine had direct inhibitory effect on 
both basal and GnRH-stimulated LH release in cultured rat pituitary 
cells. Treatment of the cells with the opiate antagonist naltrexone 
significantly increased basal LH release.
This, then led to the possibility of an intra-pituitary relationship 
between the endogenous opioids and gonadotropin release since endoge-
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nous opioids are produced in the anterior pituitary as a result of the 
processing of POMC (Bloom et al., 1977). The pituitary gland is also 
exposed to high levels of 0-endorphins through the hypophyseal portal 
system (Wehrenburg et al., 1982). Furthermore, opiate receptors have 
been detected in the pituitary gland (Simantov and Snyder, 1977;
Lightman et al., 1983).
The inhibitory effects of endogenously produced endorphins was also 
evaluated by Blank et al., (1986). Cultured rat pituitary cells were 
exposed to rabbit anti-serum against human 0-endorphin. The antiendor­
phin increased basal and GnRH-stimulated release of LH over controls. 
Exposure of the cells to CRF had an an inhibitory effect on basal LH
secretion. Since CRF stimulates the release of POMC it increases the
levels of the endogenous opioids (0-endorphin and 0-lipotropin) in the 
pituitary, thus mediating the decreased basal LH levels.
Using an in-vitro perfusion system utilizing ovine tissue, Matteri and 
Koberg, (1985) observed elevated basal LH levels after treatment with 
Y-endorphin or human 0-endorphin. Upon subsequent stimulation of the 
cells vith GnRH, the release of LH was inhibited by the 0-endorphin
pretreatment. Neither ovine 0-endorphin nor met-enkephalin influenced 
gonadotropin secretion. Furthermore, naloxone pretreatment did not 
reverse the effect of human 0-endorphin on gonadotropin release. Based 
On these results, a faciliatory role for the regulation of pituitary 
gonadotropins by the endogenous opioids was postulated.
In-vitro release of LH from dispersed bovine anterior pituitary cells
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was inhibited by met-enkephalin. Met-enkephalin also antagonized the 
ability of LH-releasing hormone to stimulate in-vitro release of LH 
(Chao et al., 1986).
Hathevs and Murdoch, (1984) investigated the effect of intramuscular 
injection of naloxone on serum concentrations of LH and ovarian activi­
ty in prepubertal eves. Naloxone treatment resulted in the release of 
LH over a period of approximately 3 hr. Subsequently, they found no 
difference between control and naloxone-treated animals. This could 
have been due to a depletion of the releasable pool of LH. Serum con­
centrations of estradiol-17p were elevated 8 hr after treatment with 
naloxone.
Adrenal Hormones
In hyperthermia, adrenal function is reduced, and this may allow the 
animal to cope with the environment because of the lover calorigenic 
actions due to reduced levels of glucocorticoids (Gvazdauskas 1985). 
There are two distinct phases of heat stress in cattle. The cow re­
sponds immediately to acute heat stress by secreting cortisol. Plasma 
cortisol levels and turnover rates remain greatly elevated for up to 12 
hr after the onset of stress, but decline to normal levels within 1 to 
days (Christison and Johnson, 1972). Glucocorticoid levels declined to 
subnormal as the animal adjusted to the chronic heat stress.
Estrogens
In heat-stressed cows estrogens are depressed during the proestrous and 
metestrous periods of the estrous cycle and during late gestation.
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This has been related to a shorter duration of estrus and lower birth 
weights, respectively (Gvazdauskas 1985). Roman-Ponce et al., (1977) 
found that under conditions of natural fluctuating daily environment 
where black, globe temperatures averaged 27.7°C and temperatures under 
shade were 24.8°C, there were no overall differences in concentrations 
of estradiol or lengths of estrous cycle.
Progesterone
Several studies have reported that progesterone concentrations were 
reduced during the luteal phase (Rosenberg et al., 1982; Stott and 
Wiersma, 1973) of the cycle when the animal was heat stressed. The 
lower luteal progesterone concentrations have been associated with 
lower conception rates. In contrast to these reports, others have 
reported elevated progesterone concentrations during the estrous cycle 
in hot weather (Roman-Ponce et al., 1977; Vaught et al., 1977) or under 
elevated conditions in a climate chamber.
De Silvia at al., (1981) found a negative relationship between pro­
gesterone at 12 hr after initial observation of estrus and fertility. 
Mills et al., (1972) found higher progesterone concentrations in plasma 
near breeding associated with reduced fertility in heifers exposed to 
32.2°C compared with heifers at 21.0°C. Dickman (1970) reported that 
elevated progesterone in rats near the time of insemination, fertili­
zation or early embryo cleavage may be detrimental to fertility since 
progesterone retards early embryo cleavage. On the other hand, higher 
progesterone levels prior to luteolysis and at day 15 post-insemination 
were positively related to fertile inseminations.
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Aldosterone and Antidiuretic Hormone
Aldosterone changed In a curvilinear manner during the estrous cycle in 
heifers and lactating cows (Roussel et al., 1983). During exposure to 
a hyperthermic environment, aldosterone in plasma was not affected dur­
ing the first 8 hr of exposure to 35°C. However, at 24 hr of heat 
stress the drop in aldosterone was significant compared to thermo­
neutral cattle. Collier et al., (1982) found lower aldosterone levels 
in cattle without access to shade when exposed to natural summer heat 
stress. Exposure to heat stress tended to increase plasma ADH for 30 
hr (Collier et al., 1982).
STATEMENT OF THE PROBLEM
The hot, humid climates of the southern United States and tropics in­
duce elevated body temperatures in dairy cattle that in turn depress 
reproductive efficiency. The physiological mechanism by which heat 
stress reduces reproductive efficiency is not completely understood. 
Since the pituitary-adrenal axis has been proven to be one of the most 
important and invasive in terras of its ability to alter or disrupt 
reproductive events, it is necessary to test the effects of heat stress 
on the pituitary-adrenal axis and its subsequent effect on ovarian ste­
roidogenesis.
The response of the whole animal to heat stress with emphasis on con­
trol of steroidogenesis via pituitary gonadotropins and ovarian temp­
erature has been evaluated. Although some answers have been forth­
coming, the effect of temperature on steroidogenesis in the heat- 
stressed cattle is not fully resolved.
This project sought to evaluate the effect of heat stress on hormone 
production by using a cell-culture system. Cell culture offers a me­
thod for studying cellular physiology under controlled conditions. The 
hypothesis that the reduced plasma levels of estrogens, cortisol and 
aldosterone reported in heat-stressed cattle are due to depressed ac­
tivity of temperature-sensitive enzymes in the ovary and adrenal cortex 
was .tested using this in-vitro system.
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GENERAL MATERIALS AND METHODS
Pituitary Cell Culture Haterials and Methods:
Penicillin, gentamycin, amphotericin B, Hepes buffer, Fibroblastic 
Growth Factor (FGF), collagenase, dispase, and neuraminadase were 
obtained from Sigma Chemical Co. (St. Louis, MO). Fetal bovine serum 
and Minimal Essential Media (MEM) were obtained from GIBCO (Grand 
Island, NY).
Pituitary glands were obtained from freshly slaughtered cows and were 
transported to the laboratory in an ice-cold buffer containing 137 nM 
NaCl, 5 mM KC1, 0.7 mM Na2HP0^, 25 mM Hepes, 100 ug/ml penicillin, 50 
ug/ml gentamycin, and 2.5 ug/ml amphotericin B, pH 7.36. Preparation 
of pituitary cells was by the method used by Kudlow and Gerrie (1983). 
The glands were carefully dissected on ice to remove the capsule and 
the posterior lobe. After washing with buffer, the glands were
chopped and digested at 37°C using two consecutive enzymatic solutions
exactly as described by Brazeau et al.(1981). The first solution
consisted of a 100 ml solution in Hepes buffer (pH 7.35) of collagenase 
(4 mg/ml) and dispase (2 mg/ml). After an exposure of 70 min. in this 
solution, the digested tissues were seperated by gentle centrifugation 
(50xg, 5 min) and resuspended in a solution of neuraminadase (8 ug/ml)
and 200 ug/ml EDTA in Hepes buffer pH 7.35 for 10 min. After this
second digestion, the cells were washed twice with plating media. The
plating media consisted of MEM containing X0X fetal calf serum, sodium
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bicarbonate, 100 ug/ml penicillin, 50 ug/ml gentamycin, 2.5 ug/ml am­
photericin B and 50 ng/ml FGP. The final cell suspension was passed 
through four layers of gauze before plating.
The primary suspension of cells was plated at a density of 2x10 cells
per well, into 24-well Primaria plates (Becton Dickinson, Lincoln Park,
NJ). The growth area which was a surface modified polystyrene was ap-
2
proximately 2.0 cm . Plating efficency, determined by approximately 
the area with attached cells after a 48-hr incubation period, was 
80-85£. The cells were incubated at 37°C in a humidified atmosphere
containing 95% O2 and 5% Hedia was initially changed at 48-hr
periods until confluency was reached, thereafter, media was changed at 
24-hr periods. Upon reaching confluency the cells were assigned to the 
treatments.
Luteinizing hormone was quantified using a double antibody radioimmuno­
assay as described by Thompson et al., (1983). Intra- and interassay 
coefficients of variation were 10 and 12%, respectively.
Adrenal Cell Culture Materials and Methods:
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Porcine adrenalcorticotropin (ACTH), Human Synthetic Angiotensin IX, 
collagenase/dispase, DNase and Fibroblastic Growth Factor (FGF) were 
obtained from Sigma Chemical Co. (St. Louis, MO). Cell culture media, 
sera and antibiotics/antimycotics were purchased from Grand Island 
Biological Company (Grand Island, NY). Tissue culture dishes were from 
Falcon Labware (Oxnard, CA).
Bovine adrenal glands were obtained from freshly slaughtered cows at a 
local slaughter house and placed in cold Hank's Balanced Salt Solution 
(HBSS) that contained 1000 IU penicillin per ml and 100 mg streptomycin 
per ml for transport to the laboratory. Preparation of isolated adre­
nocortical cells was by the method used by Kramer et al.(1983). Under 
aseptic conditions, adrenal glands were cleaned of adhering tissue and 
bisected. The adrenal medulla was removed and the adrenal cortex was 
scraped from the capsule. Cortical fragments were minced, washed with 
HBSS, and then incubated in HBSS containing sodium bicarbonate (23.8 
mM), Hepes (25 mM) buffer (pH 7.2), collagenase/dispase (0.2%), DNase 
(0.01%), and bovine serum albumin (0.5%, w/v) for 60 minutes at 37°C on 
a gyratory shaker. The tissue was then mechanically dispersed by pi- 
peting through a 10 ml plastic pipette with a 3 mm aperture. The undi­
gested fragments were allowed to settle and the digestion medium was 
decanted through four layers of gauze. The cells Were collected by 
centrifuging at lOOg for 5 min, and the cell pellet was washed 3x with 
HBSS containing horse serum (10%, v/v). The final pellet was resuspen­
ded in a mixture of Ham's F-12 Medium and Dulbecco's Modified Eagles
Medium <1:1, v/v) that contained fetal calf serum (2.5%, v/v), horse
serum (12.5%, v/v), penicillin (100 IU/ml), streptomycin (100 ug/ml),
fungizone (0.25 ng/ml) and FGF (50 ng/ml). Cells were then plated at a
density of approximately 10^ cells per ml in 1.5 cm multivell chambers
(Becton Dickinson Labware, Lincoln Park, NJ). The growth area which
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was a surfaced modified polystyrene was approximately 2.0 cm . 
Chambers were incubated at 37°C in air supplemented with 5% COg* 
Medium was harvested at 24 hour and replaced with identical medium. At 
that time approximately 50% of the cells had attached firmly. There­
after, medium was replaced at 48-hr intervals. Confluent monolayers of 
cells generally were achieved within 6-7 days. At confluency FGF was 
removed from the medium and the concentration of horse serum reduced to 
2.0%, v/v.
Aldosterone, progesterone, cortisol and corticosterone concentrations 
were measured using non-extracted solid phase kits (Dianostic Products 
Corp., Los Angeles CA). Intra- and interassay coefficients of varia­
tion were as follows: Aldosterone 8% and 11%, respectively; Progeste­
rone 7% and 8%, respectively; Cortisol 5% and 10%, respectively; and 
Corticosterone 10% and 13%, respectively.
Granulosa Cell Culture Materials and Hethods:
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17-B Estradiol and progesterone solid-phase radioimmunoassay kits were 
obtained from Diagnostic Products Corp. (Los Angeles, CA). Penicillin, 
streptomycin, cell culture media, and sera were purchased from Grand 
Island Biological Company (Grand Island, NY). Tissue culture dishes 
were Falcon Labware (Oxnard, CA).
Fresh bovine ovaries were obtained at a local slaughter house and were 
transported on ice to the laboratory in sterile Hank's Balanced Salt 
solution (HBSS) containing penicillin (100 ug/ml), steptomycin (100 
mg/ml), and amphotericin-B (2.5 ug/ml). Follicular fluid was aspirated 
from large non-atretic follicles with a needle and syringe. The folli­
cles were then incised open and the internal follicular wall was gently
scraped and flushed repeatedly with a pasteur pipette containing HBSS.
The granulosa cells in the pooled flushings were centrifuged and washed 
3 times with HBSS. The graulosa cell number was determined using a 
haemocytometer and their viability determined by the trypan blue exclu­
sion test. Cells were then incubated at a density of 3x10^ cells per 
well in one of three media. Medium A (basal medium) consisted of Mini­
mal Essential Media, 10% fetal calf serum, penicillin (100 IU/ml),
streptomycin (100 ug/ml), Hepes buffer and sodium bicarbonate. Medium 
B consisted of basal medium supplemented with 1.0 ug/ml testosterone, 
while medium C was the basal medium containing added testosterone (1.0 
ug/ml) and FSH (0.1 ug/ml). Cells were plated in triplicates in 3 mis 
of media into 6-vell culture plates.
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Plates were incubated in a humidified incubator containing 5% CO^ and 
95% Og at 37°C and 40°C. The cell culture media was harvested after 24 
hrs, thereafter every 48 hrs. The entire experiment was repeated four 
times. 17-B Estradiol and progesterone assays were performed on har­
vested media using the non-extracted solid phase kits. Intra- and in­
terassay coefficients of variation were 8% and 12%, respectively for 
estradiol, and 7% and 8%, respectively for progesterone.
PITUITARY CELL CULTURE
Objectives:
1. To determine the effects of temperature stress on gonadotropin- 
releasing hormone (GnRH)-stimulated luteinizing (LH) and follicle- 
stimulating hormonal (FSH) production and release. (Expt. I).
2. To determine the effects of temperature stress on GnRH-, estradiol- 
and GnRH with estradiol-stimulated LH and FSH production and re­
lease. (Expt. II).
3. To determine the effects of the endogenous opioids on basal and GnRH 
with estradiol-stimulated LH and FSH release. (Expt. III).
4. To determine the effect Of temperature stress on GnRH receptor 
number. (Expt. IV).
38
Pituitary Experiment I
The objective of this study was to determine the effects of temperature 
stress on GnRH-stimulcited LH and FSH production and release. Madan and 
Johnson, (1973) reported lower basal and preovulatory surge concentra­
tions of LH in cattle housed in controlled hyperthermic environments. 
Conversely, Gwazdauskas et al., (1981) and Rosenberg et al., (1982) re­
ported no effects of hyperthermia on preovulatory LH surges. Srikanda- 
kumar (1986) reported delayed but normal LH peaks in cattle under heat 
stress in a controlled environment. There are no reports concerning 
the effects of heat stress on FSH.
Method:
Bovine anterior pituitary cells were established in primary culture
using the method of Kudlow and Gerrie, (1983), (General Materials and
Methods for Cell Culture). Cells were in a confluent monolayer in ap­
proximately 11 days. Upon reaching confluency, half of the wells were 
assigned to the higher incubation temperature (40°C) while the others 
remained at 37°C. After a 24-hr acclimatization at the 40°C tempera­
ture, 4 wells each were assigned to the following treatments:
37°C 40°C
No GnRH No GnRH
GnRH (3 ng/ml) GnRH (3 ng/ml)
GnRH (30 ng/ml) GnRH (30 ng/ml)
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Three levels of GnRH (Abbott Laboratories, North Chicago, IL) were used 
in order to identify whether or not there was a dose-dependent effect 
of GnRH on LH and FSH release. All of the media was harvested and re­
placed with fresh media containing the respective treatments at speci­
fied times throughout the course of the experiment. During the first 
24 hr of treatment, 2 ml of media was harvested at 0.08, 0.75, 6 and 24 
hr after incubation with various levels of GnRH to evaluate a time-de­
pendent aspect on GnRH stimulation. Media was then harvested at 24-hr 
periods followed by 48-hr periods for 192 hr. At the termination of 
the experiment the cells were lysed by the addition of 2 ml of 0.05% 
sodium dodecyl sulphate (SDS) to each well. SDS containing lysed cells 
was then removed. The hormone stored in the cells during the incuba­
tion period was determined.
LH and FSH were quantified using a double antibody radioimmunoassay as 
described by Thompson et al., (1983). Intra- and interassay coeffi­
cients of variation for LH were 10 and 12%, respectively.
Analysis of variance was performed on data with the General Linear 
Model procedure of the statistical analysis system (SAS, 1985) using a 
split-plot model. All possible two-way interactions were considered. 
Duncan's multipie-range test was used to assess the significance of 
differences among treatment means (Steel and Torrie, 1980). Statisti­
cal significance was set at P<0.05.
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Results:
The results of a time course of LH secretion and storage with increas­
ing concentrations of GnRH at the 37 and 40°C incubation temperatures 
are graphed in Figs. 4 and 5, respectively. The time indicated by -24 
hr represents the 24-hr acclimatization period after assigning the 
cells to the higher incubation temperature. No GnRH was added to the 
media during this period. Control, or basal, levels of LH secretion 
vere not affected by temperature during the first 24 hr of incubation 
at the higher temperature.
No significant increases in LH above control levels vere secreted after 
the first 6 hr of incubation vith GnRH. Only this period was, there­
fore, included in the statistical analysis..
Effect Of Temperature
The effect of temperature on LH levels during the first 6 hr of treat­
ment is shown In Fig. 6. The higher incubation temperature lowered LH 
secretion (P<0.01) across all treatments. However, higher levels of 
hormone were stored at the 40°C incubation temperature (P<0.01), (Table 
1).
Effect of Treatment:
LH secretion was not significantly altered by GnRH treatment. LH sto­
rage was altered by GnRH treatment (P<0.02), (Table 2).
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Table 1: Least square means of LB concentration (ng/ml) secreted
during the first 6 hr after the addition of GnRH or stored at the end 
of the expt. by anterior pituitary cells at the two incubation tem­
peratures over all treatments in Pituitary Bxpt. I
Secreted Stored
Temperature LH LH
C°C) (ng/ml) (ng/ml)
37 9.31 7.64
40 4.23a 13.76a
a, Different from LB at 37°C (P<0.01)
Table 2 shows the least square mean secreted and stored LH at the three 
levels of GnRH. LH secretion at 0 ng/ml GnRH was lower than LH secre­
tion at 3 ng/ml (P<0.01). However, there was no significant difference 
between 0 ng/ml and 30 ng/ml. Higher levels of LH were stored in the 
gonadotrophs when the cells were stimulated with 3 ng/ml GnRH (F<0.05) 
and 30 ng/ml GnRH (P<0.01). There was, however, no significant diffe­
rence between LH storage when the cells vere stimulated with 3 ng/ml or 
30 ng/ml GnRH.
Highest levels of LH were measured after approximately 0.08 hr of sti­
mulation. LH secretion decreased with time thereafter. After the ini­
tial stimulation it was not possible to substantially stimulate the 
cells with GnRH.
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Table 2: Least square means of LH concentration (ng/ml) secreted
during the first 6 hr after the addition of GnRH or stored at the end 
of the expt. by anterior pituitary cells with the three levels of GnRH 
in Pituitary Expt. I
Treatment
Secreted
LH
(ng/ml)
Stored
LH
(ng/ml)
GnRH (0 ng/ml) 6.32a 8.103
GnRH (3 ng/ml) 9.01b 11.34b
GnRH (30 ng/ml) 5.003 12.67b
ar b. Least square means 
different (P<0.05)
in each column vith same superscript are not
Table 3: Summary of the statistical model for secreted LH during
the first 6 hr of incubation with GnRH
Source DF SS PR>F
Temperature 1 464.87 0.0069
GnRH 2 199.90 0.1646
Temperature * GnRH 2 121.37 0.3204
Rep(Temperature * GnRH) 18 900.40 0.1562
Time3 2 2811.37 0.0001
Time * Temperature 2 873.04 0.0001
Time * GnRH 4 241.64 0.1534
Time * Temperature * GnRH 4 173.02 0.2969
a, Hedia harvested at 0.08, 0.75 and 6 hr
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Figure 4: Mean (n=4) LH profiles vith the three levels of GnRH at 37°C
in Pituitary Expt. I. Standard deviations are presented in the Appen­
dices, Table 65.
*-24 hr represents preincubation tine prior to the addition of any
treatments.
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Figure 5: Mean (n=4) LH profiles vith the three levels of GnRH at 40°C
in Pituitary Bxp|. I. Standard deviations are presented in the Appen­
dices, Table 65.
-24 hr represents preincubation tine prior to the addition of any
treatments.
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Figure 6: Mean (n=4) LH, secreted and stored, in Pituitary Expt. I,
over all treatments at the tvo incubation temperatures. Standard devi­
ations are presented in the Appendices, Table 65.
The analyses of variance for secreted and stored LH are presented in 
Tables 3 and 4, respectively.
Table 4: Summary of the statistical model for stored LH
Source DP SS PR>F
Temperature 1 225.16 0.0001
GnRH 2 88.13 0.0210
Temperature * GnRH 2 58.36 0.0650
Discussion:
The observation that GnRH stimulated the release of LH in cultured 
anterior pituitary cells is well established (Padmanabhan et al., 1978 
and Huang Su-Rong and Miller, 1980). Results obtained in the present 
study confirm these observations. Using this in-vitro system as our 
model, the effect of temperature stress on basal and GnRH-induced re­
lease of LH from bovine anterior pituitary cells was evaluated.
Before the addition of treatments, temperature did not affect the basal 
levels of LH secreted during the first 24 hr of incubation at the high­
er temperature. The higher incubation temperature decreased the re­
sponse of the gonadotrophs to the initial GnRH stimulation (3 ng/ml). 
This could be due to either a decrease in the number of receptors for 
GnRH or a decreased receptor affinity at the higher incubation tempera­
ture. The inability to stimulate the cells after the initial stimula­
tion with GnRH suggests that the effect of GnRH on the gonadotrophs in 
culture was on the releasable gonadotropin pool rather than on de novo
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synthesis of LH. Apparently the releasable pool of LH was depleted 
after the initial stimulation. This is reflected by the levels of 
stored hormone at both incubation temperatures. Using bovine pituitary 
cell cultures, Padmanabhan et al., (1978) observed that only a very 
small portion (2-10£) of the total LH content could be released by 
GnRH. This further supports the lack of significant LH release after 
the initial stimulation.
The inability of 30 ng/ml GnRH to stimulate higher levels of GnRH above 
the control could be explained by down-regulation of the GnRH receptors 
by the high concentration of GnRH. The erratic levels of LH secreted 
may be due to lack of estrogen in the media. Estrogen has been pro­
posed to have a priming effect on the pituitary gonadotrophs (Hansel 
and Convey, 1983), thereby increasing the responsiveness of the cell. 
Therefore, Pituitary Expt. II in vhich estradiol was added to the media 
was initiated.
Pituitary Experiment II
Estradiol (50 ng/ml) was added to the treatment regimen to see i£ its 
effect on LH secretion was synergistic with GnRH. The objective of 
this study, therefore, was to determine the effects of temperature 
stress on GnRH and estradiol-stimulated LH production and release.
Method:
Bovine anterior pituitary cells were established in primary culture 
using the method of Kudlow and Gerrie, (1983), (General Materials and 
Methods for Cell Culture). Confluent monolayers were acheived in ap­
proximately 12 days. Upon reaching confluency, half of the wells were 
assigned to the 40°C incubation temperature while the other half re­
mained at 37°C. After a 24-hr acclimatization period, 4 wells each 
were assigned to the following treatments:
37°C 40°C
No GnRH No GnRH
GnRH (30 ng/ml) GnRH (30 ng/ml)
Estradiol (50 ng/ml) Estradiol (50 ng/ml)
GnRH (30 ng/ml) with GnRH (30 ng/ml) with
Estradiol (50 ng/ml) Estradiol (50 ng/ml)
All of the media was harvested and replaced with fresh media containing 
the respective treatments at specified times throughout the course of 
the . experiment. Media was initially harvested at 24-hr intervals fol­
lowed by 48-hr Intervals for 216 hr. At the termination of the experi­
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ment the cells were lysed with 0.05% SDS and the hormone stored in the 
cells during the incubation period was determined.
LH and FSH were quantified using a double antibody radioimmunoassay as 
described by Thompson et al., (1983). Intra- and interassay coeffi­
cients of variation for LH were 10 and 12%, respectively.
Analysis of variance was performed on data with the General Linear 
Model procedure of the statistical analysis system (SAS, 1985) using a 
split-plot model. All possible two-way interactions were considered. 
Duncan's multiple-range test was used to assess the significance of 
differences among treatment means (Steel and Torrie, 1980). Statisti­
cal significance was set at P<0.05.
Results:
Basal levels of LH were not altered at 24 hr of incubation at the 4Q°C 
temperature. This is represented by -24 hr (Figs. 7, 8, 9 and 10). As 
in Expt. I, after the initial stimulation with GnRH it was not possible 
to get a significant LH response again. Only the first 24 hr, there­
fore, after the addition of GnRH are included in the statistical analy­
sis.
Effect of Temperature:
The effect of temperature on LH secretion and storage across all treat­
ments is graphed in Fig. 11. Higher levels of LH vere secreted 
(P<0.01) and stored (P<0.01) at the lower incubation temperature (Table 
5).
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Table 5: Least square means of LH concentration (ng/ml) secreted
during the first 24 hr after the addition of treatments or stored at 
the end of the expt. by anterior pituitary cells at the two incu­
bation temperatures over all treatments in Pituitary Expt. II
Secreted Stored
Temperature LH LH
(oC) (ng/ml) (ng/ml)
37 14.87 14.03
40 4.38a 9.35a
a Different from LH at 37°C (P<0.01)
Effect of Treatment:
The effects of no GnRH, GnRH, estradiol and estradiol with GnRH at the 
two incubation temperatures are graphed in Figs. 7, 8, 9, and 10, 
respectively. Treatment increased LH secretion (P<0.07) but had no 
significant effect on LH storage (Table 6). Estradiol (P<0.02) and 
GnRH (P<0.08) increased LH secretion above the control. There vas no 
significant difference in LH secretion between control and GnRH with 
estradiol treatments.
A comparison of hormonal secretion across all treatments at the two 
incubation temperatures showed less hormone being secreted at the high­
er incubation temperature in the control (P<0.02), estradiol (P<0.01), 
GnRH (P<0.01), and GnRH with estradiol (P<0.08) wells. However, higher 
levels of LH were stored at the lower incubation temperature for the 
control (P<0.01) and GnRH treatments (P<0.05) only.
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Figure 7: Mean (n=4) LH profiles in Pituitary Expt. II at the two
incubation tenperatures without GnRg. Standard deviations are pre­
sented in the Appendices, Table 66.
*-24 hr represents preincubation tine prior to the addition of any
treatnents.
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Figure 8: Mean (n«4) LH profiles in Pituitary Expt. II at the two 
incubation teaperatures with GnRH (30 gg/al). Standard deviations are 
presented in the Appendices, Table 66.
-24 hr represents preincubation tiae prior to the addition of any
treataents.
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Figure 9: Mean (n*=4) LH profiles in Pituitary Expt. II at the tvo
Incubation temperatures vith estradiol (50^ng/ml). Standard deviations 
are presented in the Appendices, Table 66.
*-24 hr represents preincubation tine prior to the addition of any
treatments.
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Figure 10: Hean (n=4) LB profiles in Pituitary Expt. II at the two
incubation temperatures vith GnRH (30 ng/ml) and estradiol (5g ng/ml). 
Standard deviations are presented in the Appendices Table 66.
-24 hr represents preincubation time prior to the addition of any
treatments.
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Figure 11: Mean (n=4) LH secreted and stored in Pituitary Expt. II
over all treatments at the tvo incubation temperatures. Standard devi­
ations are presented in the Appendices, Table 66.
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Table 6: Least square means of LH concentration (ng/ml) secreted
during the first 24 hr after the addition of treatments and stored at 
the end of the expt. by anterior pituitary cells exposed to GnRfi and 
estradiol in Pituitary Expt. II
Treatment
Secreted
LH
(ng/ml)
Stored
LH
(ng/ml)
No GnRH and No
Estradiol 7.09a 12.97a
Estradiol (50 ng/ml) 12.36b 14.25a
GnRH (30 ng/ml) 11.12bc 14.87a
GnRH (30 ng/ml) and
7.94acEstradiol (50 ng/ml) 8.60
a, b, and c Least square means in each column vith same suberscript 
are not different (P<0.05)
Table 7: Summary of the statistical model for secreted LH during the 
first 24 hr of incubation vith GnRH in Pituitary Expt. II
Source DP SS PR>F
Temperature 1 882.32 0.0001
Treatment 3 152.29 0.0727
Temperature * Treatment 3 125.96 0.1164
The analyses of variance for secreted and stored LH are presented in 
Tables 7 and 8 respectively.
58
Table 8: Summary of the statistical model for stored LH in Pituitary
Expt. II
Source DF ss PR>F
Temperature 1 175.36 0.0086
Treatment 3 56.14 0.4681
Temperature * Treatment 3 179.68 0.0617
Discussion:
As in Pituitary Expt. I, temperature did not affect the basal levels of 
LH secreted by 24 hr at the higher incubation temperature. GnRH was 
again able to stimulate the release of LH from the pituitary cells in 
culture. The response of the gonadotrophs to the initial GnRH stimu­
lation, however, was again suppressed at the higher incubation tempera­
ture. Also, a significant LH response after the initial GnRH stimula­
tion was again unsuccessful. Again, this was probably due to depletion 
of the releasable pool of LH after this initial stimulation.
Varied effects were observed with estradiol treatment. It has been 
well established that estradiol can induce a gonadotropin surge con­
sisting of both FSH and LH (Hansel and Convey, 1983; Padmanabhan et 
al., 1978). Although this effect has been attributed to the action of 
estradiol at the hypothalamic level, a pituitary site of action has al­
so been demonstrated (Padmanabhan et al., 1978). Leavitt et al., 
(1973) demonstrated that estradiol was specifically retained by anteri­
or pituitary cells in suspension, and specific estrogen binding has 
been observed in cytosolic preparations from anterior pituitaries 
(Korach and Huldoon, 1973; Davies et al., 1975). The ability of estra­
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diol to stimulate LH secretion in culture in the above experiment may 
be a validation of this.
Huang and Miller, (1980) further demonstrated an increase in basal se­
cretion of LH after incubating ovine pituitary cells in primary cul­
ture vith estradiol for 10 hr. This magnitude of the enhancement of 
basal LH secretion vas a function of estradiol treatment time. Short­
term exposure to estradiol (6 hr) augmented the responsiveness to GnRH. 
However, the response to GnRH after long-term exposure (44 hr) to es­
tradiol vas significantly smaller.
The LH response of the cells to the combination of estradiol and GnRH 
vas less than the response for either estradiol or GnRH. This vas pro­
bably due to the addition of both estradiol and GnRH to the culture me­
dia simultaneously and not to a desensitization of the cells by chronic 
exposure to estradiol since exposure to estradiol alone for the same 
time period stimulated higher levels of LH. This may also be a valida­
tion of the chronic effect of estradiol in decreasing GnRH stimulated 
LH release in culture (Huang and Miller, 1980).
Miller et al., (1977) reported that in a long-term culture of ovine 
pituitary cells, estradiol significantly suppressed spontaneous FSH 
secretion as veil as the concentration of intracellular FSH. However, 
the response to GnRH stimulation vas augmented by estradiol pretreat­
ment. In our experiments ve were unable to measure any levels of ei­
ther secreted or stored FSH. During the time in which the cells were 
growing to confluency, no GnRH or estradiol were added to the media 
since it vas felt that this would deplete the gonadotropin storage.
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Estradiol may also have been added prior to GnRH stimulation in order 
to observe its effect on FSH production. Further experiments are 
needed in which GnRH is added to the media while the cells are growing 
to confluency or prior to stimulation with GnRH. Levels of FSH should 
then be evaluated.
Pituitary Experiment III
The inhibitory effects of morphine on pituitary secretion of gonado­
tropins and ovulation in animals has been established. Blank (1986) 
evaluated the inhibitory effects of endogenously produced endorphins on 
cultured rat pituitary cells. Basal and GnRH-stimulated release of LH 
were decreased. Conversely, Matter! and Moberg, (1985) perfused ovine 
pituitary tissue vith y-endorphin or human 8-endorphin. Basal levels 
of LH were elevated by the endorphin treatment. Upon subsequent stimu­
lation of the cells with GnRH, LH release was inhibited.
During stress, levels of endogenous opioids are increased (Madden et 
al., 1977). These opioids are believed to have an intrapituitary 
action on the gonadotrophs by occupying GnRH receptors, thus inhibiting 
the secretion of the gonadotropins (Blank et al., 1986).
The objective of this study was to determine the effect of 8-endorphin 
on basal and GnRH with estradiol-stimulated LH and FSH release at the 
level of the pituitary gland at the 37°C and 40°C incubation tempera­
tures.
Method:
Bovine anterior pituitary cells were established in primary culture 
using the method of Kudlov and Gerrle, (1983), (General Materials and 
Methods for Cell Culture). Confluent monolayers were acheived in 
approximately 6 days. Upon reaching confluency, half of the wells were
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assigned to the 40°C incubation temperature while the other half 
remained at 37°C. After a 24-hr acclimatization at the higher incuba­
tion temperature, 4 wells each were assigned to the following treat­
ments:
37°C 40°C
No P-Endorphin No p-Endorphin
P-Endorphin (10~^mM) P-Endorphin (10"^mM)
After 24 hr with or without p-endorphin media were harvested and as­
sayed for LH to determine the effect of p-endorphin on basal secretion 
of LH. Replacement media containing GnRH and estradiol (30 ng/ml and 
50 ng/ml, respectively), were added to the culture system to determine 
the effect of P-endorphin on GnRH and estradiol-stimulated LH release. 
Incubation time was again 24 hr. Harvested media were assayed for LH 
content.
Analysis of variance was performed on data with the General Linear 
Model procedure of the statistical analysis system (SAS, 1985) using a 
split-plot model. All possible two-way interactions were considered, 
Duncan's multiple-range test was used to assess the significance of 
differences among treatment means (Steel and Torrie, 1980). Statisti­
cal significance was set at P<0.05.
Results:
There was a significant interaction (Table 11) between B-endorphin 
treatment and temperature prior to the addition of GNRH and estradiol 
to the media (Table 9). The LH concentration in the media was lower
(P<0.05) for (3-endorphin treatment at 40°C than at 37°C. This diffe­
rence was more evident when the cells were stimulated with GnRH and 
estradiol (Table 10). It appears, therefore, that temperature accentu­
ates the ability of 0-endorphin to suppress GNRH-stimulated LH release.
Table 9: Least square means of LH concentration (ng/ml) secreted at
the two incubation temperatures during treatment vith and vithout 
0-endorphin, prior to the addition of GNRH vith estradiol to the media
Temperature
(°C)
No 0-Endorphin 
(ng/ml)
0-Endorphin
(ng/ml)
Avg.
(ng/ml)
37 8.49 10.89 9.69
40 9.92 6.24a 8.09
Avg. 9.21 8.57
a, Different from LH at 37°C
Table 10: Least square means of LH concentration (ng/ml) secreted at
the tvo incubation temperatures during treatment vith GnRH
Temperature
(°C)
No 0-Endorphin 
(ng/ml)
0-Endorphin
(ng/ml)
Avg.
(ng/ml)
37°C 7.81 9.34 8.57
40°C 5.80 3.07a 4.43a
Avg. 6.80 6.20
a, Different from LH at 37°C (P<0.01)
The analyses of variance for secreted LH during incubation vith 0-en- 
dorphin and GnRH treatments are presented in Tables 11 and 12, respec­
tively.
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Table 11: Summary of the statistical model for secreted LB during
incubation vith 0-endorphin in Pituitary Expt. Ill
Source DF SS PR>F
Temperature 1 20.67 0.2653
Treatment 1 3.28 0.6537
Temperature * Treatment 1 73.87 0.0404
Table 12: Summary of the statistical model for secreted LH during
incubation vith GnRH in Pituitary Expt. Ill
Source DF SS PR>F
Temperature 1 137.36 0.0005
Treatment 1 2.92 0.5743
Temperature * Treatment 1 36.21 0.0550
Discussion:
Blank et al., (1986) found that morphine had a direct inhibitory effect 
on both basal and GnRH-stimulated LH release by cultured rat pituitary 
cells. The ability of morphine to inhibit gonadotropin secretion 
through a direct action on pituitary opiate receptors suggests that 
long-term exposure to exogenous opiates may suppress reproductive func­
tion at the hypophyseal level. Matter! and Moberg, (1985) perfused 
ovine pituitary glands vith y-endorphin or human 0-endorphin. Treat­
ment vith y-endorphin or human 0-endorphin resulted in elevated basal 
LH .release folloved by an inhibition in the response to a subsequent 
GnRH challenge.
In the above experiment, an interaction existed between 3-endorphin and 
temperature. 3-endorphin enhanced the suppressive effects of high tem­
perature on GnRH with estradiol-stimulated LH release. At 37°C, 3-en­
dorphin did not have a suppressive effect. This supports the hypothe­
sis that the endogenous opioids may be involved in suppressing LH re­
lease during heat stress probably by occupying receptors for GnRH 
(Blank et al., 1986). Further experiments are needed in which levels 
of endogenous opioids would be monitored in the pituitary cell-culture 
system since these may play a role in basal and GnRH with estradiol- 
stimulated LH release.
Pituitary Experiment IV
In pituitary Experiments I, II and III, media was assayed for levels of 
FSH. No detectable levels of FSH were produced or secreted by the an­
terior pituitary cells in culture. Immunocytochemistry was then uti­
lized as a tool in characterizing the gonadotrophs in culture to see if 
any FSH producing cells were present.
The LH response of the cells to GnRH stimulation was lower at the high­
er incubation temperature in Expts. I and II. This could be due to a 
decrease in the gonadotroph number at the higher incubation tempera­
ture, a decrease in receptor number and/or sensitivity, or a decrease 
in LH production at the 40°C temperature.
In Experiment I, higher levels of LH were stored at the 40°C incubation 
temperature. However, in Experiment II, the converse was true. In 
Experiment I, there was no difference in LH production (total of se­
creted and stored) at the two incubation temperatures. Lower levels of 
LH were, however, produced at the higher incubation temperature in 
Expt. II. These results suggest a possible effect of temperature on LH 
synthesis and release. Using immunocytochemistry, the second objective 
of the study was to label GnRH receptors and quantitate the number of 
labeled cells at the two incubation temperatures.
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Method:
Anterior pituitaries from cows were established in primary culture 
using the method already described by Kudlow and Gerrie, (1983), 
(General Materials and Methods for Cell Culture).
The cells were then incubated at 37°C in a humidified atmosphere con­
taining 95% CO2 and 5% Og. Media were harvested and replaced every 48 
hrs until confluent monolayers were reached. Upon reaching confluency, 
24 wells were assigned to 40°C incubation temperature while the other 
24 wells remained at 37°C.
Cells were allowed to acclimatize at their respective temperatures for 
24 hr; thereafter the cells were stimulated with GnRH or biotinylated 
GnRH (bio-GnRH). Bio-GnRH is a potent GnRH analog that is also useful 
as a cytochemical probe for receptors on target cells in the pituitary. 
The addition of biotin to the analog is proposed to not affect its po­
tency as a stimulator of LH and FSH secretion in the female rat (Kudlow 
and Gerrie, 1983).
Biotinyl-D-Ala^ GnRH was prepared by reaction of (D-Ala^) GnRH (0.6 mg) 
(Sigma Chemical CO., St. Louis, MO) with 2 molar equivalents d-biotin- 
nitropheny1-ester in methanol-dimethylformamide (10:1, by vol) in the 
presence of 1.2 equivalents of triethy1-amine (Childs et al., 1983).
After standing at 24°C for 3 hr, the product was precipitated by the 
addition of ether and washed three times with ethylacetate in order to 
remove unreacted d-biotin-p-nitrophenyl ester.
Using the method described by Childs (1983), the biotin-labeled analog 
vas diluted in Eagles MEM (+Hepes and 0.3X bovine serum albumin) in the 
range of 3 to 30 ng/ml concentration. Unlabeled GnRH was prepared at a 
concentration of 30 ng/ml. Cell monolayers were then washed three 
times in MEM containing no fetal calf serum. The cells were then ex­
posed to either the biotin-labeled GnRH or unlabeled GnRH for 3 hr.
Following this exposure, the cells were fixed immediately in 2.5% glu-
taraldehyde diluted in 0.1 M phosphate buffer containing 4.5% sucrose 
(pH.7.41; osmolality 386) over a period of 30 min.
Monolayers which were stimulated with unlabeled GnRH were then used to 
localize LH and FSH. Bovine anti-rabbit LH was diluted in MEM at a 
dilution of 1:100. Cells were incubated with the primary antibody for 
3 hr. Veils were then washed with 10% normal goat serum to block non­
specific staining followed by a 30-min incubation vith anti-rabbit IgG 
peroxidase. A wash vith 10% normal goat serum was repeated and cells 
stained vith the Immustain Kit (Diagnostic Products Corp., Los Angeles, 
CA) which utilized the Avidin Biotin Peroxidase (ABC) technique. The 
enzyme substrate which was used for the localization of LH vas diamino- 
benzidine (DAB).
4f
Bovine anti-rabbit LH was obtained courtesy of Dr. Donald Thompson, 
Department of Animal Science, LSU.
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Monolayers treated vith bio-GnRH were used to localize GnRH labeled 
cells. Veils were first washed vith 10% normal goat serum to block 
non-specific staining. Cells were then stained vith DAB using the 
above ABC technique.
Using the Immustain Kit, endogenous peroxidase activity vas blocked by 
incubating monolayers with 2-3 drops of an aqueous 3% hydrogen per­
oxidase solution for 5 rain. Excess reagent vas removed and monolayers 
were washed with the buffered-wash working solution. Two to 3 drops of 
linking reagent which consisted of a biotinylated anti-mouse immunoglo­
bulin in a carrier preservative protein were then added to each well. 
Incubation was for a period of 30 min at room temperature. Excess re­
agent vas removed and monolayers were washed for 5 min in buffered-wash 
solution. Two to 3 drops of horseradish peroxidase-conjugated strep- 
avidin in a carrier protein-preservative solution were then added to 
the wells for 30 min. Excess reagent vas removed and the monolayers 
were again washed in buffered-wash solution.
The DAB was prepared by adding 2 drops of 1M acetate buffer (pH 5) and 
2 drops of 1% hydrogen peroxide to 5 ml of distilled water. Four drops 
of DAB chromogen were then added to the solution. Cells which were 
stimulated with unlabeled GnRH and bio-GnRH were exposed to DAB for a 
period of 10 min.
LH stained cells were then double-stained for FSH using 4-chloro-l- 
napthol. Cells were first incubated vith bovine anti-rabbit FSH for a 
period of 3 hrs. Monolayers were washed vith buffered wash solution
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followed by a 30 min incubation with anti-rabbit IgG peroxidase. The 
above procedure utilizing the linking reagent and Strepavidin enzyme 
label was followed by a wash. After another wash in buffered-wash 
solution, 4-chloro-l-napthol was added to the wells for a period of 10 
min.
The 4-chloro-l-napthol was prepared by reacting 3 mg of 4-chloro-l- 
napthol in 1 ml of MeOH. Tris buffer (5 ml) was then added (pH 6.8)
followed by 2 ul of 30% 8^02* All wells were counterstained with
haematoxylin.
Control wells were set up in which bio-GnRH, anti-FSH and anti-LH were
omitted to test the specificity of the staining procedure.
The bio-GnRH stained cells were quantified by analysing 12 fields/well 
and counting the number of cells. These cells were then expressed as 
percentages of the monolayer cell population counted. Multiple wells 
were used for each treatment, and the percentage of cells were averaged 
from the seperate counts of each well. One-way analysis of variance 
was used to determine whether the variation between the two incubation 
temperatures was significant.
*Bovine anti-rabbit FSH was obtained courtesy of Dr. Donald Thompson, 
Department of Animal Science, LSU.
The LH and FSH stained cells were not quantified. Fields of cells were 
observed for FSH stained cells.
Results:
The LH-stained cells and the GnRH-stained cells were colored golden 
brown with DAB (Fig. 12). Four-chloro-l-napthol stained FSH-containing 
cells dark purple (Fig. 13). Staining was diffuse throughout the cell. 
Background staining with haematoxylin was light purple. On an average 
110 cells per 12 fields were stained with bio-GnRH at the 37°C incuba­
tion temperature. One hundred and fourteen cells per 12 fields were 
stained with bio-GnRH at the higher incubation temperature (Table 67, 
Appendices). LH-stained cells were in a disproportionately larger
amount than FSH-stained cells. Approximately 1 to 2 cells per field 
were stained for FSH compared with 10 to 12 cells per field for LH.
Discussion:
Bio-GnRH is a potent GnRH analog that is also useful as a cytochemical 
probe for target cells on the pituitary. Bio-GnRH was localized on 
anterior pituitary cells of female rats with sensitive stains that 
employed labeled avidin probes (Childs 1983). Stains were detected on 
16% of the cell population, and double immunocytochemical stains for LH 
or FSH were used to confirm the identity of the target cells that bound 
the GnRH analog (Childs 1983).
This study was modified in that double staining was done for the pitui­
tary gonadotropins and the cells which were stained for GnRH receptors 
were not double-stained for either of the gonadotropins. Further expe-
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Figure 12: Pituitary gonadotropins (bio-GnRH) stained vith diamino-
benzidine.
Figure 13: Pituitary gonadotropins (FSH-containing) stained vith
4-chloro-l-napthol.
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riments should involve double staining the bio-GnRH stained cells since 
this would be another validation that the cells were gonadotropes.
Since there was no significant difference in bio-GnRH labeled cells at 
the two incubation temperatures, the source of altered LH secretion may 
be due to post-receptor alterations or to a decrease in the releasable 
pool of LH at the 40°C temperature. After the initial LH release,
levels of LH in the media were the same at the two incubation tempera­
tures in Expt. I and II. This would tend to suggest that after the 
initial GnRH stimulation this releasable LH pool was not replenished 
since significant levels of LH were not secreted. No conclusive 
statements concerning the effects of temperature on stored LH may be 
made since results obtained in Experiments I and II were different.
The presence of FSH-staining cells were detected in culture. The rea­
son for the absence of detectable levels of FSH in the media may be due
to the concentration of FSH-producing cells being too low, the sensi­
tivity of the assay being too high or the inability to respond to GnRH 
stimulation after confluency.
Summary of Pituitary Experiments:
Basal levels of LH were unaffected by temperature stress in Expts. I 
and II. However, in Expt. Ill, basal levels of LH were lover after 24 
hr at the 40°C incubation temperature. Therefore, conditions may exist 
in which basal secretion of LH may be lowered during heat stress.
Consistent in Pituitary Expts. I and II, vas a decrease in LH release 
at the higher incubation temperature in response to GnRH stimulation. 
There was, however, no difference in GnRH-stained cells at the two 
incubation temperaures in Expt. IV. The decrease in LH release at the 
higher incubation temperature may be attributed to either a decrease in 
the releasable pool of LH or to a decrease in sensitivity of the GnRH 
receptor. Estradiol, at the lower incubation temperature, was able to 
stimulate the release of LH from the gonadotrophs.
An interaction between 3-endorphin and temperature existed. p-endor- 
phin enhanced the suppressive effects of high temperature on GnRH-
stimulated LH release. This supports the hypothesis that the endoge­
nous opioids may be involved in suppressing LH release during heat
stress.
No detectable levels of FSH were measured in our pituitary cultures. 
This may be attributed to the relatively lower number of FSH-stained
cells in culture, to a loss in responsiveness to GnRH while the cells
were growing to confluency or to the lack of sensitivity of the assay.
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ADRENAL CELL CULTURE
Objectives:
1. To determine the effects of temperature stress on ACTB- and angio­
tensin II-stimulated adrenal hormonal (progesterone, corticosterone, 
aldosterone and cortisol) synthesis. (Expt. I, II, and III).
2. To determine the effects of temperature stress on the 17 a- and 11 
0-hydroxylase systems. (Expt. IV).
3. To determine the effect of arginine vasopressin on adrenal steroido­
genesis at the two incubation temperatures. (Expt. V).
4. To determine the effect of low-density lipoprotein on adrenal ste­
roidogenesis at the two incubation temperatures. (Expt. VI).
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Adrenal Experiment I
After the onset of heat stress, animals respond by secreting elevated 
levels of cortisol (Christison and Johnson, 1972). Levels of cortisol 
remained elevated for up to 12 hr after the onset of heat stress but 
returned to normal levels within 1 to 2 days. The decline then con­
tinued below the resting level over the next several days. Gwazdauskas 
(1985), also reported reduced adrenal function in hyperthermic animals. 
This may allow the animal to cope with the environment because of the 
reduced calorigenic stimulation from the glucocorticoids. Aldosterone 
has been reported to be suppressed in heat-stressed animals (Collier et 
al., 1982). Reports concerning heat stress and plasma progesterone are 
inconsistent. Heat stress has been reported to cause an increase in 
plasma progesterone in a cycling heifer (Gwazdauskas et al., 1981). 
Collier et al., (1982) reported increased progesterone levels in heat- 
stressed cows. Hill and Alliston, (1981) reported depressed plasma 
progesterone from days 7 to 13 of the cycle with an increase 2 days 
before estrus in cycling ewes. The current study was proposed to test 
the hypothesis that the reduced plasma levels of adrenal steroids in 
heat-stressed cattle are due to depressed activity of temperature sen­
sitive enzymes in the adrenal cortex.
Hethod:
Bovine adrenocortical cells were established in primary culture by the 
method used by Kramer et al., (1983), (General Materials and Methods 
Section). A confluent monolayer vas achieved in approximately 8 days.
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Upon reaching confluency, half of the veils were assigned to the 40°C 
incubation temperature while the other half remained at 37°C. Four 
wells each were assigned to the following treatments:
37°C 40°C
No ACTH (Control) No ACTH (Control)
ACTH (10"7M) ACTH (10_7M)
ACTH (10_7M) Delayed
Culture media were changed every 48 hr for 456 hr. The harvested media 
were placed in sample vials and frozen at -20°C to be assayed for ste­
roids at a later date. ACTS was added to the delayed ACTH wells 24 hr 
after initiating the 40°C incubation temperature. This was done in 
order to evaluate the effect of treatment delay on adrenal steroidoge­
nesis. Adrenal Expt. I consisted of two phases. Phase I included the 
first 456 hr after beginning treatments. After 456 hr, wells were 
switched, ie., wells at 37°C were switched to 40°C and, wells at 40°C 
were switched to 37°C. This was done to evaluate the effect of tempe­
rature reversal on adrenal steroidogenesis after a prolonged time in 
culture. This will be referred to as Phase II. Phase II was termi­
nated 240 hr after the switch vith media being changed every 48 hr.
Analysis of variance vas performed on data vith the General Linear 
Model procedure of the statistical analysis system (SAS, 1985) using a 
split-plot model. All possible two-way interactions were considered. 
Duncan's multiple-range test vas used to assess the significance of 
differences among treatment means (Steel and Torrie, 1980). Statisti­
cal significance vas set at P<0.05.
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Results:
Phase 1:
Aldosterone, progesterone and cortisol at the two incubation tempera­
tures, vith and without ACTH, are shown in Figs. 14, 15, and 16, re­
spectively.
Total steroids in the media increased with time, with peak production 
of cortisol occurring at approximately 100 hr (Fig. 16) and aldosterone 
(Fig. 14) at approximately 150 hr. Progesterone production was some­
what different in that an oscillatory pattern was followed with multi­
ple peaks occurring (Fig. 15). In the control wells, levels of proges­
terone remained elevated after 200 hr (Fig. 18) even though aldosterone 
and cortisol production were depressed (Figs. 17 and 19, respectively).
Table 15 shows the effect of ACTH treatment on aldosterone, progester­
one and cortisol production. ACTH decreased aldosterone (P<0.01) and 
progesterone (P<0.01) levels and increased cortisol (P<0.01) when com­
pared with the control wells.
Table 13: Least square means of adrenal hormones from bovine adreno­
cortical culture Expt. I, Phase I, vith and without ACTH
Treat­ Aldosterone Progesterone Cortisol
ment (ng/dl) (ng/ml) (ng/ml)
Control 4.95 29.00 569.59
ACTH 3.39a 10.723 2085.94a
a, different from control (P<0.01)
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Figure 14: Head (n«4) aldosterone profiles in Adrenal Expt. I (Phase
I) vith and vithout ACTH (10 H) at the tvo incubation temperatures. 
Standard deviations are presented in the Appendices, Table 68.
0 hr represents incubation at 37°C. At 24 hr, half of the veils vere
placed at 40 C and treatments vere added to all veils.
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Figure 15: Mean (n=4) progesterone profiles in Adrenal Expt. I (Phase
I) vith and without ACTH (10~ M) at the two incubation temperatures. 
Standard deviations are presented in the Appendices, Table 68.
0 hr represents incubation at 37°C. At 24 hr, half of the wells were
placed at 40 C and treatments were added to all wells.
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Figure 16: Mean (n=4) cortisol profiles in Adrenal Rxpt. I {Phase I)
vith and vithout ACTS (10~ H) at the tvo incubation temperatures. 
Standard deviations are presented in the Appendices, Table 68.
*0 hr represents incubation at 37°C. At 24 hr, half of the veils vere
placed at 40 C and treatments vere added to all veils.
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The 40°C incubation temperature decreased aldosterone production 
(P<0.01) and increased progesterone concentrations in the media 
(P<0.05), (Figs. 17 and 18, respectively), and had no significant ef­
fect on cortisol (Fig. 19), in veils without ACTH stimulation. Table 
14 shows temperature and treatment least square means for aldosterone, 
progesterone and cortisol.
Table 14: Least square means of adrenal hormones (Fig. 14, 15, and 16) 
from bovine adrenocortical culture Expt. I, Phase I, at the two incu­
bation temperatures during the first 456 hr with and without ACTH
Tempera­
ture (°C)
Treat­
ment
Aldosterone
(ng/dl)
Progesterone
(ng/ml)
Cortisol
(ng/ml)
37 Control 8.54a 25.lla 574.88a
37 ACTH 4.17b 11.26b 1956.78b
40 Control 1.35° 32.88c 564.30a
40 ACTH 2.62d 10.18b 2215.09b
40 Del. ACTH 2.95d 13.40b 2090.23b
a, b, c, d, Least-square means in each column with same superscript are 
not different (P<0.05)
Table 15 summarizes the statistical analysis for media concentrations 
of aldosterone, progesterone and cortisol at the two incubation tem­
peratures. ACTH treatment at 40°C gave decreased aldosterone when
compared to ACTH at 37°C (P<0.01) (Fig. 20) but had no significant 
effect on progesterone concentrations. Cortisol was not significantly 
different at the two incubation temperatures with ACTH treatment (Fig. 
21). Delaying ACTH (which was only done for wells at 40°C) did not 
significantly alter aldosterone, progesterone and cortisol concentra-
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Figure 17: Mean (n=4) aldosterone profiles in Adrenal Expt. I (Phase
I) without ACTH at the two incubation teaparaturgs. Standard devia­
tions are presented in the Appendices, Table 68.
*0 hr represents incubation at 37°C. At 24 hr, half of the wells were 
placed at 40°C and treatments were added to all wells.
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Figure 18: Mean (n=4) progesterone profiles in Adrenal Expt. I (Phase
I) without ACTH at the two incubation teaperaturgs. Standard devia­
tions are presented in the Appendices, Table 68.
*0 hr represents incubation at 37°C. At 24 hr, half of the wells vere
placed at 40°C and treatments vere added to all wells.
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Figure 19: Mean (n=4) cortisol profiles in Adrenal Expt. I (Phase I)
vithout ACTH at the tvo incubation teapera|ures. Standard deviations 
are presented in the Appendices, Table 68.
*0 hr represents incubation at 37°C. At 24 hr, half of the veils vere
placed at 40 C and treatments vere added to all veils.
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Figure 20: Mean£n=4) aldosterone profiles in Adrenal Bxpt. I (Phase
I) vith ACTH (10 H) at the two incubation temperatures. Standard de­
viations are presented in the Appendices, Table 68.
*0 hr represents incubation at 37°C. At 24 hr, half of the veils vere
placed at 40°C and treatments vere added to all veils.
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Figure 21: Mean (n=4) cortisol profiles in Adrenal Bxpt. I (Phase I)
with ACTH (10 H) at the tvo incubation tenperatyres. Standard devia­
tions are presented in the Appendices, Table 69.
*0 hr represents incubation at 37°C. At 24 hr, half of the veils vere
placed at 40°C and treatments vere added to all veils.
tion vhen compared with ACTH treatment at 40°C.
Table 15: Summary of the statistical analysis for media concentrations
of aldosterone, progesterone and cortisol (Adrenal Expt. I, Phase I)
Comparisons Aldosterone Progesterone Cortisol
Control 37°C vs 
Control 40°C ** ** NS
ACTH 37°C vs 
ACTH 40°C ** NS NS
ACTH 40°C vs 
Del. ACTH 40°C NS NS NS
** PC0.01 
* P<0.05 
NS Not Significant
The analyses of variance for aldosterone, progesterone and cortisol in 
Phase I are presented in Tables 16, 17 and 18, respectively.
Table 16: Summary of the statistical model for aldosterone secretion
in Phase I, Adrenal Expt. I
Source DF ss PR>F
Temperature 1 571.42 0.0001
Treatment 2 90.81 0.0062
Temperature * Treatment 2 237.61 0.0001
Rep(Temperature * Treatment) 10 51.45 0.0065
Date 9 2318.68 0.0001
Date * Temperature 9 815.83 0.0001
Date * Treatment 18 371.80 0.0001
Date * Temperature * Treatment 9 289.62 0.0001
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Table 17 : Summary of the statistical model for progesterone secretion
in Phase If Adrenal Expt. I
Source DF SS PR>F
Temperature 1 335.67 0.0345
Treatment 2 11339.18 0.0001
Temperature * Treatment 2 587.42 0.0089
Rep(temperature * Treatment) 10 561.04 0.0001
Date 9 1393.74 0.0001
Date * Temperature 9 1110.60 0.0001
Date * Treatment 18 11288.05 0.0001
Date * Temperature * Treatment 9 544.33 0.0001
Table 18: Summary of the statistical model for cortisol secretion in
Phase I, Adrenal Expt. I
Source DF SS PR>F
Temperature 1 453961.49 0.3238
Treatment 2 78345773.87 0.0001
Temperature * Treatment 2 534798.64 0.2863
Rep(temperature * Treatment) 10 4214473.72 0.0001
Date 9 491426558.09 0.0001
Date * Temperature 9 7596722.81 0.0001
Date * Treatment 18 101938955.85 0.0001
Date * Temperature * Treatment 9 4288290.11 0.0001
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Phase II:
Table 19 shows the least square mean hormonal production with and with­
out ACTH for Phase II. ACTH decreased aldosterone (P<0.01) and proges­
terone production (P<0.01) and increased cortisol production (P<0.01). 
Lower levels of aldosterone (P<0.01) were produced at the higher incu­
bation temperature (Table 20). However, except for control wells in 
Phase II, progesterone levels were not significantly altered by tempe­
rature. Cortisol levels were, however, suppressed by the higher incu­
bation temperature (P<0.01) in Phase II as opposed to not being sig­
nificantly altered by temperature in Phase I.
Table 19: Least square means of adrenal hormones from bovine adreno­
cortical culture Expt. I, Phase II, with and without ACTH at the two 
incubation temperatures
Treat­ Aldosterone Progesterone Cortisol
ment (ng/dl) (ng/ml) (ng/ml)
Control 1.67 40.20 35.93
ACTH 0.31a 10.02a 116.04a
a, Different from control (P<0.01)
Least square mean hormonal production at the two incubation tempera­
tures in Phase II is shown in Table 20. ACTH treatment at 40°C tended 
to decrease aldosteone production (P<0.07) and had no significant ef­
fect on progesterone production when compared with ACTH treatment at 
37°C. ACTH increased cortisol production at both incubation tempera­
tures (P<0.01).
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Table 20: Least square means of adrenal hormones from bovine adreno­
cortical culture Expt* I, Phase II, with and without ACTH, at the two 
incubation temperatures
Tempera­
ture (°C)
Treat­
ment
Aldosterone
(ng/dl)
Progesterone
(ng/ml)
Cortisol
(ng/ml)
37 Control 2.56a 36.99a 46.38a
37 ACTH 0.51b 10.92b 162.16b
37 Del. ACTH 0.47b 10.39b 117.93b
40 Control 0.78b 43.40c 25.47c
40 ACTH 0.11c 9.13b 69.93a
a, b, c Least square means in each column with same superscript are not 
different (P<0.05)
A summary of significant temperature comparisons is presented in Table 
21.
Table 21: Summary of the statistical analysis for media concentrations
of aldosterone, progesterone and cortisol (Adrenal Expt. I, Phase II)
Comparisons Aldosterone Progesterone Cortisol
Control 37°C vs 
Control 40°C ** ** **
ACTH 37°C vs 
ACTH 40 C NS NS 'k'k
Del. ACTH 37°C vs 
ACTH 40°C NS NS **
** P<0.01
NS Not Significant
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The analyses of variance for aldosterone, progesterone and aldosterone 
in Phase II are presented in Tables 22, 23 and 24, respectively.
Table 22: Summary of the statistical model for aldosterone secretion
in Phase II, Adrenal Expt. 1
Source DF SS PR>F
Temperature 1 21.08 0.0001
Treatment 2 46.62 0.0001
Temperature * Treatment 2 8.61 0.0007
Rep(Temperature * Treatment) 10 3.71 0.5305
Date 5 3.67 0.1294
Date * Temperature 5 1.81 0.4966
Date * Treatment 10 5.18 0.2713
Date * Temperature * Treatment 5 9.43 0.0015
Table 23: Summary of the statistical model for progesterone secretion
in Phase II, Adrenal Expt. I
Source DF SS PR>F
Temperature 1 96.14 0.2799
Treatment 2 18599.41 0.0001
Temperature * Treatment 2 302.58 0.0702
Rep(Temperature * Treatment) 10 736.65 0.0006
Date 5 815.90 0.0001
Date * Temperature 5 129.55 0.2549
Date * Treatment 10 795.18 0.0003
Date * Temperature * Treatment 5 232.94 0.0464
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Table 24: Summary of the statistical model for cortisol secretion in
Phase IX, Adrenal Expt. I
Source DF SS PR>F
Temperature 1 57601.42 0.0023
Treatment 2 117765.01 0.0006
Temperature * Treatment 2 22887.30 0.0284
Rep(Temperature * Treatment) 10 34931.11 0.0001
Date 5 26218.49 0.0001
Date * Temperature 5 5195.60 0.0775
Date * Treatment 10 8057.10 0.1201
Date * Temperature * Treatment 9 5554.65 0.0613
Discussion:
Steroids are synthesized from cholesterol in the gonads and adrenal 
cortex by a group of enzymes referred to as mixed function oxidases 
that contain cytochrome P-450. As cited in the literature review, 
estrogens, cortisol and aldosterone have been reported to be suppress­
ed in heat-stressed cattle. It was hypothesized that some of the en­
zymes involved in their synthesis may be heat-sensitive and their ef- 
feciency may be depressed in cattle with elevated body temperature. The 
above experiment was initiated to test that hypothesis.
ACTH, the stimulus for the synthesis and release of cortisol, is pro­
posed to be increased during heat stress (Marple et al., 1972), yet 
cortisol levels increase for only an 12 hr (Christison and Johnson,
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1972) and then are chronically depressed for the duration of the body 
temperature elevation. Shayanfar et al., (1975) reported that the 
adrenal gland was less responsive to ACTH at temperatures above 21.1°C.
At 40°C incubation temperature there was no effect on cortisol levels 
during the first phase of Expt. I. In Phase II, higher levels of cor­
tisol were produced at the lower incubation temperature. However, at 
this time production levels were only about one-tenth of what they were 
in Phase I.
An effect of temperature on steroidogenesis in this experiment was most 
evident for aldosterone. It was depressed by about 1/2 by the higher 
incubation temperature. The results clearly support the hypothesis 
that there may be temperature-sensitive enzymes in the system. Deoxy­
corticosterone (in the aldosterone pathway) is converted to corticos­
terone by an enzyme common to both systems. Corticosterone is convert­
ed to 18-hydroxycorticosterone and then to aldosterone. Enzymes in­
volved in either of these conversions might possibly be depressed. 
Questions concerning which enzymes were instrumental were initiated in 
Adrenal Expt. V.
During Phase I, temperature did not alter cortisol production. 
However, in Phase II cells at 40°C had lower cortisol production.
Switching the cells at the end of Phase I demonstrated that the cells 
did not lose the ability to respond to ACTH stimulation with time at 
the higher incubation temperature. However, with time in culture the
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levels of cortisol decreased greatly. This is supported by Horera et 
al. (1978), and Duperray and Chambaz, (1980) vho reported decreased 
output of glucocorticoids with time in primary bovine adrenocortical 
culture. Furthermore, Kramer et al. (1983) reported that the initial 
steroidogenesis induced by ACTH is followed by a dose- and time-depen­
dent refractoriness in the capacity of the cultured adrenocortical 
cells to produce cortisol.
Adrenal Experiment II
Introduction:
Angiotensin II (10-7M) was included in the treatment to evaluate its 
effect on aldosterone production at the two incubation temperatures. 
Angiotensin II is proposed to act on the 18-OH-dehydrogenase enzyme 
system which is involved in the conversion of 18-hydroxycorticosterone 
to aldosterone (Granner 1985).
Method:
Bovine adrenocortical cells were established in primary culture by the 
method used by Kramer et al., (1983), (General Materials and Methods 
Section). A confluent monolayer was reached in approximately 8 days. 
Upon reaching confluency half of the wells were assigned to the 40°C 
incubation temperature while the other half remained at 37°C. After a 
24-hr acclimatization period at the higher incubation temperature, 4 
wells each were assigned to the following treatments:
37°C 40°C
Control (No ACTH or Angiotensin II) Control (No ACTH or Angiotensin II) 
ACTH (10"7M) ACTH (10_7M)
Angiotensin II (10-7M) Angiotensin II (10-7M)
Media were harvested at 48-hr intervals after addition of 10-7 M ACTH
_7
and . 10 M Angiotensin II to the culture media and steroid concen­
tration was analysed. The experiment was terminated 576 hr after the
96
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addition of treatment.
Analysis of variance was performed on data with the General Linear 
Model procedure of the statistical analysis system (SAS, 1985) using a 
split-plot model. All possible two-way interactions were considered. 
Duncan's multiple-range test was used to assess the significance of 
differences among treatment means (Steel and Torrie, 1980). Statisti­
cal significance was set at P<0.05.
Results:
The effects of treatment on aldosterone, progesterone and cortisol 
concentration at the two incubation temperatures are shown in Figs. 22, 
23, and 24, respectively.
Aldosterone and progesterone followed an oscillatory pattern with lower 
levels of aldosterone being produced at the higher incubation tempera­
ture (P<0.01), (Table 25). Temperature did not significantly affect 
progesterone concentration. The pattern of cortisol production was 
similar to that of Expt. I. However, the level of cortisol synthesis 
was much lower than Expt. I, Phase I, and the cortisol peak common to 
all treatments in Expt. 1, Phase I, occurred much later (Fig. 24). 
Lower levels of cortisol were secreted at the 40°C incubation tempera­
ture.
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Figure 22: Kean (n=4) aldosterone profiles in Adrenal Expt. 11 vith
and vithout ACTH (10” H) and angiotensin II (10 M) at the tvo incuba­
tion teaperatujes. Standard deviations are presented in the Appendi­
ces, Table 70.
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Means at 48 hr represents 48-hr incubation vith treatments at the re­
spective tenperatures.
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Figure 23: Mean (n=4i progesterone profiles in Adrenal Expt. II vith
and vithout ACTH (10~ M) and angiotensin II (10“ M) at the tvo incuba­
tion teaperatuges. Standard deviations are presented in the Appendi­
ces, Table 70.
*Means at 48 hr represents 48-hr incubation vith treataents at the re­
spective temperatures.
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Figure 24: Mean£n=4) cortisol profiles in Adrenal Expt. II vith and
without ACTE (10“ H) and angiotensin II (10~ H) at the tvo incubation 
temperatures. Standard deviations are presented in the Appendices, 
Table 70.
*Heans at 48 hr represents 48-hr incubation vith treatments at the re­
spective temperatures.
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Table 25: Least square means of adrenal hormones from bovine adreno­
cortical culture Expt. II, vith and without ACTH/Angiotensin II, at the 
two incubation temperatures
Tempera­ Aldosterone Progesterone Cortisol
ture (°C) (ng/dl) (ng/ml) (ng/ml)
37 5.00 10.99 45.50
40 1.00a 11.32 13.61a
a, Different from control 37°C (P<0.01)
Treatment had a limited effect on aldosterone release into the media 
(P<0.08) and none on progesterone concentration, but increased cortisol 
production (P<0.01), (Table 26). Angiotensin II did not significantly 
increase aldosterone production above the control. ACTH increased cor­
tisol significantly above the Control and Angiotensin II treatment 
wells (P<0.01).
Table 26: Least square means of adrenal hormones from bovine adreno­
cortical culture Expt. II, vith and without ACTH and Angiotensin II, at 
the tvo incubation temperatures
Treat- Aldosterone Progesterone Cortisol 
aent (ng/dl) (ng/ml) (ng/ml)
Control 2.80a 10.71a 16.26a
ACTH 3.90b 11.15a 54.80b
Angiotensin II 3.10ab 11.60a 17.59a
a, b, Least square means in each column vith same superscript are not 
different (P<0.05)
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Table 27 lists least square means for aldosterone, progesterone and 
cortisol by temperature And treatment. Aldosterone and cortisol con­
centrations vere reduced at the higher temperature for all treatments. 
Progesterone concentrations vere not significantly altered by tempera­
ture.
Table 27: Least square means of adrenal hormones for bovine adrenocor­
tical culture Expt. II, vith and without ACTH and Angiotensin II, at 
the two incubation temperatures
Tempera- Treat- Aldosterone Progesterone Cortisol
ture (°C) ment (ng/dl) (ng/ml) (ng/ml)
37 Control 4.06a 10.98a 23.82a
37 ACTH 6.40a 10.74a 87.44b
37 Angiotensin II 5.10a 11.25a 25.24a
40 Control 1.00b 10.45a 8,71c
40 ACTH 1.40b 11.56a 22.17a
40 Angiotensin II 1.10b 11.94a 9.94°
a, b, c, Least square means in each column vith same superscript are 
not different (P<0.05)
A summary of the effects of temperature by treatment is presented in 
Table 28.
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Table 28: Summary of the statistical analysis for media concentration
of aldosterone, progesterone and cortisol (Adrenal Expt. II)
Comparisons Aldosterone Progesterone Cortisol
Control 37°C vs
Control 40°C ** NS **
ACTH 37°C vs
ACTH 40°C ** NS **
Angiotensin II 37°C vs 
Angiotensin II 40°C ** NS **
** P<0.01
NS Not Significant
The analyses of variance for aldosterone, progesterone and cortisol are
presented in Tables 29, 30 and 31, respectively. Only cortisol had a
significant temperature * treatment interaction.
Table 29: Summary of the statistical model for aldosterone secretion
in Adrenal Bxpt. II
Source DP SS PR>F
Temperature 1 0.0943 0.0001
Treatment 2 0.0046 0.0785
Temperature * Treatment 2 0.0017 0.3345
Rep(Temperature * Treatment) 12 0.0087 0.0001
Date 11 0.0071 0.0003
Date * Temperature 11 0.0111 0.0001
Date * Treatment 22 0.0037 0.5773
Date * Temperature * Treatment 22 0.0054 0.1667
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Table 30: Summary of the statistical model for progesterone secretion
in Adrenal Expt. II
Source DF SS PR>F
Temperature 1 5.83 0.7666
Treatment 2 28.27 0.8030
Temperature * Treatment 2 20.09 0.8549
Rep(Temperature * Treatment) 12 759.16 0.0001
Date 11 212.91 0.0001
Date * Temperature 11 267.84 0.0001
Date * Treatment 22 198.67 0.0010
Date * Temperature * Treatment 22 120.70 0.0925
Table 31: Summary of the statistical model for cortisol secretion in
Adrenal Expt. II
Source DF SS PR>F
Temperature 1 54928.61 0.0001
Treatment 2 68930.32 0.0001
Temperature * Treatment 2 30087.05 0.0001
Rep(Temperature * Treatment) 12 3848.80 0.0001
Date 11 58576.69 0.0001
Date * Temperature 11 29368.29 0.0001
Date * Treatment 22 49242.90 0.0001
Date * Temperature * Treatment 22 22127.23 0.0001
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Discussion:
In Adrenal Experiment II, the higher incubation temperature suppressed 
cortisol production. Progesterone concentration was unaltered by tem­
perature. Since progesterone is an intermediate metabolite in the ad­
renal steroidogenic pathway, its level could be used to indicate the 
level of enzymatic activity (Fig. 1). If its concentration increases 
it could indicate either increased production or decreased use since 
progesterone is a substrate for other adrenal hormones. Progesterone 
may be converted to either 11-deoxycorticosterone via the 21 fj-hydroxy- 
lase enzyme system or to 17-hydroxyprogesterone via the 17 ot-hydroxy- 
lase enzyme system. The 21 p-hydroxylase enzyme commits progesterone 
to the mineralocorticoid pathway whereas the 17 a-hydroxylase enzyme 
commits progesterone to either the glucocorticoid or sex-steroid path­
way.
Angiotensin II had no effect on the 18-OH-dehydrogenase enzyme since 
aldosterone production was not increased above control levels. This 
could be due to the concentration of Angiotensin II being too low, de­
pressed levels of the steroidogenic intermediates or other unrecognized 
factors. The concentration of angiotensin II (10~^M) was selected from 
a study by Crivello et al. (1982) using cultured bovine adrenocortical 
zona glomerulosa cells. In the study human angiotensin II was used and 
increased aldosterone synthesis was obtained. Hornsby (1980) reported 
that elevated levels of cortisol induced by ACTH administration in 
bovine adrenalocortical culture may inactivate the 11 (3- and 18-hydro­
xylase enzymes. Levels of cortisol in the control and angiotensin II 
wells (16.26 ng/ml and 17.59 ng/ml) were significantly lower than
levels in the ACTH wells (54.80 ng/ml). However, aldosterone levels 
were not significantly different between ACTH and angiotensin II treat­
ments. Perkinson et al. (1984) reported relative insensitivity of 
glomerulosa cells to angiotensin II stimulation due to factors such as 
potassium, sodium, calcium and previous exposure to angiotensin II. 
Further work is needed with regards to the 18-0H-dehydrogenase enzyme 
system and its level of activity in relation to time in culture.
Adrenal Experiment III
Adrenal Expt. II was repeated and an ACTH with Angiotensin II treatment
n
evaluated at both incubation temperatures. Dexamethasone (10 M) was 
added to the treatments to see if it had a latent effect on adrenal 
ACTH-stimulated steroidogenesis as suggested by Toutain et al., (1982).
Method:
Bovine adrenocortical cells were established in primary culture by the 
method used by Kramer et al., (1983), (General Materials and Methods). 
A confluent monolayer was acheived in approximately 6 days. Upon 
reaching confluency, half of the wells were assigned to the 40°C incu­
bation temperature while the other half remained at 37°C. After a 
48-hr acclimatization period at the higher incubation temperature, 4 
wells each were assigned to the following treatments:
37°C
Control (No Treatments) 
ACTH (10"7M) 
Angiotensin II (10_7M) 
ACTH (10-7M) and
Angiotensin II (10~7M)
* -7Dexamethasone (10 M)
40°C
Control (No Treatments) 
ACTH (10_7M)
Angiotensin II (10-7M) 
ACTH (10"7M) and 
Angiotensin II (1(T7M) 
Dexamethasone* (10“7M)
Dexamethasone was added to the media for 48 hr continuously. There­
after, media was harvested and replaced with media containing ACTH.
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Media vere then harvested every 48 hr and steroid concentration was 
analysed after addition of 10-  ^M ACTH and 10-  ^M Angiotensin II to the 
culture media for 48-hr periods over 240 hr.
Analysis of variance vas performed on data with the General Linear 
Model procedure of the statistical analysis system (SAS, 1985) Using a 
split-plot model. All possible two-way interactions vere considered. 
Duncan's multiple-range test vas used to assess the significance of 
differences among treatment means (Steel and Torrie, 1980). Statisti­
cal significance was set at P<0.05.
Results:
Aldosterone, progesterone, cortisol and corticosterone production at 
the two incubation temperatures and the various treatments are shown in 
Figs. 25, 26, 27, 28 29, 30, 31 and 32. In Figs. 25 and 26 aldoste­
rone production was close to peak levels prior to the addition of 
treatments, and declined to base line by approximately 150 hr. Proges­
terone levels also declined after the addition of treatments (Figs. 27 
and 28). Cortisol levels were, however, increased by treatments, with 
peak levels ocurring at approximately 50 hr after the addition of 
treatments (Figs. 29 and 30). Corticosterone declined with time after 
the addition of treatments (Figs. 31 and 32).
Tables 32 and 33 show the least square means of hormonal production at 
the .two incubation temperatures and the various treatments, respective­
ly. The 40°G incubation temperature decreased aldosterone production 
(P<0.01) and increased progesterone (P<0.01) and cortisol production
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Figure 25: Mean (n=41 aldosterone profiles in Adrenal Bxpt~ III vith
and without ACTH (10 H), angiotensin II (10~LH), ACTH (10 M) with 
angiotensin II (10~ H) and dexaaethasone (10 H) at 3£°C. Standard 
deviations are presented in the Appendices, Table 71.
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0 hr represents a 48-hr preincubation period at the respective tem­
perature prior to the addition of treatments. 48 hr represents a 48-hr 
incubation period vith treatments which vere added at 0 hr.
Dexamethasone vas added at 0 hr and removed at 48 hr. Thereafter,
cells vere stimulated vith ACTH (10 H).
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Figure 26: Mean (n=41 aldosterone profiles in Adrenal Expt. Ill vith
and vithout ACTH (10 H)f angiotensin II (10%H), ACTH (10~ H) vith 
angiotensin II (10~ H) and dexamethasone (10 H) at 4g°C. Standard 
deviations are presented in the Appendices, Table 71.
0 hr represents a 48-hr preincubation period at the respective tem­
perature prior to the addition of treatments. 48 hr represents a 48-hr 
incubation period vith treatments vhich vere added at 0 hr.
Dexamethasone vas added at 0 hr and removed at 48 hr. Thereafter,
cells vere stimulated vith ACTH (10 H).
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Figure 27: Hean (n=n41 progesterone profilesin Adrenal Expt. Ill v;
and vithout ACTH (10“ H), angiotensin II (10 'd), ACTH (10H) vith 
angiotensin II (10 H) and dexamethasone (10M) at 3J°C. Standard 
deviations are presented in the Appendices, Table 71.
0 hr represents a 48-hr preincubation period at the respective tem­
perature prior to the addition of treatments. 48 hr represents a 48-hr 
incubation period vith treatments which vere added at 0 hr.
Dexaaethasone vas added at 0 hr and reaoved at 48 hr. Thereafter,
cells vere stimulated vith ACTH (10“ H).
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Figure 28: Hean (n=41 progesterone profilesin Adrenal Expt. Ill vith
and without ACTH (10 H), angiotensin II (10 _H)t ACTH (10 H) vith 
angiotensin II (10“ H) and dexamethasone (10“ H) at 4J C. Standard 
deviations are presented in the Appendices, Table 71.
*
0 hr represents a 48-hr preincubation period at the respective tem­
perature prior to the addition of treatments. 48 hr represents a 48-hr 
incubation period vith treatments which vere added at 0 hr.
Dexamethasone vas added at 0 hr and removed at 48 hr. Thereafter,
cells vere stimulated vith ACTH (10 H).
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Figure 29: Meaning) cortisol profilesin Adrenal Expt. Ill vith and
without ACTH (10 M), angiotensin II (10- M), ACTH (10 M) vith angio­
tensin II (10 H) and dexamethasone (10” H) at 3J°C. Standard devia­
tions are presented in the Appendices, Table 71.
£
0 hr represents a 48-hr preincubation period at the respective tem­
perature prior to the addition of treatments. 48 hr represents a 48-hr 
incubation period vith treatments which vere added at 0 hr.
Dexamethasone vas added at 0 hr and removed at 48 hr. Thereafter,
cells vere stimulated vith ACTH (10 M).
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Figure 30: Mean £n=4) cortisol profiles in Adrenal Expt. Ill vith and
without ACTH (10" M), angiotensin II (10~ M)f ACTH (10" M) vith angio­
tensin II (10" M) and dexaaethasone (10 H) at 4Q°C. Standard devia­
tions are presented in the Appendices, Table 71.
0 hr represents a 48-hr preincubation period at the respective tem­
perature prior to the addition of treatments. 48 hr represents a 48-hr 
Incubation period vith treatments vhich vere added at 0 hr.
Dexamethasone vas added at 0 hr and removed at 48 hr. Thereafter,
cells vere stimulated vith ACTH (10 H).
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Figure 31: Mean (n=4) corticosterone profiles in Adrenal Expt. Ill
vith and without ACTH <1Q M), angiotensin II (10"'h), ACTH (10“'h) 
vith angiotensin II (10“ M) and dexamethasone (10” M) at 3£°C. Stan­
dard deviations are presented in the Appendices, Table 71.
*
0 hr represents a 48-hr preincubation period at the respective tem­
perature prior to the addition of treatments. 48 hr represents a 48-hr 
incubation period vith treatments vhich vere added at 0 hr.
Dexamethasone vas added at 0 hr and removed at 48 hr. Thereafter,
cells vere stimulated vith ACTH (10” M).
116
600 - i
o> n  Control 
♦  ACTH 
n Angiotensin 
o ACTH & Ang. 
x Dexamethasone
500
400 -
300 -
200 -
100 
o =• 
o 200100 300
HOURS
Figure 32: Kean (n=4) corticosterone profiles in Adrenal Expt. Ill
vith and vithout ACTH (10 H), angiotensin II (10“.Jh), ACTH (10 M) 
vith angiotensin II (10 H) and dexamethasone (10 M) at 40°C. Stan­
dard deviations are presented in the Appendices, Table 71.
0 hr represents a 48-hr preincubation period at the respective ten- 
perature prior to the addition of treatments. 48 hr represents a 48-hr 
incubation period vith treatments vhich vere added at 0 hr.
**Dexamethasone vas added at 0 hr and removed at 48 hr. Thereafter,
cells vere stimulated vith ACTH (10 M).
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(P<0.01). Treatment did not significantly alter aldosterone and corti­
costerone production. Treatment, however, was significant for proges­
terone (P<0.01) and cortisol production (P<0.01).
Table 32: Least square means of adrenal hormones from bovine adreno­
cortical culture Expt. Ill at the two incubation temperatures
Tempera­
ture
Aldos­
terone
(ng/dl)
Proges­
terone
(ng/ml)
Cortisol
(ng/ml)
Corticos­
terone
(ng/ml)
37°C 0.54 5.40 170.19 169.04
40°C 0.19a 8.78a 277.24a 178.14
a, Different from least square mean at 37°C (P<0.01)
Table 33: Least square means of adrenal hormones from bovine adreno-
cortical culture Expt. Ill at the various treatments
Treat­
ment
Aldos­
terone
(ng/dl)
Proges­
terone
(ng/ml)
Cortisol
(ng/ml)
Corticos-
terone
(ng/ml)
Control 0.37a 12.51a 68.86a 185.68a
ACTH 0.36a 3.89b 337.62b 169.30a
Angiotensin II 0.41a 7.28° 92.13a 146.24
ACTH and 
Angiotensin II 0.44a 4.27b 286.31b 195.66a
Dexamethasone
(pretreatment)
0.34a 7.50C 333.66b 171.0Ba
a, b, c, Least square means in each column vith the same superscript 
are not different (P<0.01)
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Tables 34 and 35 show the least square means for the two incubation 
temperatures and five treatments. Control 40°C had lower levels of 
aldosterone (P<0.01) than the control treatment at 37°C. Cortisol and 
corticosterone levels were, however, not significantly different in the 
control wells at the two incubation temperatures. ACTH at 40°C had 
decreased aldosterone (P<0.01) and higher cortisol production (P<0.01). 
Progesterone and corticosterone levels were not significantly different 
with ACTH treatment at the two incubation temperatures. Angiotensin II 
at 40°C decreased aldosterone production over angiotensin II at 37°C. 
ACTH with angiotensin II at 40°C gave decreased aldosterone production 
over ACTH with angiotensin II at 37°C. Higher levels of cortisol were, 
however, produced at the 40°C incubation temperature in the ACTH with 
Angiotensin II treatment. Dexamethasone pretreatment did not alter 
subsequent ACTH-stimulated cortisol release. After the media change 
cortisol levels increased and peaked at approximately 100 hr (Figs. 29 
and 30).
Table 34: Least square means of adrenal hormones from bovine adreno­
cortical culture Expt. Ill, vith and vithout ACTH and angiotensin II,
at the tvo incubation temperatures
Tempera­
ture
<°C)
Treat­
ment
Aldos­
terone
(ng/dl)
Proges­
terone
(ng/ml)
Corti­
sol
(ng/ml)
Corticos­
terone
(ng/ml)
37 Control 0.53a 7.32a 52.29a 181.61a
37 ACTH 0.55ab 3.79a 281.73b 165.71a
37 Angioten­
sin II 0.63ac 5.10a 63.55ac 135.14a
37 ACTH A Angio­
tensin II 0.67bc 4.34a 215.56b 201.68a
37 Dexametha­
sone (Pre- 
treatment)
0.50a 6.48a 237.81b 161.06a
40 Control 0.21d 17.71b 85.42ad 189.75a
40 ACTH 0.18d 4.00a 393.51e 172.89a
40 Angioten­
sin II 0.20d 9.46a I20.71cd 157.34a
40 ACTH A Angio­
tensin 0.20d 4.21a 357.05e 189.64a
40 Dexametha­
sone (Pre­
treatment)
0.18d 8.52a 429.51e 181.10a
a, b, c, d, e, Least square means in each column vith the same super­
script are not different (P<0.05)
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Table 35: Summary of the statistical analysis for media concentrations
of aldosterone, progesterone, and cortisol (Adrenal Expt. Ill)
Comparisons Aldos­
terone
Proges­
terone
Corti­
sol
Corticos­
terone
Control 37°C vs 
Control 40°C ** ** NS NS
ACTH 37°C vs 
ACTH 40°C kk NS kk NS
Angiotensin II 37°C vs 
Angiotensin II 40°C kk dr* kk NS
ACTH & Angioten­
sin II 37 C vs ACTH & 
Angiotensin II 40°C kk NS ** NS
Dexamethasone 37°C vs 
Dexamethasone 40°C ** NS ** NS
** P<0.01
NS Not Significant
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The analyses of variance for aldosterone, progesterone, cortisol and 
corticosterone are presented in Tables 35, 36, 37 and 38, respectively.
Table 36: Summary of the statistical model for aldosterone secretion
in Adrenal Expt. Ill
Source DP SS PR>F
Temperature 1 7.22 0.0001
Treatment 4 0.27 0.2409
Temperature * Treatment 4 0.17 0.3974
Rep(Temperature * Treatment) 30 1.22 0.0710
Date 4 54.58 0.0001
Date * Temperature 4 9.57 0.0001
Date * Treatment 16 1.20 0.0010
Date * Temperature * Treatment 16 0.78 0.0001
Table 37: Summary of the statistical model for progesterone secretion
in Adrenal Expt. Ill
Source DF SS PR>F
Temperature 1 570.85 0.0004
Treatment 4 1911.09 0.0001
Temperature * Treatment 4 742.88 0.0027
RepCTemperature * Treatment) 30 1074.67 0.0002
Date 4 5925.59 0.0001
Date * Temperature 4 819.13 0.0001
Date * Treatment 16 3372.96 0.0001
Date * Temperature * Treatment 16 822.65 0.0001
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Table 38: Summary of the statistical model for cortisol secretion in
Adrenal Expt. Ill
Source DF SS PR>F
Temperature 1 572996.90 0.0001
Treatment' 4 2810969.64 0.0001
Temperature * Treatment 4 163267.73 0.0626
Rep(Temperature * Treatment) 30 487590.98 0.0001
Date 4 2099228.22 0.0001
Date * Temperature 4 92913.90 0.0001
Date * Treatment 16 2357545.64 0.0001
Date * Temperature * Treatment 16 118280.31 0.0124
Table 39: Summary of the statistical model for cortcosterone secretion
in Adrenal Expt. Ill
Source DF SS PR>F
Temperature 1 4146.41 0.4755
Treatment 4 56242.65 0.1608
Temperature * Treatment 4 7427.34 0.9171
Rep(Temperature * Treatment) 30 238198.14 0.0052
Date 4 794121.26 0.0001
Date * Temperature 4 142485.47 0.0001
Date * Treatment 16 37301.84 0.8932
Date * Temperature * Treatment 16 22408.74 0.9904
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Discussion:
In Adrenal Expt. Ill, the higher incubation temperature increased cor­
tisol production. This vas not consistent vith results obtained in
Expts. I and II. Levels of progesterone vere increased at the higher 
incubation temperature.
Aldosterone vas again depressed by half at the higher incubation 
temperature. The results clearly support the hypothesis that there may 
be temperature sensitive enzymes in the system.
Levels of corticosterone in the media vere measured to see if there vas 
a build up of this intermediate along the aldosterone pathvay. Incuba­
tion temperatures did not affect corticosterone levels. This there­
fore suggests that the 21 0- and 11 3-hydroxylase enzymes in the al­
dosterone biosynthetic pathvay are unaffected by temperature.
Angiotensin II did not have any effect on aldosterone production since 
levels of aldosterone vere not significantly different in the control 
and the angiotensin II veils. The concentration of angiotensin II 
added to the system may be the major cause of this. Added to this, 
none of the treatments used in this study had a significant effect on 
aldosterone synthesis (Table 36).
The combination of ACTH and angiotensin II increased cortisol levels 
significantly above angiotensin II by itself. This effect vas due to 
ACTH since there vas no significant difference in cortisol levels be- 
tveen ACTH and ACTH vith angiotensin II.
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Dexamethasone treatment did not have a lasting effect on adrenal ste­
roidogenesis since levels of cortisol vere not significantly different 
between wells which contained dexamethasone treatment for a 48-hr peri­
od followed by ACTH stimulation and wells which were- stimulated with 
ACTH from the beginning.
Adrenal Experiment IV
Levels of 17 a- and 11 ^-hydroxylase enzymes were evaluated by bioas­
say. The 17 a-hydroxylase enzyme is involved in the conversion of 
pregnenolone and progesterone to 17-hydroxypregnenolone and 17-hydroxy- 
progesterone, respectively, in the cortisol biosynthetic pathway. The 
11 fi-hydroxylase enzyme converts 11-deoxycorticosterone to corticoste­
rone in the aldosterone pathway and 11-deoxycortisol to cortisol in the 
cortisol pathway (Fig. 1). The levels of these enzymes as measured by 
bioassay should reflect the steroidogenic ability of the adrenalcorti- 
cal monolayer.
Kethod:
Primary culture of bovine adrenocortical cells were established using 
the method of Kramer et al., (1983), (General Materials and Methods). 
Confluent monolayers were reached in approximately 7 days. When con- 
fluency was reached, horse serum was reduced to 2.5% and FGF vas re­
moved from the media.
Prior to wells being assigned to temperature treatments levels of 17 a- 
and 11 {3-hydroxylase, activities were measured using the following pro­
cedure:
1. The 11 0-hydroxylase activity was assayed by the rate of conversion 
of .11-deoxycortisol to cortisol by intact cells incubated in the 
presence of aminogluthethimide (0.5 mM). Aminogluthethimide is an
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inhibitor of cholesterol side-chain cleavage. This completely 
inhibited the production of steroids from endogenous substrates (Kra­
mer et al., 1983).
2. The 17 a-hydroxylase activity was assayed by the rate of conversion 
of progesterone to androstenedione.
Ascorbic acid (4 mM) vas added to the incubation media since it is a 
powerful inhibitor of 21 P-hydroxylation (Greenfield et al., 1980). 
Inhibiting the 21-hydroxylase enzyme ensured that the products (andro­
stenedione and cortisol) were from the exogenous substrates (progester­
one and 11-deoxycortisol), (Figs. 1 and 2).
The incubation media contained progesterone (75 uM), 11-deoxycortisol 
(75 uM), aminogluthethimide (0.5 mM) and ascorbic acid (4 mM), (Sigma 
Chemical Co., St. Louis, MO), in Ham's F-12/DMEM (1:1 v/v), vith Hepes 
(25 mM) buffer (pH 7.4). Incubation time was 120 min at 37°C. There­
after, media were harvested and replaced with media containing 2.5% fe­
tal calf serum, 100 IU penicillin, 100 ug/ml streptomycin, and 0.25 
ng/ml fungizone, with no 11-deoxycortisol, progesterone, aminogluthe­
thimide and ascorbic acid. Veils vere then assigned to 37°C and 40°C 
prior to assignment to treatment groups. After a 24 hr acclimatization 
at the designated temperature, 4 wells each were assigned to the fol­
lowing treatments:
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37°C 40°C
No ACTH 
ACTH (10"7M) 
Angiotensin II (10~7M) 
ACTH (10-7M) and 
Angiotensin II (10~7M)
No ACTH 
ACTH (10"7H) 
Angiotensin II (10“7M) 
ACTH <10-7M) and 
Angiotensin II (10-7M)
The experiment vas terminated after 96 hrs vith media being replaced 
every 48 hrs. At the termination of the experiment the bioassay for 17 
a- and 11 |3-hydroylases vas repeated. Harvested media vere analysed 
for cortisol and androstenedione.
Analysis of variance vas performed on data vith the General Linear 
Model procedure of the statistical analysis system (SAS, 1985) using a 
split-plot model. All possible tvo-vay interactions vere considered. 
Duncan's multiple-range test vas used to assess the significance of 
differences among treatment means (Steel and Torrie, 1980). Statisti­
cal significance vas set at P<0.05.
Mean and standard deviation for cortisol and androstenedione production 
prior to temperature stress and ACTH and Angiotensin II treatment vere 
104.99 + 9.37 ng/ml and 8.76 + 4.52 ng/ml, respectively. After 96 hrs 
at their respective temperatures vith ACTH and Angiotensin II treat­
ments, mean levels of cortisol and androstenedione produced vere higher 
at the lover incubation temperature (P<0.01) (Table 40).
Results:
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Table 40: Mean adrenal hormones for bovine adrenocortical culture
Expt. IV the tvo incubation temperatures after 96 hr treatment
Temperature Cortisol Androstenedione
(°C) (ng/ml) (ng/ml)
37 47.05 27.03
40 40.98 23.86a
a, Least square mean different from 37°C (P<0.01)
Treatment was not significant for cortisol but was significant for 
androstenedione (P<0.01) production. Table 41 shows the least square 
means for cortisol and androstenedione by temperature and treatment.
Table 41: Least square mean adrenal hormones for bovine adrenocortical
culture Expt. IV, with and without ACTH and angiotensin II, at the tvo 
incubation temperatures
Treatment Cortisol Androstenedione
(ng/ml) (ng/ml)
Control 37°C vs 39.62 23.69
Control 40°C 42.20 14.47
ACTH 37°C vs 50.51 25.53
ACTH 40°C 41.64 23.38
Angiotensin II 37°C vs 45.63 30.61
Angiotensin II 40°C 35.65 27.67
ACTH and Angiotensin II 37°C 52.43 28.30
vs
ACTH and Angiotensin II 40°C 44.40 29.91
^Significantly different (P<0*01)
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The analyses of variance for cortisol and corticosterone are presented 
in Tables 42 and 43.
Table 42: Summary of the statistical model for cortisol secretion in
Adrenal Expt. IV
Source DF SS PR>F
Temperature 1 47.04 0.2780
Treatment 3 104.84 0.4484
Temperature * Treatment 3 167.89 0.2489
Rep(Temperature * Treatment) 24 916.45 0.7950
Date 1 59502.45 0.0001
Date * Temperature 1 970.71 0.0003
Date * Treatment 3 486.81 0.0493
Date * Temperature * Treatment 3 302.47 0.1602
Table 43: Summary of the statistical 
tion in Adrenal Expt. IV
model for androstenedione secre-
Source DF SS PR>F
Temperature 1 243.39 0.0018
Treatment 3 191.64 0.0400
Temperature * Treatment 3 87.86 0.2444
Rep(Temperature * Treatment) 24 474.11 0.0304
Date 1 4450.39 0.0001
Date * Temperature 1 8.34 0.3460
Date * Treatment 3 532.05 0.0001
Date * Temperature * Treatment 3 50.47 0.1628
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Discussion:
Levels of cortisol produced reflect the 11 0-hydroxylase enzyme system 
and levels of androstenedione the 17 a-hydroxylase enzyme system. The 
11 0-hydroxylase was unaffected by temperature since there was no dif­
ference in cortisol levels at the two incubation temperatures. The 17 
a-hydroxylase enzyme activity was depressed at the higher incubation 
temperature since less androstenedione was produced at 40°C (P<0.01).
In Adrenal Expt. I (Phase II) and Adrenal Expt. II, decreased levels of 
cortisol were produced at the higher incubation temperature. This is 
further validated by the lower levels of androstenedione produced at 
the 40°C incubation temperature. These results, however, conflict with 
results obtained in Expt. I (Phase I) in which temperature had no ef­
fect on cortisol levels, and Expt. Ill in which higher levels of corti­
sol were produced at the higher incubation temperature.
In Adrenal Expts. I (Phases I and II), II, and III, aldosterone pro­
duction was depressed at the higher incubation temperature. Tempera­
ture was, however, not significant for corticosterone production 
(Adrenal Expt. Ill), which suggests no alteration in 11 0-hydroxylase 
activity at the two incubation temperatures in the aldosterone pathvay. 
Furthermore, levels of cortisol were higher at the 40°C incubation 
temperature in Adrenal Expt. Ill, suggesting an increase in 11 0-hydro- 
xylase activity. In the bioassay, androstenedione levels vere de­
creased at the 40°C incubation temperature, indicating a decrease in 17 
a-hydroxylase activity along the cortisol pathway.
Adrenal Experiment V
The principle physiologic effect of arginine vasopressin (AVP) is re­
tention of water by the kidney. It is proposed to be increased in heat 
stress (El-Nouty et al., 1980). The following mechanism concerning 
heat stress and increased AVP has been proposed.
Increased levels of AVP decrease the activity of the 17 a-hydroxylase 
enzyme (Wathes 1983). As a result, levels of progesterone are elevated 
and cortisol, testosterone and estradiol biosynthesis supressed. High­
er levels of corticosterone, due to the increase in progesterone syn­
thesis, result in increased mineralocorticoid activity. The end re­
sult is an increase in atrial natriuretic peptide which inhibits al­
dosterone production (Anderson and Bloom, 1985). The effect of AVP on 
the 17 a-hydroxylase enzyme was evaluated at the two incubation tem­
peratures by measuring levels of cortisol and aldosterone produced.
Methods:
Bovine adrenocortical cells were established in primary culture using 
the method already described by Kramer et al., (1983), (General Materi­
als and Methods). Confluent monolayers were reached in approximately 8 
days. At confluency, wells were assigned to their respective tempera­
tures for a 24-hr acclimatization period. Four wells each were assign­
ed to the following treatments:
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37°C 40°C
Control (No AVP, ACTH and Control (No AVP, ACTH and 
Angiotensin II)
AVP (10“7H)
AVP (10~7M) and ACTH (10~7M) 
AVP (10"7M), ACTH (10~7M) and 
Angiotensin II
Angiotensin II)
AVP (10“7)
AVP (10“7) and ACTH (10“7M) 
AVP (10“7), ACTH (10-7M) and
Angiotensin II
Media vere harvested every 48 hrs and assayed for cortisol and aldoste­
rone.
Analysis of variance vas performed on data with the General Linear 
Model procedure of the statistical analysis system (SAS, 1985) using a 
split-plot model. All possible two-way interactions were considered. 
Duncan's multiple-range test was used to assess the significance of 
differences among treatment means (Steel and Torrie, 1980). Statisti­
cal significance was set at P<0.05.
Aldosterone and cortisol production at the two incubation temperatures, 
with and without AVP, is shown in Pigs. 33 and 34, respectively. Al­
dosterone production was suppressed (P<0.01) and cortisol increased 
(P<0.01) at the higher incubation temperature (Table 44) over all 
treatments.
Results:
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Figure 33: Mean (n=41 cortisol profiles in Adrenal Bxpt. V with and
vithout arginine (10 H), ACTH (10 H) and angiotensin II (10“ M) at 
the two incubation temperatures• Standard deviations are presented in. 
the Appendices, Table 73.
*48 hr represents a 48-hr incubation with treatments at the respective
temperatures.
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Figure 34: Mean (n=4i aldosteronenrofiles in Adrenal Expt. V?vith and
without arginine (10 M), ACTH (10 M) and angiotensin II (10 H) at 
the two incubation temperatures. Standard deviations are presented in 
the Appendices, Table 73.
*48 hr represents a 48-hr incubation vlth treatments at the respective
temperatures.
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Table 44: Least square means of hormones from bovine adrenocortical
culture Sxpt. V at the tvo incubation temperatures
Temperature Aldosterone Cortisol
<°C) (ng/dl) (ng/ml)
37 21.21 112.93
40 7.32a 159.71a
a, Different from Least square means at 37°C
Table 45: Least square means of 
culture Expt. IV vith the various
hormones from bovine adrenalcortical 
: treatments
Treatment Aldosterone Cortisol
(ng/dl) (ng/ml)
Control 10.41a 13.86a
AVP 12.96ab 18.12a
AVP and ACTH
AVP, ACTH and 
Angiotensin II
16.97b
K
255.llb
16.71 258.16°
a, b, Least square means in each column vith the same superscript are 
not different (P<0.01)
Table 45 lists least square means for aldosterone and cortisol vith the 
various treatments.
AVP vith ACTH and AVP vith ACTH and Angiotensin II increased aldoste­
rone production over control veils (P<0.01 and P<0.01, respectively). 
There vas no significant difference in aldosterone production vith Con­
trol vs AVP. Cortisol levels vere not increased by arginine vasopres­
sin treatment. AVP vith ACTH and AVP vith ACTH and Angiotensin II
increased cortisol levels above control (P<0.01).
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The analyses o£ variance for cortisol and aldosterone production are 
presented in Tables 46 and 47. Temperature * treatment interactions 
were not significant for cortisol and aldosterone production.
Table 46: Summary of the statistical model for cortisol secretion in
Adrenal Expt. V
Source DF SS PR>F
Temperature 1 52506.34 0.0235
Treatment 3 1389949.08 0.0001
Temperature * Treatment 3 35920.21 0.2864
Rep(Temperature * Treatment) 24 215281.04 0.0034
Date 2 1957791.04 0.0001
Date * Temperature 2 49031.09 0.0024
Date * Treatment 6 1490534.49 0.0001
Date * Temperature * Treatment 6 33517.91 0.1798
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Table 47: Summary of the statistical model for aldosterone secretion
in Adrenal Expt. V
Source DF SS PR>F
Temperature 1 4634.26 0.0001
Treatment 3 716.58 0.0281
Temperature * Treatment 3 213.63 0.3792
Rep(Temperature * Treatment) 24 1592.86 0.1081
Date 2 28274.88 0.0001
Date * Temperature 2 936.08 0.0001
Date * Treatment 6 1037.76 0.0027
Date * Temperature * Treatment 16 359.21 0.2459
Discussion:
The results obtained in this experiment do not support the hypothesis 
that AVP is capable of decreasing the level of activity of the 17 a- 
hydroxylase enzyme thus increasing aldosterone production since there 
was no difference in aldosterone levels between control and AVP treat­
ments. Cortisol levels were also not depressed over the controls with 
AVP.
Again, temperature decreased aldosterone production at the higher incu­
bation temperature over all treatments. As in Expt. Ill, cortisol 
production was increased by the higher incubation temperature across 
all treatments.
Adrenal Experiment VI
Bovine adrenocortical cells in monolayer culture produce cortisol and 
respond to ACTH by an increase in cortisol secretion. Much of the cho­
lesterol that serves as a precursor for steroid hormone biosynthesis by 
these cells is derived from low-density lipoprotein (LDL) cholesterol 
that is taken up by endocytosis via specific receptors localized in the 
adrenocortical plasma membranes (Chatterton 1982). Bovine LDL 
(lOug/ml), (Simonian et al., 1982) was added to the culture media to 
evaluate its effect on adrenal steroidogenesis at the two incubation 
temperatures.
Bovine adrenocortical cells were established in primary culture using 
the method of Kramer et al. (1983), (General Materials and Methods). 
Confluent monolayers were reached in approximately 8 days. At conflu- 
ency wells were assigned to their respective temperatures for a 24-hr 
acclimatization period. Four wells each were then assigned to the 
following treatment groups:
Method:
37°C 40°C
No LDL and No ACTH No LDL and No ACTH
LDL (10 ug/ml) 
ACTH (10_7M)
LDL (10 ug/ml) 
ACTH (10"7M)
LDL (10 ug/ml) and 
ACTH (10"7M)
LDL (10 ug/ml) and 
ACTH (10_7M)
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Media was harvested at 48-hr intervals and was assayed for cortisol 
levels.
Analysis of variance was performed on data with the General Linear 
Model procedure of the statistical analysis system (SAS, 1985) using a 
split-plot model. All possible two-way interactions were considered. 
Duncan's multiple-range test was used to assess the significance of 
differences among treatment means (Steel and Torrie, 1980). Statisti­
cal significance was set at P<0.05.
Results:
Figure 35 shows the cortisol profiles with and without ACTH and LDL at 
the 37°C and 40°C incubation temperature. Higher levels of cortisol 
were produced at the higher incubation temperature (P<0.01), (Table 
48). Tables 48 and 49 list least square means for cortisol production 
at the two incubation temperatures and the various treatments, respec­
tively. LDL alone did not significantly increase cortisol levels above 
control. ACTH and ACTH with LDL had higher levels of cortisol than 
Control wells (P<0.01). There was also a significant difference be­
tween ACTH and ACTH and LDL treatments for cortisol production 
(P<0.01).
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Figure 35: Mean £n=4) cortisol profiles in Adrenal Expt. VI vith and
vithout ACTH (10~ M) and U)L (10 ug/al) at the tvo incubation tenpe- 
ratyres. Standard deviations are presented in the Appendices, Table
*
48 hr represents a 48-hr incubation vith treatments at the respective
tenperatures.
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Table 48: Least square means of cortisol from bovine adrenocortical
culture Expt. VI at the two incubation temperatures
Temperature Cortisol
<°C> (ng/ml)
37 128.33
40 150.35a
a, Least square mean different from 37°C (P<0.01)
Table 49: Least square means of cortisol from bovine adrenocortical 
culture Expt. VI vith and vithout ACTH or LDL
Treatment Cortisol
(ng/ml)
No LDL and No ACTH 18.12a
ACTH 176.57b
LDL 24.76a
ACTH and LDL 337.91c
a, b, c, Least mean squares in column vith the same superscript are not 
different (P<0.01)
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The analysis of variance for cortisol is presented in table 48.
Table 50: Summary of the statistical model for cortisol secretion in
Adrenal Expt. VI
Source DF SS PR>F
Temperature 1 11636.69 0.0211
Treatment 3 1647328.34 0.0001
Temperature * Treatment 3 76311.51 0.0001
Rep(Temperature * Treatment) 24 45879.41 0.1256
Date 2 1926836.00 0.0001
Date * Temperature 2 116678.58 0.0001
Date * Treatment 6 1608693.73 0.0001
Date * Temperature * Treatment 6 106575.95 0.0001
Discussion:
Ohashi et al., (1982) reported that in the absence of LDL, ACTH had no
effect on steroid biosynthesis. In our experiments, the incubation 
media included 2,5% fetal calf serum which served as a source of LDL. 
ACTH stimulates LDL metabolism in bovine adrenocortical cells by in­
creasing the number of LDL-binding sites in the plasma membrane (Ohashi 
et al., 1982). In an extensive study by Kovanen et al., (1979) evi­
dence was presented that quite high concentrations of LDL receptors 
were found in the plasma membranes of bovine adrenocortical cells and 
that cholesterol derived from LDL is a major contributor to the main- 
tainence of steroidogenesis.
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Higher levels of cortisol were produced at the higher incubation 
temperature. There was no difference between control and LDL treat­
ments indicating that without ACTH, LDL did not increase cortisol. 
ACTH increased cortisol levels (P<0.01). The combination of ACTH and 
LDL, however, doubled cortisol above the ACTH treatment. These results 
indicate that the amount of LDL present in the media may be a limiting 
factor in adrenal steroidogenesis.
Summary of Adrenal Experiments:
The results of adrenal experiments I, II and III are summarized in 
Tables 51 and 52. The mean values represent the concentrations of hor­
mones present in each replicate over the entire experimental period.
Table 51: Least square means of hormone concentrations for adreno­
cortical cells incubated at 37°C or 40°C (Listed by Expt. Number)
Treat- Expt. Aldos- Proges- Cortisol Cortlcos-
ment terone terone terone
37°C 40°C 37°C 40°C 37°C 40°C 37°C 40°C
(ng/dl) (ng/ml) (ng/ml) (ng/ml)
Control I(PI) 8.5 1.4 25.1 32.9 574.9 564.3 - -
I(PII) 2.6 0.8 37.0 43.4 46.4 25.5 - -
II 0.5 0.1 11.0 10.5 23.8 8.7 - _
III 0.5 0.2 7.3 17.7 52.3 85.4 181.6 189.8
ACTH I(PI) 4.2 2.6 11.3 10.2 1956.7 2215.1 - -
I(PII) 0.5 0.1 43.4 9.1 162.2 70.0 - -
II 0.6 0.1 10.7 11.6 87.4 22.2 - -
III 0.6 0.2 3.8 4.0 281.7 393.5 165.7 172.9
Del. I(PI> 3.0 13.4 2090.2
ACTH
I(PII) 0.5 10.4 “ 117.9 — — —
Angio­ II 0.05 0.01 11.3 11.9 25.2 9.9 _ _
tensin
III 0.6 0.2 5.1 9.5 63.6 120.7 135.1 157.3
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Table 52: Least square means of hormone concentrations for adreno­
cortical cells at the two incubation temperatures (Listed by Expt. 
Number)
Tempera­
ture
<°C)
Expt. Aldos­
terone
(ng/dl)
Proges­
terone
(ng/ml)
Cortisol
(ng/ml)
Corticos­
terone
(ng/ml)
37 I(PI) Non-Est Non-Est Non-Est -
I(PII) 1.18 19.44 108.82 -
II 0.50 10.99 45.50 -
III 0.57 5.40 170.19 169.19
40 I(PI) 2.31 18.82 1623.20 -
I(PII) Non-Es t Non-Est Non-Est _
II 0.10 11.32 13.61 -
III 0.19 8.78 277.24 178.14
In Expt. I, (Phase I) and Expt. Ill, the higher temperature tended to 
increase progesterone production (P<0.06 and P<0.01, respectively). 
Temperature was not significant for progesterone synthesis in Expt. I, 
(Phase II) and Expt. II. Generally, a change in temperature did not 
affect the progesterone response to the various treatments. ACTH de­
creased progesterone levels in Expt. I, (Phases I and II), and Expt. 
Ill regardless of temperature. In Expt. II, ACTH did not significantly 
decrease progesterone levels when compared with the control.
The . results for cortisol synthesis were varied. In Expt. I, Phase I, 
cortisol levels at the two incubation temperatures were not signifi­
cantly different. Temperature was, however, significant (P<0.02) for
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cortisol synthesis after the switch (Expt. I, Phase II). In Expt. II, 
the higher incubation temperature depressed cortisol synthesis in all 
treatments (P<0.01). Expt. II was distinctive in two other aspects. 
The level of cortisol synthesis was lower than in Expt. I, and the cor­
tisol peak common to all three experiments did not occur until after 
360 hr of incubation with treatment media (Fig. 24). In the other ex­
periments, it occurred within the first 72 hrs (Fig. 16). Cortisol
synthesis was increased for all treatments (P<0.01) at the higher incu­
bation temperature in Expt. Ill (Fig. 30, Table 32). In Expt. V and VI 
cortisol production was increased at the higher incubation temperature. 
LDl. increased cortisol production in Expt. VI.
Aldosterone levels were depressed (P<0.01) by the 40°C incubation tem­
perature in all treatments in Expts. I, (Phase I and II), II, III and 
V. Angiotensin II and AVP treatments did not alter aldosterone levels 
from those in the ACTH or control wells.
In Expt. IV, the results of a bioassay indicated depressed 17 a-hy­
droxylase enzymatic activity at the higher incubation temperature. 
These results, however, conflict with the increased levels of cortisol 
obtained at the 40°C incubation in Expts. I (Phase I), III, V and VI. 
No change in the 11 ^-hydroxylase activity at the higher incubation
temperature does not support the depressed aldosterone production 
obtained in Expts. I, II, III and V at 40°C.
In summary, the experimental results support the hypothesis that ele­
vated body temperature may suppress some enzymes in the adrenal cortex.
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It was most fully supported by the effect of elevated temperature on 
aldosterone synthesis.
Granulosa Cell Culture
Objectives:
1. To observe the effect of chronic temperature stress on estradiol and 
progesterone production.
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Gwazdauskas (1985) reported lower levels of estrogens during the pro- 
estrus to metestrus period of the estrous cycle in heat-stressed cows. 
This may explain in part their shorter duration of estrus during heat 
stress. Conversely, Roman-Ponce et al., (1985) found that under na­
tural conditions of heat stress there was no overall difference in 
concentrations of estradiol and length of estrous cycles between cows 
with or without access to shade. Srikandakumar (1986) reported that 
total estrogens were unaltered by heat stress.
The effect of heat stress on progesterone levels is controversial. 
Several studies have reported that progesterone concentrations were re­
duced during the luteal phase of the estrous cycle (Rosenberg et al., 
1982, Stott and Wiersma, 1973). Hills et al., (1972) found higher le­
vels of progesterone in plasma near breeding. This was associated with 
reduced fertility. Srikandakumar (1986) reported that plasma progeste­
rone was unaltered by temperature.
The objective of this experiment was to evaluate the effects of heat 
stress on estradiol and progesterone production by bovine granulosa 
cells in culture.
Method:
Bovine granulosa cells were established in primary culture (General 
Materials and Methods). Cells were assigned to the following treat­
ments upon plating:
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37°C 40°C
Medium A (Basal Medium) Medium A (Basal Medium)
Medium B (Basal Medium & Medium B (Basal Medium A
1 ug/ml Testosterone) 1 ug/ml Testosterone)
Medium C (Basal Medium, Medium C (Basal Medium
1 ug/ml testosterone A 1 ug/ml testosterone &
0.1 ug/ml FSH) 0.1 ug/ml FSH)
The bovine granulosa cell culture experiment was repeated four times. 
Each trial was a seperate experiment vith fresh ovaries being harvested 
from the slaughter house. Ovaries were pooled. In trial IV, estrus vas 
synchronized vith prostaglandin 2 days prior to slaughter in an effort 
to harvest granulosa cells during the follicular stage of the estrous 
cycle.
Analysis of variance vas performed on data vith the General Linear 
Model procedure of the statistical analysis system (SAS, 1985) using a 
split-plot model. All possible tvo-vay interactions vere considered. 
Duncan's multiple-range test vas used to assess the significance of 
differences among treatment means (Steel and Torrie, 1980). Statisti­
cal significance vas set at P<0.05.
Results:
In .Trials I, II and III confluent monolayers vere reached in approxi­
mately 8, 9 and 16 days respectively.
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Effect of treatment:
Tables 53 and 54 show the least square mean estradiol and progesterone 
concentrations, respectively, in Trials I, II and III. Production of 
17 3-estradiol vas dependent upon the presence of testosterone as an 
aromatizable substrate. Fig. 36 illustrates the virtual lack of estra­
diol production by cells at 37°C (Trial I) in the basal medium. This 
trend was consistent in Trials II and III, also. This confirmed the 
absence of thecal cells in the culture.
Production of estradiol was greatly increased by testosterone (p<0.01) 
and FSH with testosterone (P<0.01) in all three trials. Progesterone 
synthesis was not affected by testosterone in Trial I (Figs. 37 and 
38). In Trial II, progesterone synthesis vas significantly altered by 
the media with higher levels being produced with testosterone and tes­
tosterone with FSH (P<0.01). In Trial III highest levels of progeste­
rone were produced in the basal media (P<0.01).
Table 53: Least square means of estradiol concentration (pg/ml) vith
the different media during the entire incubation period
Media Trial
I II III
A 18.89a 8.83a 2.98a
B 265.llb 127.58b 40.17b
C 303.02b 133.30b 41.86b
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Figure 36: Hean (n=>4) estradiol profiles in Ovarian Trial I vith
aediun* aediun containing testosterone* and aediun containing testos­
terone vith FSH at J7°C. Standard deviations are presented in the Ap­
pendices* Table 75.
0 day represents the tine of plating the cells.
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Figure 37: Hean (n«4) progesterone profiles in Ovarian Trial I vith
aediun, lediui containing testosterone and aediun containing testoste­
rone vith FSH at 37°C. Standard deviations are presented in the Ap­
pendices, Table 76.
*
0 day represents the tine of plating the cells.
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Table 54: Least square means of progesterone concentration (ng/ml)
vith the different media during the entire incubation period
Media
I
Trial
II III
A 58.78a 32.43a 65.40a
B 60.09a 154.81b 43.18b
C 77.75k 191.16b 54.83b
a, b, Least square means in columns vith the same superscript are not 
different (P<0.01)
Effect of temperature
Tables 55 and 56 show the least square means of estradiol and progeste­
rone in the four trials. The response of granulosa cells to tempera­
ture stress varied among the four trials. In Trial I, the effect of 
temperature on the production of estradiol and progesterone by cells 
incubated in Medium C (basal medium, testosterone and FSH) is shown in 
Fig. 39 (Tables 55 and 56). The higher incubation temperature increas­
ed both estradiol (P<0.01) and progesterone (P<0.01) production up to 
13 and 16 days in culture, respectively. Thereafter, the production of 
estradiol and progesterone declined to below the output by cells 
incubated at 37°C.
Fig. 40 illustrates the effect of temperature on estradiol and proges­
terone production by granulosa cells incubated in medium C at the two 
incubation temperatures in Trial II (Tables 55 and 56). Lower levels 
of estradiol were produced at the higher incubation temperature 
(P<0.01). There was, however, no significant difference in progeste­
rone levels at the two incubation temperatures. However, progesterone 
peaked a day earlier at the higher incubation temperature.
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Figure 40: Mean (n=4) estradiol and progesterone profiles in Ovarian
Trial II vith Medium containing testosterone and FSH at the tvo incuba­
tion temperatures. Standard deviations are presented in the Appendi­
ces, Tables 77 and 78.
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Lower levels of estradiol were produced at the higher incubation tem­
perature (P<0.01)in Trial III (Table 55). There was, however, no sig­
nificant difference in progesterone levels at the two incubation tem­
peratures (Table 56).
Table 55: Least square means of estradiol concentrations (pg/ml) in
medium C at the two incubation temperatures in the four trials
Temperature
(°C) I
Trial
II III IV
37 128.78 101.50 33.61 27.41
40 265.33a 78.31a 23.07a 26.68
a, Different from least square mean at 37°C
Table 56: Least square means of progesterone concentrations (ng/ml) in
medium C at the two incubation temperatures in the four trials
Temperature
<°C) I
Trial
II III IV
37 51.61 133.42 33.61 36.83
40 81.32a 118.84 23.07 36.54
a, Different from mean at 37°C
In Trial IV, cows were estrous synchronized. All cells were incubated 
in basal media containing FSH and testosterone. Confluent monolayers 
were reached in approximately 16 days. Temperature did not signifi­
cantly alter estradiol or progesterone concentration in the media.
The analyses of variance for estradiol and progesterone for granulosa 
cell Trials I, II, III and IV are shown in Tables 57 through 64, re­
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spectively.
Table 57: Summary of the statistical model for estradiol secretion in
granulosa cell Trial I
Source DF SS PR>F
Technician 1 659853.25 0.0001
Medium 2 3626546.63 0.0001
Temperature 1 1024694.31 0.0031
Temperature * Medium 2 565179.90 0.0729
Rep(Temperature * Medium * 
Technician)
29 2854913.67 0.0001
Days 7 5690660.65 0.0001
Medium * Days 14 4695462.44 0.0001
Temperature * Days 7 1676992.57 0.0001
Temperature * Medium * Days 14 1743291.27 0.0001
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Table 58: Summary of the statistical model for progesterone secretion
in granulosa cell Trial I
Source DF SS PR>F
Medium 2 8715.00 0.0001
Temperature 1 23050.20 0.0001
Temperature * Medium 2 5166.37 0.0001
Rep(Temperature * Medium) 29 1219.00 0.0009
Days 7 50942.75 0.0001
Medium * Days 14 12894.63 0.0001
Temperature * Days 7 22374.73 0.0001
Temperature * Medium * Days 14 3647.35 0.0001
Table 59: Summary of the statistical model for estradiol secretion in
granulosa cell Trial II
Source DF SS PR>F
Medium 2 592523.88 0.0001
Temperature 1 24197.61 0.0001
Temperature * Medium 2 20644.01 0.0001
Rep(Temperature * Medium) 12 5634.00 0.1702
Days 9 3289061.67 0.0001
Medium * Days 18 1431605.34 0.0001
Temperature * Days 9 225962.78 0.0001
Temperature * Medium * Days 18 128562.10 0.0001
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Table 60: Summary of the statistical model for progesterone secretion
in granulosa cell Trial II
Source DF SS PR>F
Hedium 2 912903.30 0.0001
Temperature 1 10522.24 0.3061
Temperature * Medium 2 29762.93 0.2391
Rep(Temperature * Medium) 12 110497.51 0.0001
Days 9 1123442.72 0.0001
Medium * Days 18 415221.45 0.0001
Temperature * Days 9 298239.03 0.0001
Temperature * Medium * Days 18 95632.99 0.0001
Table 61: Summary of the statistical model for estradiol secretion in
granulosa cell Trial III
Source DF SS PR>F
Medium 2 63732.40 0.0001
Temperature 1 5494.19 0.0001
Temperature * Medium 2 5399.07 0.0001
Rep(Teraperature * Medium) 12 180.12 0.4758
Days 10 123131.05 0.0001
Medium * Days 20 40352.04 0.0001
Temperature * Days 10 13446.20 0.0001
Temperature * Medium * Days 20 8297.37 0.0001
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Table 62: Summary of the statistical model for progesterone secretion
in granulosa cell Trial III
Source DF SS PR>F
Medium 2 9802.99 0.0001
Temperature 1 30.71 0.6453
Temperature * Medium 2 2806.47 0.0026
Rep(Temperature * Medium) 12 1653.67 0.0001
Days 10 621290.02 0.0001
Medium * Days 20 20722.43 0.0001
Temperature * Days 10 10573.67 0.0001
Temperature * Medium * Days 20 3652.59 0.0001
Table 63: Summary of the statistical model for estradiol secretion in
granulosa cell Trial IV
Source DF SS PR>F
Temperature 1 27.47 0.6683
Cow 2 198.78 0.5167
Temperature * Cow 2 490.56 0.2200
Rep(Temperature * Cow) 12 1708.90 0.2220
Days 11 173836.54 0.0001
Temperature * Days 11 1456.21 0.2833
Cow * Days 22 24143.61 0.0001
Temperature * Cow * Days 22 2470.06 0.4325
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Table 64: Summary of the statistical model for progesterone secretion
in granulosa cell Trial IV
Source DF SS PR>F
Temperature 1 4.46 0.9505
Cow 2 96893.75 0,0001
Temperature * Cow 2 6576.29 0.0903
Rep(Temperature * Cow) 12 13337.46 0.0001
Days 11 178095.66 0.0001
Temperature * Days 11 38940.22 0.0001
Cow * Days 22 54859.35 0.0001
Temperature * Cow * Days 22 4708.97 0.0470
Discussion:
A model of the current concepts of control of steroidogenesis in bovine 
preovulatory cells was proposed by Fortune (1981). Granulosa cells of 
cows are capable of producing estradiol only when provided with an aro- 
matizable substrate or co-cultured with thecal tissue (Hansel and 
Fortune* 1978). Progesterone is synthesized in both the theca interna 
and granulosa cells. Both cell types are involved in estradiol synthe­
sis. Estradiol is synthesized in the granulosa cells from androgens 
which are synthesized in the thecal cells. Aromatization is stimulated 
by FSH. This was validated in our experiment by the virtual lack of es­
tradiol production when the cells were cultivated in basal media only. 
The combination of FSH and testosterone tended to add cyclicity to the 
estradiol profile.
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Temperature increased estradiol and progesterone production in Trial I. 
In Trials II and III lower levels of estradiol were produced at the 
higher incubation temperature. Temperature, however, had no signifi­
cant effect on progesterone production. In Trial IV, temperature did 
not significantly affect estradiol or progesterone production. These 
results tend to be in favor of temperature not affecting progesterone. 
This of course, depends on the stage of the cycle of the harvested 
cells. Most of the cells were from ovaries in the mid-luteal stage of 
the cycle. Rosenberg et al., 1982 and Stott and Wiersma, 1973 reported 
reduced luteal progesterone during the luteal phase of the cycle in 
heat-stressed animals. These results conflict with the results obtain­
ed in our experiment. In the cell culture obtained from synchronized 
animals temperaure had no effect on progesterone production.
Temperature decreased estradiol production in two of the four trials, 
increased in one and had no effect in the other. The doubling of es­
tradiol production in Trial I at 40°C negates an absolute statement 
that high temperatures depress the enzymes necessary for converting 
testosterone to estradiol.
SUMMARY OP EXPERIMENTS
The main objective of this study was to test the hypothesis that re­
duced plasma levels of adrenal and ovarian hormones in heat-stressed 
cattle are due to depressed activities of temperature-sensitive enzymes 
in the adrenal cortex and ovary, respectively. An in-vitro approach 
was chosen because it was believed that tissue culture has the advan­
tage of an almost fully controlled environment.
A 37°C incubation temperature was chosen to represent our control 
studies since this was the reference temperature used in most of the 
in-vitro studies. Temperature stress was represented by a 40°C incuba­
tion temperature. The effect of elevated temperature on hormone syn­
thesis was, therefore, evaluated using an in-vitro system. Trophic 
hormones and other biological agents were added to the media. The ma­
jor effect, however, being evaluated was that of temperature.
The project involved three cell-culture systems: (1) anterior pituita­
ry, (2) adrenocortical and (3) granulosa. At the level of the pitui­
tary gland, questions concerning the control of the secretion of the
pituitary gonadotropins and the effect of temperature on GnRH receptors 
were addressed. In the adrenal and granulosa experiments, the effects 
of temperature on hormonal synthesis were evaluated.
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Pituitary Cell Culture:
Experiments I through III support the hypothesis that the 40°C incuba­
tion temperature depresses LH secretion. Neither GnRH nor GnRH with 
estradiol treatments had a significant effect on LH secretion in 
Pituitary Expts. I and III, respectively. However, in Expt. II the LH 
release resulting from GnRH and GnRH with estradiol stimulation was de­
creased at the higher incubation temperature. Expt. II also indicated 
that estradiol could directly stimulate LH release from the pituitary 
gonadotropes. In Pituitary Expt. Ill, gonadotropes treated with 0-en- 
dorphin at the higher incubation temperature had a depressed LH re­
sponse to GnRH stimulation.
It therefore appears that the higher incubation temperature decreased 
the secretion of LH from the gonadotropes in both stimulated and un­
stimulated cells. The endogenous opioids appear to play a role in the 
secretion of LH in temperature-stressed cells since at the 40°C incu­
bation temperature 0-endorphin supressed the release of LH. This in­
teraction between 0-endorphin and temperature was further reemphasized 
when the cells were stimulated with GnRH. Levels of stored hormone 
were measured in Expts. I and II. The effect of temperature on stored 
LH was inconsistent. Whether or not temperature affects LH synthesis 
is still unanswered.
GnRH receptor-labelling seemed to be the second step in identifying the 
source of altered hormonal secretion. There was, however, no diffe­
rence in the number of labeled gonadotropes at the two incubation tem­
peratures with the assay used. Therefore, the source of altered LH
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secretion in heat-stressed animals may be due to post-receptor condi­
tions not evaluated in the experiments.
No FSH was detected in the media with the available assay, although FSH 
labeled cells were observed in the culture by imraunocytochemistry. The 
sensitivity of the FSH assay was 1.8 ng/ml. Possible causes of the 
inability to measure any FSH may result from: (1) the sensitivity of
the assay (2) the concentration of FSH producing cells in culture and 
(3) lack of expression of FSH receptors due to the absence of GnRH in 
the media while the cells were growing to confluency.
Adrenal Cell Culture:
Results regarding the effect of temperature on adrenal steroidogenesis 
were varied. Aldosterone levels were consistently depressed by the 
higher incubation temperature in all the adrenal experiments. Cortisol 
levels were significantly depressed in two trials, significantly ele­
vated in three and not significantly different in two trials. Proges­
terone levels were increased at the higher incubation temperature in 
two experiments and unaltered by the 40°C temperature in two experi­
ments. Levels of corticosterone secreted into the media were not sig­
nificantly different at the two incubation temperatures in Expt. III.
The suppression of aldosterone at the higher incubation temperature 
supports the hypothesis of temperature-sensitive enzymes being af­
fected in the aldosterone biosynthetic pathway. Levels of progeste­
rone and corticosterone indicated a build up of intermediates along the 
steroidogenic pathways and, therefore, were not compared across ex­
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periments. It appears that the response of cortisol synthesis to ele­
vated incubation temperature is controlled by undefined factors. Ad­
dition of LDL to the media proved that the concentration of LDL in the 
media may be a limiting factor in steroidogenesis in-vitro. Since an 
undefined media was used and the source of sera was not the same in 
all experiments an additional source of variation was presented.
The bioassay for levels of 11 fJ- and 17 a-hydroxylase enzymes indicated 
suppression of 17 a-hydroxylase at the 40°C incubation temperature. 
This vas supported by the depressed levels of cortisol obtained in two 
of the adrenal experiments. The 11 (3-hydroxylase enzyme being unaf­
fected by temperature conflicts vith the lover levels of aldosterone 
produced at the 40°C incubation temperature. Further work with regard 
to the hydroxylase enzymes is therefore needed.
Granulosa Cell Culture:
Results regarding the effect of temperature on ovarian steroidogenesis 
were also inconsistent. Estradiol secretion was significantly increas­
ed in one experiment at 40°C, depressed in two others and unaltered in 
one. Progesterone vas increased in one experiment and not significant­
ly changed in three others. A source of this inconsistency vas thought 
to be the variation in the granulosa cells from the harvested ovaries. 
With ovaries from synchronized cows* there vas a significant difference 
among granulosa cells for progesterone production only, vith tempera­
ture not being significant for either estradiol or progesterone secre­
tion.
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An in-vitro approach to answering questions concerning the source of 
altered steroidogenesis in heat-stressed animals proved to be just as 
conflicting as the in-vivo approach. One of the main problems arising 
from this study was the inconsistency among experiments. This may be 
due to: (1) not knowing the physiological state of the cells prior to
harvest (2) a lack of understanding of factors which govern expression 
of cellular receptors in culture and (3) the inability to predict 
changes in cell response as the cells grew to maturity. Due to these 
inconsistencies inferences drawn from the study are limited. Further 
work should involve the use of a defined media or the same serum 
throughout the experiments. Receptor assays for trophic hormones and 
bioassays for cytochrome P-450's may prove to be invaluable tools. 
Either a closer look at the physiological changes in the cell receptors 
during division as the culture grows to confluency or taking samples as 
the cells grow to confluency may be a better approach. A cell culture 
approach should also be compared with a cell suspension or tissue 
perfusion method.
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APPENDICES
Table 65: Dataset for bovine anterior pituitary cell culture Expt.
(Mean LH concentrations (n=4) and standard deviations)
Time Treatment
(hr)
(preincubation)
0
.75
6.0
24.0
48.0
No GnRH 37°C 
GnRH (3 ng/ml) 
GnRH (30 ng/ml) 
No GnRH 40 C 
GnRH (3 ng/ml) 
GnRH (30 ng/ml)
No GnRH 37°C 
GnRH (3 ng/ml) 
GnRH (30 ng/ml) 
No GnRH 40DC 
GnRH (3 ng/ml) 
GnRH (30 ng/ml)
No GnRH 37°C 
GnRH (3 ng/ml) 
GnRH (30 ng/ml) 
No GnRH 40 C 
GnRH (3 ng/ml) 
GnRH (30 ng/ml)
No GnRH 37°C 
GnRH (3 ng/ml) 
GnRH (30 ng/ml) 
No GnRH 40 C 
GnRH (3 ng/ml) 
GnRH (30 ng/ml)
No GnRH 37°C 
GnRH (3 ng/ml) 
GnRH (30 ng/ml) 
No GnRH 40°C 
GnRH (3 ng/ml) 
GnRH (30 ng/ml)
No GnRH 37°C 
GnRH (3 ng/ml) 
GnRH (30 ng/ml) 
No GnRH 40°C 
GnRH (3 ng/ml) 
GnRH (30 ng/ml)
LH
(ng/ml)
16.08 + 7.11
17.25 + 3.53
19.97 + 7.40
11.98 + 2.39
11.98 + 4.43
18.72 + 3.76
26.27 + 19.57
29.24 + 11.38
13.66 ± 7.60
3.87 + 1.88
12.81 + 9.50
7.77 + 4.92
2.20 + 1.34
2.50 + 1.23
2.47 + 0.69
1.19 + 0.44
2.79 + 2.10
1.81 + 0.56
2.33 + 1.65
2.43 + 0.88
1.96 0.38
1.31 + 0.29
4.23 + 2.59
2.35 ± 0.52
8.63 + 7.82
6.11 + 1.21
5.10 + 1.11
4.09 + 1.49
6.64 + 3.12
4.55 + 1.38
4.82 + 3.14
4.58 + 1.55
4.25 + 1.18
2.62 + 0.80
5.38 + 2.63
3.91 + 0.92
Table 65 contd.: Dataset for bovine anterior pituitary cell culture
Expt. I (Mean LH concentrations (n=4) and standard 
deviations)
Time
(hr)
Treatment
96.0 No GnRH 37°C 
GnRH (3 ng/ml 
GnRH (30 ng/m 
No GnRH 40WC 
GnRH (3 ng/ml 
GnRH (30 ng/m
144.0 No GnRH 37°C 
GnRH (3 ng/ml 
GnRH (30 ng/m 
No GnRH 40 C 
GnRH (3 ng/ml 
GnRH (30 ng/ra
192.0 No GnRH 37°C 
GnRH (3 ng/ml 
GnRH (30 ng/m 
No GnRH 40°C 
GnRH (3 ng/ml 
GnRH (30 ng/m
Stored No GnRH 37°C 
GnRH (3 ng/ml 
GnRH (30 ng/m 
No GnRH 40 C 
GnRH (3 ng/ml 
GnRH (30 ng/m
LH
(ng/ml)
8.66 + 6.57
6.01 + 1.33
) 6.93 + 1.16
6.14 + 2.02
6.37 + 1.73
) 6.11 + 0.88
5.11 + 2.39
4.23 + 1.48
) 4.20 + 1.21
3.88 ± 1.56
5.00 ± 2.25
) 3.78 + 0.78
3.26 + 2.32
2.50 + 0.96
) 2.36 ± 0.59
6.47 + 9.73
5.58 + 4.10
) 3.06 + 0.87
6.89 + 0.33
8.40 + 2.00
) 7.64 + 0.22
9.33 + 5.37
14.28 + 3.23
) 17.70 + 3.33
190
Table 66 Dataset for bovine anterior pituitary cell culture Expt. II 
(Mean LH concentrations (n=4) and standard deviations)
Time
(hrs)
Treatment LH
(ng/ml)
24
48
72
No GnRH 37°C 2.78 + 1.71
GnRH (30 ng/ml) 4 * 06 + 1.30
Estradiol (50 ng/ml) 3.97 7 0.90
GnRH (30 ng/ml) and
Estradiol (50 ng/ml) 2.50 + 1.30
No GnRH 40 C 4.23 + 0.60
GnRH (30 ng/ml) 3.99 + 0.39
Estradiol (50 ng/ml) 4.06 + 0.83
GnRH (30 ng/ml) and
Estradiol (50 ng/ml) 3.62 + 0.62
No GnRH 37°C 10.90 + 4.83
GnRH (30 ng/ml) 18.24 + 9.01
Estradiol (50 ng/ml) 19.64 + 5.58
GnRH (30 ng/ml) and
Estradiol (50 ng/ml) 10.73 + 3.20
No GnRH 40 C 3.28 + 1.13
GnRH (30 ng/ml) 3.99 + 0.28
Estradiol (50 ng/ml) 5.09 + 2.03
GnRH (30 ng/ml) and
Estradiol (50 ng/ml) 5.15 + 1.59
No GnRH 37°C 1.46 + 0.81
GnRH (30 ng/ml) 3-15 ± 0.99
Estradiol (50 ng/ml) 3.06 + 0.79
GnRH (30 ng/ml) and
Estradiol (50 ng/ml) 2.10 + 0.56
No GnRH 40 C 1.35 + 0.40
GnRH (30 ng/ml) 2.12 + 0.23
Estradiol (50 ng/ml) 2.48 + 1.10
GnRH (30 ng/ml) and
Estradiol (50 ng/ml) 1.73 + 0.74
No GnRH 37°C 1.11 + 0.68
GnRH (30 ng/ml) 3.37 + 1.38
Estradiol (50 ng/ml) 1.89 + 0.58
GnRH (30 ng/ml) and
Estradiol (50 ng/ml) 1.28 + 0.89
No GnRH 40°C 1.17 + 0.49
GnRH (30 ng/ml) 2.42 + 1.64
Estradiol (50 ng/ml) 1-75 + 0.72
GnRH (30 ng/ml) and
Estradiol (50 ng/ml) 0.87 + 0.37
191
Table 6 Contd.: Dataset for bovine anterior pituitary cell culture
Expt. II (Mean LH concentrations (n=4) and standard 
deviations)
Time Treatment LH
(hrs) (ng/ml)
120
168
212
Stored
No GnRH 37°C 1.02 + 0.63
GnRH (30 ng/ml) 2.11 + 0.70
Estradiol (50 ng/ml) 
GnRH (30 ng/ml) and
1.80 + 1.02
Estradiol (50 ng/ml) 
No GnRH 40°C
1.26 + 0.66
1.58 + 0.89
GnRH (30 ng/ml) 1.78 + 0.73
Estradiol (50 ng/ml) 
GnRH (30 ng/ml) and
2.08 + 0.72
Estradiol (50 ng/ml) 1.34 + 0.63
No GnRH 37°C 2.44 + 2.25
GnRH (30 ng/ml) 2.62 + 1.21
Estradiol (50 ng/ml) 2.24 + 1.66
GnRH (30 ng/ml) and
Estradiol (50 ng/ral) 
No GnRH 40°C
2.28 + 1.50
1.84 + 1.02
GnRH (30 ng/ml) 3.05 + 0.71
Estradiol (50 ng/ml) 
GnRH (30 ng/ml) and
2.51 + 0.88
Estradiol (50 ng/ml) 1.83 + 0.23
No GnRH 37°C 0.79 + 0.56
GnRH (30 ng/ral) 1.14 + 1.01
Estradiol (50 ng/ml) i.Oi + 0.42
GnRH (30 ng/ml) and
Estradiol (50 ng/ml) 
No GnRH 40°C
0.57 + 0.40
0.53 + 0.19
GnRH (30 ng/ml) 0.90 + 0.29
Estradiol (ng/ml) 1.83 + 1.87
GnRH (30 ng/ml) and
Estradiol (50 ng/ml) 0.78 + 0.24
No GnRH 37°C 18.35 + 10.72
GnRH (30 ng/ml) 14.88 + 3.29
Estradiol (50 ng/ml) 1.4.25 + 4.60
GnRH (30 ng/ml) and
Estradiol (50 ng/ml) 
No GnRH 40°C
8.68 + 2.17
7.59 + 0.67
GnRH (30 ng/ml) 7.86 + 0.13
Estradiol (50 ng/ml) 11.31 + 4.27
GnRH (30 ng/ml) and
Estradiol (50 ng/ml) 10.66 + 0.93
192
Table 67: Dataset for bovine anterior pituitary cell culture Expt. IV
(Average number of cells stained for bio-GnRH in 12 fields)
Well 37°C 40°C
1 106 83
2 110 154
3 97 96
4 128 101
5 130 104
6 114 123
7 120 116
8 104 110
Table 68: Dataset for bovine adrenocortical culture Expt. 1 (Phase I)
(Means and standard deviations of adrenocortical cortical
hornones (n=4))
Tine
(hrs)
0
24
48
72
Treatment
Cortisol
(ng/al)
No ACTH 37°C 35.17 + 12.29
ACTH 51.27 + 35.98
No ACTH 40°C 56.45 + 22.27
Del. ACTH 70.23 + 38.98
ACTH 50.83 + 16.18
No ACTH 37°C 60.26 + 24.52
ACTH 72.50 + 32.29
No ACTH 40°C 83.15 + 25.84
Del. ACTH 100.50 + 10.43
ACTH 90.50 + 18.9
No ACTH 37°C 494.37 + 35.68
ACTH 1599.33 + 540.54
No ACTH 40°C 691.00 + 140.88
Del. ACTH 793.00 + 79.50
ACTH 2343.50 + 6.36
No ACTH 37°C 1412.33 + 151.40
ACTH 4603.67 + 826.78
No ACTH 40°C 2204.00 + 240.44
Del. ACTH 4874.67 + 148.14
ACTH 6188.00 + 110.27
Mean
Progesterone Aldosterone
(ng/al) (ng/dl)
29.13 + .83 .04 + .04
29.50 + 4.45 .60 + 1.00
37.87 + 11.19 .02 + .00
31.23 + 1.10 .02 + .00
28.93 + 1.68 .02 + .00
17.17 + 1.03 .02 + .00
15.90 + 3.77 .02 + .00
13.93 + .81 .02 + .00
15.37 + .59 .02 + .00
13.90 + 1.56 .02 + .00
13.23 + 2.18 .02 + .00
14.83 + 6.86 .27 + .00
19.67 + 1.40 .02 + .00
22.03 + 1.10 .02 + .00
23.57 + 3.86 1.32 + .70
11.13 + .55 .08 + .10
35.23 + 15.36 2.60 + .57
11.53 + .75 .02 + .00
46.40 + 8.39 3.33 + .25
17.87 + 1.51 3.29 + .52
Table 68 contd.: Dataset for bovine adrenocortical culture Expt. I
(Phase I) (Means and standard deviations of adreno­
cortical cortical hornones (n=4>)
Tine
(hrs)
120
168
216
264
Treatnent
Cortisol
(ng/nl)
Mo ACTH 37°C 2844.67 + 268.22
ACTH 7202.67 + 984.85
No ACTH 40°C 2294.33 + 87.88
Del. ACTH 8980.00 + 450.64
ACTH 8634.67 + 167.90
No ACTH 37°C 338.77 + 77.51
ACTH 2169.33 800.80
No ACTH 40°C 115.67 + 6.03
Del. ACTH 2662.67 + 419.69
ACTH 1967.00 4* 145.04
No ACTH 37°C 132.67 4- 20.50
ACTH 1745.00 + 517.05
No ACTH 40°C 63.33 + 8.62
Del. ACTH 1557.33 4- 222.87
ACTH 1072.00 + 186.97
No ACTH 37°C 100.33 + 6.67
ACTH 1109.67 + 328.66
No ACTH 40°C 100.33 + 31.02
Del. ACTH 730.00 + 158.07
ACTH 687.00 + 76.61
Mean
Progesterone Aldosterone
(ng/nl) (ng/dl)
16.80 + .35 7.23 4- 3.70
10.40 + 1.80 11.13 4- 5.00
25.00 + .36 4.53 + .82
16.43 + 4.48 10.68 4- 1.55
10.17 + 1.79 8.17 + .77
24.17 + 2.73 29.56 + 4.76
8.87 + .42 13.81 4- 2.71
40.07 + 1.70 4.15 4- 1.52
8.57 + 1.27 7.74 4- 1.65
7.43 + .60 6.68 + 1.11
37.43 + 2.86 20.83 4- 2.58
7.37 + .15 6.06 4- 2.08
38.30 + 6.22 .95 + .34
8.17 + .55 3.47 4- 1.46
7.83 + .15 2.54 + .52
35.67 + 3.01 10.38 4- 1.66
8.27 + .45 2.91 4- .67
33.33 4- 1.98 .60 + .20
7.90 4- 1.06 .98 4- .50
7.50 4- .26 .89 4- .57
LO
Table 68 contd.: Dataset for bovine adrenocortical culture Expt. I
(Phase I) (Means and standard deviations of adreno­
cortical cortical hornones (n=4))
Tine
(hrs)
312
360
408
456
Treatment
Cortisol
(ng/nl)
No ACTH 37°C 70.40 + 25.96
ACTH 386.76 + 56.77
No ACTH 40°C 42.87 + 9.00
Del. ACTH 486.87 + 126.98
ACTH 318.13 + 49.38
No ACTH 37°C 118.83 9.70
ACTH 299.00 + 90.80
No ACTH 40°C 50.53 + 15.74
Del. ACTH 305.50 + 95.47
ACTH 296.93 + 97.98
No ACTH 37°C 141.83 + 51.65
ACTH 245.97 + 119.86
No ACTH 40°C 53.03 + 26.18
Del. ACTH 184.30 + 80.49
ACTH 213.80 + 91.23
No ACTH 37°C 94.67 + 63.31
ACTH 132.77 + 38.92
No ACTH 40°C 27.90 + 7.60
Del. ACTH 327.93 + 80.13
ACTH 456.83 + 85.19
Kean
Progesterone Aldosterone
(ng/nl) (ng/dl)
29.37 + 9.75 4.92 + 2.08
10.93 + 2.87 1.70 + .82
29.30 + 3.34 .52 + .49
5.63 + .71 1.41 + .60
5.67 + .51 1.12 + .38
30.60 + 9.53 4.04 + 1.54
5.73 + 1.01 .88 + .67
38.83 + 5.49 1.24 + .08
5.97 + .15 .90 .32
6.77 + .55 1.37 .19
27.30 + 7.45 3.89 + .58
6.73 + 1.25 .64 + .55
41.83 + 3.02 1.26 + .80
8.00 + .53 .19 + .15
9.80 + .45 .79 + .58
25.40 + 5.86 4.42 + 1.76
4.27 + .99 1.71 + .93
50.93 + 4.49 .31 + .23
4.87 + .67 .81 + .53
5.23 .81 .05 + .04
Table 69: Dataset for bovine adrenalcortical culture Expt. I
(Phase II) (Means and standard deviations of adrenocortical
hormones (n=4»
Time
(hrs)
0
48
96
144
Treatment
Cortisol
(ng/ml)
No ACTH 37°C 38.93 + 10.53
Del. ACTH 160.60 + 52.75
ACTH 217.97 + 47.44
No ACTH 40°C 59.23 + 17.12
ACTH 104.87 + 40.60
No ACTH 37°C 49.53 + 8.29
Del. ACTH 128.27 + 30.97
ACTH 183.10 31.66
No ACTH 40°C 23.20 + 7.57
ACTH 61.37 + 58.60
No ACTH 37°C 57.97 + 11.43
Del. ACTH 135.76 + 16.14
ACTH 182.97 + 44.81
No ACTH 40°C 12.50 + 4.43
ACTH 73.23 + 41.74
No ACTH 37°C 41.07 + 19.85
Del. ACTH 101.87 + 23.05
ACTH 131.70 + 30.79
No ACTH 40°C 13.53 + 7.65
ACTH 41.43 + 35.15
Mean
Progesterone Aldosterone
(ng/ml) (ng/dl)
29.43 + 1.96 1.52 + 0.69
8.57 + 1.50 0.17 + 0.27
8.96 + 0.12 1.08 + 1.09
31.70 + 5.50 1.50 + 0.52
7.27 + 1.96 0.11 + 0.16
38.43 6.69 2.15 + 1.05
16.23 + 4.29 0.89 + 0.31
17.23 + 1.82 0.83 + 0.24
49.27 + 7.34 1.11 + 0.25
9.00 + 3.75 0.02 + 0.00
35.70 + 7.65 2.45 + 0.34
8.27 + 1.90 0.02 + 0.00
9.63 + 1.72 0.02 + 0.00
36.33 + 5.24 0.24 + 0.15
6.10 + 2.61 0.02 + 0.00
37.07 + 10.05 3.00 + 1.67
11.67 + 1.38 0.02 + 0.00
13.23 + 2.97 0.31 + 0.16
41.77 + 6.05 0.31 + 0.29
18.57 6.72 0.49 + 0.71
Table 69 Contd.: Dataset for bovine adrenocortical culture Expt. I
(Phase II) (Means and standard deviations of adreno­
cortical cortical hornones (n=4))
Tine
(hrs)
192
240
Treatment
Cortisol
(ng/ml)
No ACTH 37°C 43.30 + 24.14
Del. ACTH 102.50 + 15.06
ACTH 142.90 + 36.14
No ACTH 40°C 12.50 + 4.50
ACTH 62.67 + 43.06
No ACTH 37°C 47.50 + 32.43
Del. ACTH 80.57 + 22.16
ACTH 114.30 + 22.98
No ACTH 40°C 31.80 + 11.04
ACTH 76.00 + 60.50
Mean
Progesterone Aldosterone
(ng/ml) (ng/dl)
44.63 + 7.78 3.72 + 1.20
7.97 + 1.35 1.51 + 1.34
7.37 + 0.38 0.02 + 0.00
49.87 + 11.72 0.69 + 0.82
6.80 + 1.93 0.02 + 0.00
36.70 + 2.60 2.49 + 0.87
9.87 + 1.81 0.22 + 0.34
9.07 + 0.42 0.78 + 0.41
51.50 + 12.74 0.84 + 0.39
7.03 + 0.90 0.02 + 0.00
Table 70: Dataset for bovine adrenocortical culture Expt. II
(Means and standard deviations of adrenocortical hormones
(n=4))
Tine Treatment Mean
(hrs) Cortisol Progesterone Aldosterone
(ng/ml) (ng/ml) (ng/dl)
48
96
144
192
No ACTH 37°C 25.03 + 9.84 10.67 + 2.77 4.79 + 3.17
ACTH 67.00 + 30.91 8.27 3.11 5.22 + 1.86
Angiotensin II 23.83 + 8.82 12.50 + 4.95 3.99 + 2.77
No ACTH 40°C 11.67 + 3.71 11.10 + .92 3.10 + 1.64
ACTH 43.50 + 9.00 9.47 + 2.00 3.49 + .84
Angiotensin II 14.20 + 2.31 12.87 + 3.45 2.19 + 1.34
No ACTH 37°C 35.00 + 9.34 12.63 + 1.85 5.56 + 2.11
ACTH 67.80 + 15.42 11.37 + 3.67 5.99 + 2.93
Angiotensin.il 35.10 + 5.84 12.97 + 4.21 7.31 + 1.63
No ACTH 40°C 12.73 + 4.78 9.63 + .60 3.02 + .25
ACTH 28.60 + 13.66 10.30 + 2.11 2.18 + 1.75
Angiotensin II 14.50 + 2.78 10.87 + 3.07 2.74 + .27
No ACTH 37°C 23.87 + 8.35 9.33 + .12 4.49 + .92
ACTH 57.60 + 13.36 11.30 + 5.03 5.94 + 1.91
Angiotensin II 27.30 + 5.18 12.20 + 4.59 6.12 + .42
No ACTH 40°C 6.93 + 1.50 9.00 + .17 1.41 .96
ACTH 12.90 + 6.52 11.73 2.63 1.87 + .28
Angiotensin II 13.27 5.63 11.30 + 1.78 1.32 + .81
No ACTH 37°C 16.50 + 4.69 11.63 + 2.40 5.32 + .47
ACTH 56.30 + 5.63 12.93 + 4.70 6.39 + 1.48
Angiotensin II 25.20 + 7.60 12.10 + 3.99 6.44 + 1.48
No ACTH 40°C 7.07 + 2.74 8.87 + 1.59 .68 + .54
ACTH 13.40 + 5.57 12.80 + 1.59 1.88 + .66
Angiotensin II 7.93 + 2.00 7.23 + 3.71 .75 + 1.25
Table 70 contd.: Dataset for bovine adrenocortical culture Expt. II
(Hearts and standard deviations of adrenocortical
hormones (n=4))
Time
(hrs)
240
288
336
384
Treatment
Cortisol
(ng/ml)
No ACTH 37°C 17.07 + 6.91
ACTH 40.80 + 16.75
Angiotensin II 20.33 + 1.76
No ACTH 40°C 10.20 + 2.62
ACTH 12.67 + 2.78
Angiotensin II 12.63 + 5.00
No ACTH 37°C 9.60 + 4.17
ACTH 33.47 + 16.12
Angiotensin II 13.80 + 4.70
No ACTH 40°C 5.30 + .62
ACTH 4.73 + .06
Angiotensin II 6.63 + 3.18
No ACTH 37°C 20.47 + 8.41
ACTH 86.33 + 9.48
Angiotensin II 25.90 + 4.85
No ACTH 40°C 8.60 + 2.26
ACTH 26.90 + 3.12
Angiotensin II 11.80 + 1.99
No ACTH 37°C 68.30 + 5.99
ACTH 255.33 + 17.51
Angiotensin II 48.90 + 13.38
No ACTH 40°C 13.40 + 1.87
ACTH 67.47 + 26.95
Angiotensin II 14.03 + 7.24
Mean
Progesterone Aldosterone
(ng/ml) (ng/dl)
11.10 + 3.50 3.90 + .25
11.77 + 1.56 5.63 + .17
12.30 + 5.52 4.36 + .12
9.97 + 2.16 .74 + .25
11.03 + 1.62 1.64 + .62
9.17 + 1.78 .16 + .15
11.60 + 3.20 3.73 + 1.50
14.37 + 5.87 5.56 + 1.87
15.50 + 4.74 4.51 + .96
9.20 + 2.76 1.29 + 1.75
13.17 + 2.58 2.0B + .66
8.70 + .21 1.99 + 1.40
8.20 + 7.80 3.35 + 1.31
8.83 + 2.72 3.58 + 2.92
7.50 + 1.81 4.03 + 1.01
8.60 + .95 .62 + 1.05
10.10 + 1.31 1.88 + 1.35
11.23 + 2.64 1.02 + 1.73
9.33 + .74 7.87 + 3.20
8.93 + 3.66 8.51 + 2.68
10.57 + 2.17 6.11 + 3.06
10.03 + 3.15 .18 + .28
10.97 1.37 .02 + .00
15.90 + 3.90 .86 + 1.47
Table 70 contd.: Dataset for bovine adrenocortical culture Expt. II
(Keans and standard deviations of adrenocortical 
hornones (n=4))
Tine
(hrs)
432
480
528
576
Treatment
Cortisol
(ng/nl)
No ACTH 37°C 29.73 6.24
ACTH 177.60 + 29.31
Angiotensin II 25.47 8.74
No ACTH 40°C 4.70 + .69
ACTH 15.47 + 5.81
Angiotensin II 2.77 + .67
No ACTH 37°C 20.10 + 4.65
ACTH 85.20 + 13.95
Angiotensin II 21.97 + 6.50
No ACTH 40°C 11.53 + 4.27
ACTH 14.23 + 7.52
Angiotensin II 2.40 + .10
No ACTH 37°C 9.37 •f 2.56
ACTH 54.40 + 10.57
Angiotensin II 13.97 + 6.45
No ACTH 40°C 5.20 + .98
ACTH 13.27 + 8.31
Angiotensin II 8.80 + 10.05
No ACTH 37°C 10.77 + 3.54
ACTH 67.47 + 12.76
Angiotensin II 21.23 + 8.30
No ACTH 40°C 7.17 + 3.45
ACTH 12.87 9.38
Angiotensin I 6.93 + 2.77
Mean
Progesterone Aldosterone
(ng/nl) (ng/dl)
9.77 + .75 5.04 + 1.27
7.67 + 1.77 7.37 + 2.12
8.37 + 1.14 5.28 + 1.38
11.57 + .06 .55 + .92
11.63 + 1.40 .02 + .00
13.80 + 5.29 .02 + .00
12.19 + 4.08 4.72 + 1.52
10.76 + 3.44 6.51 2.16
8.23 + .35 4.19 + .75
9.57 + .90 .27 + .44
13.10 + .26 2.00 + 2.08
12.57 + 4.10 .11 + .16
12.03 + 4.70 2.49 + 1.80
11.77 + 3.94 7.06 + 2.28
10.23 + .49 3.58 + 1.43
13.80 + 1.56 .02 + .00
12.27 + 2.06 .18 + .28
11.93 + 4.31 .82 + 1.39
13.23 + 4.24 4.31 + .74
12.63 + 2.00 7.78 + 2.06
11.87 + .56 4.80 + .63
14.03 1.86 .61 + .55
12.17 + 2.94 .02 + .00
15.57 + 3.59 .02 + .00
Table 71: Dataset for bovine adrenocortical culture I U
(Means and standard deviations of adrenocortical hormones (n=4))
Time
(hrs)
Treatment Mean
48
Cortisol
(ng/ml)
Proges­
terone
(ng/ml)
Aldos­
terone
(ng/dl)
Corticos­
terone
(ng/dl)
No ACTH 37°C 61.33 + 6.29 71.95 + 8.64 16.78 + .88 325.00 + 20.49
ACTH 69.28 + 10.73 66.80 + 2.72 17.11 + 3.20 375.00 + 6.83
Angiotensin 
ACTH and
65.33 + 8.34 60.17 + 8.38 13.98 + 1.50 314.50 + 12.58
Angiotensin 70.55 + 5.05 75.25 + 7.53 17.12 + 2.86 314.00 + 18.62
Dexamethasone 72.93 + 9.89 76.37 + 2.22 18.08 2.37 356.50 + 26.55
No ACTH 40°C 727.28 + 69.87 86.01 + 10.65 11.87 + 5.75 435.00 + 34.00
ACTH 403.77 + 334.28 95.52 + 18.18 8.63 + 1.43 356.00 + 94.57
Angiotensin 
ACTH and
348.03 + 291.83 93.85 + 21.09 7.92 + .92 335.00 + 135.86
Angiotensin 412.28 + 382.20 96.01 + 26.36 8.10 + .90 502.00 50.52
Dexame thasone 611.51 + 149.43 117.95 + 26.18 10.40 + 1.84 342.67 + 23.09
No ACTH 37°C 102.37 + 48.20 19.28 + 7.68 18.05 + 4.47 320.75 + 161.85
ACTH 660.32 + 249.57 5.29 + .71 18.30 + 2.82 201.79 + 59.41
Angiotensin 
ACTH and
178.83 + 64.61 9.60 + 2.07 23.43 + 8.08 213.53 + 16.53
Angiotensin 572.63 + 57.57 6.00 + .46 23.43 + 2.12 283.53 + 98.25
Dexamethasone 80.42 + 40.48 19.81 + 9.58 14.93 + 3.37 196.66 + 119.01
No ACTH 40°C 235.38 + 52.75 46.76 + 14.72 8.70 + 1.22 390.70 + 92.27
ACTH 696.35 + 154.29 7.25 + 3.00 7.52 + 2.32 350.06 + 226.63
Angiotensin 
ACTH and
371.08 + 169.71 21.28 + 10.42 8.65 2.75 448.17 + 300.86
Angiotensin 834.99 + 195.07 7.79 + 4.23 8.55 + 3.31 354.83 + 246.93
Dexamethasone 320.98 + 17.76 30.86 + 10.86 7.60 + 1.41 360.01 + 96.99
Table 71 contd.: Dataset for bovine adrenocortical culture H I
(Means and standard deviations of adrenocortical hormones (n=4))
Time
(hrs)
96
Treatment Mean
144
Cortisol
(ng/nl)
Proges­
terone
(ng/ml)
Aldos­
terone
(ng/dl)
Corticos­
terone
(ng/dl)
No ACTH 37°C 46.86 + 2.62 6.60 + 1.39 6.20 + 2.46 141.14 + 30.55
ACTH 282.74 + 111.31 4.66 + .53 7.80 + 1.04 176.98 + 43.38
Angiotensin 
ACTH and
22.43 + 4.79 6.01 + 1.22 6.22 + .74 111.08 + 14.27
Angiotensin 180.80 + 36.09 6.25 + .70 7.05 4- 1.13 201.45 + 22.69
Dexamethasone 436.22 + 14.62 4.55 + .66 7.38 + 1.42 127.27 + 49.30
No ACTH 40°C 66.45 + 44.14 26.22 + 16.47 .85 + .54 143.41 + 46.67
ACTH 451.08 + 108.32 4.28 + .89 .93 + .33 141.55 + 20.28
Angiotensin 
ACTS and
52.00 + 10.36 12.15 + 3.34 .90 + .36 128.41 + 26.76
Angiotensin 331.44 + 73.31 4.25 + .65 1.18 + .56 137.31 + 35.24
Dexamethasone 741.30 + 102.65 3.37 + .42 .80 + .35 111.65 + 24.40
No ACTH 37°C 43.09 + 5.60 3.59 + .47 1.60 + .77 157.27 + 67.90
ACTH 193.80 + 4.45 3.12 + .67 1.08 + .22 165.53 + 45.08
Angiotensin 
ACTH and
21.53 + 2.32 3.63 + .02 1.33 + .46 117.57 + 13.55
Angiotensin 154.62 + 19.58 3.41 + .21 1.93 + .81 207.06 + 37.01
Dexamethasone 277.22 + 69.84 3.10 + .20 1.97 + .45 176.76 + 36.07
No ACTH 40°C 53.66 + 17.96 7.12 + 1.97 .57 + .10 128.78 + 18.77
ACTH 394.71 + 153.61 3.74 + .52 .44 + .25 114.77 + 10.72
Angiotensin 
ACTH and
31.29 + 9.53 6.99 + 1.85 .26 + .28 115.94 + 22.77
Angiotensin 244.37 + 49.96 3.43 + .15 .38 + .37 132.45 + 22.79
Dexamethasone 486.33 + 46.77 3.12 + .36 .53 + .34 137.78 + 11.26
Table 71 contd.: Dataset for bovine adrenocortical culture TTT
(Means and standard deviations of adrenocortical hormones (n=4))
Tine
(hrs)
192
Treatment
240
Cortisol
(ng/nl)
Mean
Proges­
terone
(ng/nl)
Aldos­
terone
(ng/dl)
Corticos­
terone
(ng/dl)
No ACTH 37°C 42.63 + 16.07 3.30 + .31 .53 + .15 146.05 + 17.43
ACTH 152.10 + 26.57 2.77 + .26 .18 + .10 144.60 + 20.72
Angiotensin 
ACTH and
14.64 + 4.96 3.04 + .19 .18 + .05 110.09 7.42
Angiotensin 98.21 + 30.55 2.95 + .34 .63 + .43 160.84 + 7.77
Dexamethasone 234.04 + 51.64 2.36 + .18 .48 .13 151.09 + 6.32
No ACTH 40°C 38.73 + 9.18 4.25 + 1.15 .04 + .02 134.78 + 9.34
ACTH 247.61 + 86.09 2.33 + .39 .02 + .00 122.37 + 36.70
Angiotensin 
ACTH and
18.82 + 4.01 4.49 + 1.74 .02 + .00 104.59 + 11.74
Angiotensin 203.86 + 101.28 2.94 + .33 .02 + .00 155.50 + 24.71
Dexamethasone 317.42 + 82.48 2.74 + .43 .06 + .04 143.95 + 24.95
No ACTH 37°C 26.53 + 3.25 3.82 + .45 .09 + .14 142.83 + 14.19
ACTH 115.06 + 36.12 3.05 + .15 .11 + .10 138.38 + 18.01
Angiotensin 
ACTH and
80.55 + 11.74 3.21 + .36 .11 + .19 123.43 + 12.52
Angiotensin 71.55 + 17.33 3.08 + .36 .38 .40 155.51 + 23.13
Dexamethasone 161.12 + 42.52 2.57 + .20 .19 + .22 153.55 + 12.21
No ACTH 40°C 32.89 + 3.30 4.22 + .54 .19 + .34 151.10 + 20.91
ACTH 177.79 + 59.53 2.41 + .24 .02 + .00 135.73 + 10.97
Angiotensin 
ACTH and
130.39 + 56.70 2.39 + .35 .02 + .00 107.88 + 26.18
Angiotensin 136.54 + 59.20 2.65 + .22 .02 + .00 168.10 + 36.51
Dexamethasone 281.52 + 75.75 2.40 + .17 .03 + .02 152.10 + 4.57
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Table 72: Dataset for bovine adrenocortical culture Expt. IV
(Means and standard deviations of adrenalcortical hormones 
(n=4))
Time
(hrs)
Treatment
Cortisol
(ng/al)
Mean
Androstenedione
(ng/ml)
96
No ACTH 37°C 105.24 + 6.12 14.76 + 6.44
ACTH 99.79 + 11.66 9.73 + 4.94
Angiotensin 95.06 + 5.84 11.48 + 1.06
ACTH and
Angiotensin 100.90 + 5.93 8.33 + 3.31
No ACTH 40°C 113.18 + 6.12 9.06 + 0.82
ACTH 110.29 + 6.31 3.41 + 1.09
Angiotensin 112.91 + 5.99 8.78 + 2.88
ACTH and
Angiotensin 102.61 + 11.98 4.57 + 1.37
No ACTH 37°C 39.62 + 5.57 23.69 + 4.75
ACTH 50.51 + 8.60 25.54 ± !-59
Angiotensin 45.63 + 7.84 30.60 + 0.86
ACTH and
Angiotensin 52.43 + 4.10 28.30 + 6.96
No ACTH 40°C 42.20 + 5.75 14.47 + 5.41
ACTH 41.64 + 3.23 23.48 + 1.53
Angiotensin 35.65 + 0.46 27.66 ± 2-67
ACTH and
Angiotensin 44.40 + 1.80 29.92 + 5.10
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Table 73: Dataset for bovine adrenocortical culture Expt. V
(Keans and standard deviations of adrenocortical hormones
(n=4))
Time Treatment Kean
(hrs) Cortisol Aldosterone
48
96
(ng/ml) (ng/dl)
No Arginine,
ACTH or Angio­
tensin 37°C 19.25 + 6.32 4.81 + 4.20
Arginine 29.50 + 13.80 56.69 + 21.91
Arginine and
ACTH 544.17 + 275.84 70.45 + 24.05
Arginine, ACTH
and Angiotensin 528.12 + 98.28 60.94 + 5.99
No Arginine,
ACTH or Angio­
tensin 40°C 56.59 + 5.96 14.64 + 3.15
Arginine 62.44 + 5.22 13.24 + 3.15
Arginine and
ACTH 726.59 + 92.73 22.30 + 2.46
Arginine, ACTH
and Angiotensin 708.89 + 75.06 28.07 + 3.99
No Arginine,
ACTH or Angio­
tensin 37°C 3.00 + 2.67 3.00 + 2.67
Arginine 5.83 7 4.83 5.83 + 4.83
Arginine and
ACTH 130.55 + 128.86 5.18 + 5.16
Arginine, ACTH
and Angiotensin 83.69 + 37.38 4.69 + 2.72
No Arginine,
ACTH or Angio­
tensin 40°C 2.97 + 1.65 • 02 + .00
Arginine 9.31 + 5.99 .12 7 .00
Arginine and
ACTH 120.24 + 72.43 .24 + .45
Arginine, ACTH
and Angiotensin 213.65 + 73.70 . 89 + .69
Table 73 Contd.: Dataset for bovine adrenocortical culture Expt. V
(Means and standard deviations of adrenocortical
horaones (n=4))
Time Treatment Mean
(brs) Cortisol Aldosterone
(ng/ml) (ng/dl)
144 No Arginine,
ACTH or Angio­
tensin 37°C 0.93 + .47 .02 + .00
Arginine 0.90 .38 .02 + .00
Arginine and
ACTH 5.45 + 6.08 .02 + .00
Arginine, ACTH
and Angiotensin 3.77 + 2.10 .02 + .00
No Arginine,
ACTH or Angio­
tensin 40°C 0.65 + .43 .02 + .00
Arginine 0.74 + .17 .02 + .00
Arginine and
ACTH 3.64 + 2.54 .02 + .00
Arginine, ACTH
and Angiotensin 10.80 + 4.93 .02 + .00
207
Table f: Dataset for bovine adrenocortical culture VI (Means and
standard deviations of adrenocortical hormones (n=4))
Time Treatment Mean
(hrs) Cortisol
48
96
144
(tig/ml)
No LDL or ACTH 37°C 23.38 + 1.81
LDL 33.20 + 3.80
ACTH 341.14 + 124.62
ACTH and LDL 710.61 + 73.03
No LDL or ACTH 40°C 54.07 + 10.88
LDL 76.18 + 7.57
ACTH 651.85 + 67.37
ACTH and LDL 800.79 + 84.94
No LDL or ACTH 37°C 4.40 + .41
LDL 10.00 + 1.45
ACTH 13.68 ± 2.94
ACTH and LDL 347.22 + 40.22
No LDL or ACTH 40°C 24.32 + 2.28
LDL 7.49 1.18
ACTH 38.62 + 6.51
ACTH and LDL 131.47 + 30.71
No LDL or ACTH 37°C 0.64 + 0.03
LDL 16.21 + 12.85
ACTH 11.15 + 20.42
ACTH and LDL 28.61 + 6.29
No LDL or ACTH 40°C 2.06 + 0.96
LDL 5.51 + 0.60
ACTH 2.97 + 1.28
ACTH and LDL 8.89 + 1.77
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Table 75: Dataset for granulosa cell culture Trial I.
Estradiol means (n=4) and standard deviations
(pg/ml)
Temperature
Days Hedia 37°C 40°(
3 A 64,17 + 50.09 53.17 + 34.67
5 A 12.50 + 5.40 22.33 + 4.97
7 A 16.67 + 5.99 27.00 + 3.41
9 A 28.60 + 9.61 30.83 + 8.52
11 A 11.60 + 1.82 11.83 + 5.85
13 A 4.40 + 3.13 8.33 + 4.13
15 A 1.16 2.85 1.17 + 1.17
19 A 0 + 0 0 + 0
3 B 597.83 + 254.36 918.83 + 489.71
5 B 271.33 + 135.66 597.17 + 292.18
7 B 177.67 + 59.92 484.83 + 350.25
9 B 188.50 + 57.79 438.67 + 168.72
11 B 140.50 + 18.68 158.83 ■f 41.37
13 B 61.67 + 10.44 38.17 + 14.33
15 B 41.17 + 11.34 16.00 + 4.84
19 B 82.00 + 12.71 28.67 + 15.31
3 C 347.67 + 118.07 473.83 + 240.19
5 C 104.83 + 7.19 319.67 + 208.64
7 C 123.17 + 17.44 712.83 + 527.14
9 C 293.70 ± 110.45 1199.17 + 579.14
11 C 190.00 + 45.30 558.00 + 287.32
13 c 56.67 + 13.54 56.50 4* 21.68
15 c 42.33 + 10.13 18.40 + 2.70
19 c 133.33 + 20.58 39.67 + 4.16
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Table 76: Dataset for granulosa cell culture Trial 1.
Progesterone means (n=4) and standard deviations
(ng/ml)
Temperature 
Days Media 37°C 40°C
3 A 31.27 + 10.40 39.60 + 14.40
5 A 34.00 + 4.36 51.33 1.46
7 A 27.53 + 5.09 84.83 + 8.64
9 A 41.80 +. 4.24 90.27 + 7.35
11 A 70.10 + 0.28 97.10 + 3.20
13 A 52.00 + 0.14 67.43 + 5.42
15 A 65.95 + 5.59 72.73 ■f* 5.60
19 A 78.03 + 9.25 60.20 + 6.00
3 B 13.17 + 1.53 15.55 4* 5.30
5 B 42.67 + 1.53 62.50 + 4.95
7 B 57.27 + 3.15 101.85 4* 5.30
9 B 61.93 + 7.34 112.75 + 2.05
11 B 61.97 + 3.61 93.30 4- 6.65
13 B 52.10 + 2.84 54.55 + 10.39
15 B 64.50 + 6.10 56.40 4- 7.21
19 B 78.03 + 9.25 57.35 + 0.21
3 C 13.83 + 0.80 44.17 4- 0.80
5 C 34.33 + 4.51 76.00 + 1.73
7 C 51.10 + 2.42 145.67 + 3.37
9 C 73.63 + 8.93 182.83 + 19.31
11 C 60.73 + 3.55 124.30 + 6.31
13 C 49.77 + 4.36 76.53 + 4.86
15 C 59.13 + 1.46 71.53 + 2.15
19 c 99.53 + 3.30 80.83 4- 7.84
Table 77: Dataset for bovine granulosa cell culture Trial II.
Estradiol means (n=4) and standard deviations (pg/ml)
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Temperature
Days Media 37°C 40°C
3 A 33.33 + 9.50 -40.67 + 1.15
5 A 27.00 + 5.29 28.67 + 3.78
7 A 4.00 + 1.00 4.67 + 2.08
9 A 15.67 + 6.43 11.33 + 1.53
11 A 4.33 + .57 7.00 + 4.36
13 A - —
15 A — —
17 A — —
19 A - —
21 A _ —
Temperature
Days Hedia 37 C o QC
3 B 571.00 + 18.03 882.67 + 101.28
5 B 59.00 + 9.55 66.00 + 5.00
7 B 26.00 + 5.29 43.00 + 3.46
9 B 84.33 + 12.10 65.33 + 4.93
11 B 202.33 + 22.28 30.67 + 14.34
13 B 190.00 + 24.86 18.67 + 5.51
15 B 116.00 + 5.00 28.00 + 5.57
17 B 60.67 + 9.09 28.66 + 4.04
19 B 41.67 + 9.02 6.66 + .58
21 B 20.66 + 8.62 10.33 + 2.89
Temperature
Days Hedia 37 C 40 C
3 C 639.33 + 45.00 771.00 + 64.09
5 C 69.33 + 9.29 70.33 + 5.13
7 C 43.00 + 6.55 54.67 + 6.66
9 c 121.67 + 10.26 76.33 + 2.08
11 c 255.00 + 17.35 58.66 + 2.08
13 c 162.00 + 27.62 12.66 + 3.51
15 c 110.33 + 11.50 16.00 + 7.94
17 c 76.67 + 13.78 9.33 + 6.35
19 c 64.66 + 5.69 2.33 + 2.52
21 c 47.00 + 7.55 5.66 + 2.08
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Table 78: Dataset for bovine granulosa cell culture Trial II.
Progesterone Beans (n=4) and standard deviations
(ng/ml)
Temperature 
Days Media 37°C 40°C
3 A 3.93 + 5.95 .40 + .43
5 A 5.43 + 7.77 .33 + .29
7 A 15.30 + 23.39 .20 + .00
9 A 29.57 + 45.28 3.90 + 6.49
11 A 63.70 + 98.62 11.00 + 11.53
13 A 105.66 + 147.96 17.33 + 15.50
15 A 84.67 + 98.22 20.67 + 20.31
17 A 78.00 + 89.44 14.67 + 11.72
19 A 84.67 + 92.61 13.67 + 9.86
21 A 76.00 + 69.20 9.67 + 6.35
23 A 65.00 + 58.85 9.67 + 6.35
Days Hedia
Temperature 
37°C 40°C
3 B 3.23 + 1.70 19.47 + 2.99
5 B 7.50 + 3.27 78.87 + 3.20
7 B 22.73 ± 6.81 170.16 + 12.47
9 B 114.83 + 14.61 330.03 + 34.96
11 B 281.33 + 25.38 368.00 + 28.84
13 B 333.33 + 41.36 326.67 + 13.05
15 B 292.00 + 22.27 218.00 + 8.54
17 B 194.33 + 20.50 120.33 + 20.50
19 B 169.00 + 7.00 76.66 + 5.51
21 B 111.00 18.52 35.00 + 2.64
23 B 100.67 + 12.58 32.67 + 2.32
Days Hedia
Temperature 
37°C 40°C
3 C 6.26 + 5.80 18.37 + 8.54
5 C 14.07 + 8.26 89.86 + 25.27
7 C 50.83 + 14.27 187.87 + 29.29
9 C 164.60 + 20.05 364.73 + 31.06
11 c 325.33 + 15.94 402.33 + 29.84
13 c 353.67 + 33.53 341.00 + 19.15
15 c 306.33 + 21.39 216.00 + 7.00
17 c 256.67 + 25.74 136.67 + 4.04
19 c 276.00 + 8.54 119.67 + 4.50
21 c 216.67 + 10.50 93.00 + 3.60
23 c 190.67 + 14.22 75.00 + 2.64
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Table 79: Dataset for bovine granulosa cell culture Trial III.
Estradiol means (n=4) and standard deviations (pg/ml)
Temperature
Days Media 37°C 40°C
1 A 30.33 33.67
3 A 0.00 0.00
5 A 0.00 0.00
7 A 0.00 1.67
9 A 0.00 0.00
11 A 0.00 0.00
13 A 0.00 0.00
16 A 0.00 0.00
19 A 0.00 0.00
22 A 0.00 0.00
25 A 0.00 0.00
1 B 146.00 152.67
3 B 41.33 47,67
5 B 39.00 50.00
7 B 33.67 41.00
9 B 0.00 2.00
11 B 18.00 28.33
13 B 26.33 16.00
16 B 40.00 18.00
19 B 56.67 40.00
22 B 45.33 5.00
25 B 36.67 0.00
1 C 126.00 130.33
3 C 11.67 20.33
5 C 18.67 23.67
7 c 10.00 19.33
9 c 5.00 3.67
11 c 46.67 28.33
13 c 52.33 23.33
16 c 69.00 20.00
19 c 89.33 38.33
22 c 89.33 10.00
25 c 77.67 8.00
Table 80: Dataset for bovine granulosa cell culture Trial III.
Progesterone Beans and standard deviations (ng/ml)
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Temperature
Days Hedia 37°C
ACHuci.ai ic
40°C
1 A 0.00 0.00
3 A 3.57 2.43
5 A 4.97 2.60
9 A 13.33 3.93
11 A 35.83 11.50
16 A 75.13 43.40
19 A 86.96 70.57
22 A 183.33 201.67
25 A 198.00 222.00
1 B 0.00 —
3 B 0.10 1.23
5 B 1.03 2.30
9 B 3.93 13.17
11 B 5.63 _
16 B 38.00 —
19 B 48.07 —
22 B 134.33 —
25 B 139.00 _
1 C 0.00 0.00
3 C 0.17 2.00
5 C 1.33 4.30
9 C 6.43 13.33
11 C 22.23 41.73
16 C 65.83 61.40
19 C 78.97 67.50
22 C 191.67 127.67
25 C 175.33 127.00
Table 83: Dataset for bovine granulosa cell culture Trial IT (synchronized cows). Estradiol
means (n=4) and standard deviations
Day
Cov
538
Estradiol
Cov
719
Estradiol
Cov
487
Estradiol
„ (pg/al) (pg/ml) . (pg/ml)
37 C 40 C 37 C 40 C 37 C 40 *C
1 1.00 + 1.73 0 80.67 + 11.02 74.67 + 5.82 33.67 + 16.44 24.33 + 13.43
3 0 0 0 0 0 0
5 9.67 + 6.67 8.00 + 6.08 11.33 + 6.80 9.67 + 5.51 4.67 + 2.52 13.33 + 6.51
7 6.00 + 6.00 9.00 + 4.00 3.33 + 1.15 5.33 + 2.08 7.33 + 3.21 7.00 + 3.00
9 2.67 + 2.34 12.53 + 8.66 3.50 + 2.60 3.40 + 2.08 1.13 + 0.06 8.77 + 5.17
11 1.80 + 3.12 1.40 + 2.42 0.46 + 0.81 0.33 + 0.57 1.97 + 0.61 0
13 2.33 + 1.53 0 0 1.33 + 1.53 0.67 + 1.15 0.67 + 1.15
15 6.67 + 5.14 0 0.67 + 1.15 0 2.00 + 3.46 0
17 71.67 + 7.64 76.67 + 28.18 40.00 + 8.54 72.67 + 10.02 74.67 + 15.63 72.33 + 39.70
19 63.33 + 8.50 63.00 + 30.45 68.67 + 8.50 68.33 + 8.50 100.67 + 16.77 77.67 + 18.51
21 77.00 + 5.20 72.33 + 19.22 41.33 7 10.69 56.67 + 13.65 64.67 + 16.65 58.00 + 28.58
23 83.00 + 15.56 54.00 + 4.24 50.50 + 7.78 55.00 + 0.00 67.00 + 14.14 53.00 + 2.83
ro
-p*
Table 84: Dataset for bovine granulosa cell culture Trial IV (synchronized covs). Progesterone
means (n=4) and standard deviations
Cov Cov Cov
538 719 487
Day Progesterone Progesterone Progesterone
A (ng/ml) (ng/ml) (ng/ml)
37 C 40 C 37°C 40 C 37*Jc 40 C
1 2.23 + 1.38 3.40 + 2.05 43.06 + 0.06 0.50 + 0.00 0.23 + 0.06 0.19 + 0.01
3 3.67 + 4.01 7.60 + 6.87 0.27 + 0.06 0.27 + 0.12 0.20 + 0.00 0.34 + 0.10
5 2.90 + 3.12 15.67 + 10.22 0.23 + 0.06 1.10 + 0.61 0.33 + 0.06 0.97 + 0.42
7 4.10 + 4.50 30.37 + 15.48 0.27 + 0.06 4.27 + 1.80 0.20 + 0.10 1.87 + 0.95
9 13.20 +■ 12.04 66.73 + 21.66 3.00 + 0.26 14.23 + 5.30 0.83 + 0.35 7.07 + 3.91
11 32.20 + 18.00 82.17 + 21.11 11.79 + 1.29 27.93 + 7.12 6.03 + 2.87 13.92 + 7.94
13 66.73 + 30.54 152.20 + 37.24 23.27 + 2.99 49.10 + 10.16 17.70 ± 5.52 31.40 + 17.32
15 95.33 + 30.37 157.33 + 34.59 21.67 + 3.51 41.33 + 9.29 25.00 + 14.73 26.00 + 13.08
17 94.67 + 14.19 82.00 + 15.00 43.33 + 6.66 29.33 + 3.06 51.67 + 8.50 32.00 + 12.29
19 103.33 + 5.13 89.66 + 17.21 61.67 + 10.07 26.67 + 4.16 73.00 + 6.93 27.33 + 17.62
21 159.00 + 34.64 131.87 + 32.56 62.27 + 9.58 22.77 + 4.90 97.13 + 22.70 26.53 + 1.98
23 135.80 + 28.86 99.73 + 38.03 68.76 + 10.79 16.33 + 2.17 83.33 + 6.21 24.47 + 20.51
ro
tn
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